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We are approaching meaningful incorporation of in silico whole-cell modelling approaches and in 
vivo custom genome design. The whole-cell model of Mycoplasma genitalium, published in 2012, 
has permitted investigation into the organism’s metabolism and genome that has been impossible in 
vivo. The ongoing development of a whole-cell model for Escherichia coli, a well-annotated model 
organism, has presented us with the opportunity to test in silico predictions from a whole-cell model 
in vivo for the first time. 
In this thesis, I investigate in silico predictions made by both the M. genitalium and the E. coli whole-
cell models. Through gene ontology term analysis of eight minimal gene sets found in the literature, I 
identified the biological functions that M. genitalium cells can dispense with in silico to produce 
dividing cells. My results clarify which biological functions should be included in any minimal gene 
set for M. genitalium. I investigated the results of 1214 single gene knockouts in the E. coli whole-
cell model and compared these results with the assessment of essentiality in the Keio collection. At 
least 68.8% of knockouts agreed with the Keio collection over two generations, indicating the E. coli 
whole-cell model can predict gene essentiality with some accuracy. I also identify ways to develop 
the model to improve predictions. I prepared to use the no-SCAR system of genomic engineering in 
our laboratories to perform a proof-of-concept deletion in E. coli and enable in vivo investigation of 
E. coli whole-cell model predictions. I then worked with the Covert Lab, Stanford, to continue to 
develop the E. coli whole-cell model, curating data on the thiosulfate sulfurtransferase reaction and 
Lrp transcriptional regulation from the literature. 
Despite interruptions caused by the Covid-19 pandemic, the work reported in this thesis represents 
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Chapter 1 – Introduction 
1.1 - Statement of Collaboration  
Elements of work presented in this thesis have been published in Current Opinion in Systems Biology 
and are under review for potential publication in ACS Synthetic Biology. Any work included in this 
thesis is solely my contribution to these publications. I indicate where I use scripts or data produced 
by others. 
• Rees-Garbutt, J., Rightmyer, J., Karr, J. R., Grierson, C., & Marucci, L. (2020a). Furthering 
genome design using models and algorithms. Current Opinion in Systems Biology, 24, 120–
126.  
o Second author 
 
• Rees-Garbutt, J., Rightmyer, J., Chalkley, O., Marucci, L., & Grierson, C. (2020b). Testing 
theoretical minimal genomes using whole-cell models. BioRxiv, 2020.03.26.010363.  
o Second author 
1.2 - Current genome engineering 
Genetic engineering is the deliberate modification of the characteristics of an organism by 
manipulating its genetic material. Genome engineering is genetic engineering applied to genomes 
(Carr & Church, 2009). The process of genome design, whereby the desired genetic modifications are 
selected and tested subsequently in vivo (Haimovich et al., 2015) is time-consuming and expensive 
due to the limitations of current techniques and the inability to backtrack (Rees-Garbutt et al., 
2020c). Implementing processes to test the design of genomes in silico before conducting in vivo 
editing would incur fewer time and monetary costs than in vivo research alone and is therefore 
desirable. 
The publication of whole-cell models (WCMs) (Karr et al., 2012; Macklin et al., 2020) and the 
development of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-
associated (Cas) technology (Jinek et al., 2012; Jiang et al., 2013), when coupled with genome design 
algorithms (Rees-Garbutt et al., 2020c) present us with the opportunity to combine in silico design 
and in vivo editing and begin to design genomes using these components. Due to the difficulty of 
working with Mycoplasma genitalium (M. genitalium) in the laboratory (Hutchison et al., 2016), the 
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development of the Escherichia coli (E. coli) WCM will allow in vivo investigation of WCM predictions 
as E. coli is easily handled in the laboratory (Blount, 2015).  
Genome minimisation has been used as a proof-of-concept of genome engineering and design as it 
provides a simple functional assay whether the cell replicates or not (Rancati et al., 2018; Rees-
Garbutt et al., 2020c). Minimal genomes, cells containing only genes essential for survival (Glass et 
al., 2017), have been proposed for M. genitalium and E. coli (Hutchison et al., 1999; Yang et al., 
2019). As the simplest iteration of genome design, it may be possible to combine the technologies of 
WCMs, CRISPR-Cas9, and genome design algorithms to accelerate the design and production of 
organisms with minimal genomes.  
1.3 - Genome-scale metabolic models and whole-cell models  
Genome-scale metabolic models (GEMs) are in silico representations of a cell’s metabolism and are 
formed from networks of metabolic reactions that contain all metabolites and genes encoding 
enzymes involved in metabolism (Price et al., 2004). The overarching aims of this research are 
multifaceted, with goals including better understanding of cellular processes by comparing 
experimental data to model predictions, guided and systematic manipulation of organisms at the 
genome level, and elucidation of uncharacterised processes and genes (McCloskey et al., 2013). 
GEMs are built by integrating biochemical metabolic pathways with annotated genome sequences, 
using information on enzymes, genes, reactions, pathways, and metabolites. Reconstructions of 
GEMs, using the elements mentioned above, were initially performed manually (Oberhardt et al., 
2009). However, now there are tools that allow for semi-automatic assembly of reconstructions, 
including Pathway Tools for building models from the online database, EcoCyc. These tools include 
AutoKEGGRec, AuReMe, CarveMe, MetaDraft, and RAVEN amongst many others (Karlsen et al., 
2018; Aite et al., 2018; Machado et al., 2018; Hanemaaijer et al., 2017; Wang et al., 2018). These are 
comprehensively reviewed by Mendoza et al. (2019). GEMs are invaluable for cell biologists, giving a 
means of visualising how metabolism in a cell functions and providing predictive capabilities for 
metabolic network responses to varying conditions such as altered substrate concentration, gene 
knockouts, and synthetic lethality (McCloskey et al., 2013). It is possible to simulate the effects of 
manipulating metabolism within the in silico model, for example via Flux Balance Analysis (FBA) 
(Varma & Palsson, 1994). FBA permits the customised direction of the proportion of flux through 
different metabolic pathways, and as such provides a solution space where one can visualise the 
effects of scaling up or scaling down certain metabolic reactions on processes such as metabolite 
concentrations and cell growth (Orth et al., 2010). In essence, gene modifications act as the input in 
this system, with the altered flux distribution as the output (Landon et al., 2019).  
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Until researchers began attempts to construct a WCM, GEMs served as the most complete way to 
computationally visualise cellular processes, permitting in silico research concerning metabolite 
optimisation, gene essentiality, and wild-type cell behaviour in 78 bacterial species (Oberhardt et al., 
2009; UCSD, 2018). GEMs have also inspired early development of more detailed extended models 
that take transcription processes into account, as well as macromolecular expression models (ME-
models), which integrate macromolecular synthesis reactions alongside metabolic reactions, 
producing models with even greater fidelity to living cells (Ma et al., 2017).  The above types of 
model are of great importance, with submodels utilising FBA, for example, providing some of the 
building blocks for the first WCM (Karr et al., 2012). However, as this thesis is about using WCMs, I 
will mostly focus on those. 
Since the creation of the first GEM for Haemophilus influenzae (Edwards & Palsson, 1999), the field 
of genome modelling has seen vast progression. WCMs are computational models which utilise 
mathematical integration of either cellular parameter values (Macklin et al., 2020) or submodels 
(Karr et al., 2012) to simulate the life cycle of an entire cell. WCMs are also capable of modelling 
individual molecules and interactions, including the function of all gene products in the cell (Landon 
et al., 2019). Their creation has been revolutionary for in silico cellular research, facilitating extensive 
comparison of the literature against itself (Macklin et al., 2020) as well as allowing research to be 
carried out which is either too expensive or simply unfeasible in vivo (Waltemath & Wolkenhauer, 
2016). Two WCMs have been published: M. genitalium (Karr et al., 2012) and E. coli (Macklin et al., 
2020) (Figure 1.1). WCMs for Mycoplasma pneumoniae (M. pneumoniae), H1 human embryonic 
stem cell, and an archetypal bacterium remain in development (Whole-Cell Modeling; 
URL: https://www.wholecell.org/models/). Of the extant WCMs, M. genitalium has 100% of well-
annotated genes modelled (401 of 525 genes) (Karr et al., 2012), while E. coli has 43% of well-
annotated genes modelled (1214 of 4401 genes) (Macklin et al., 2020). Remaining genes consist of 
genes of unknown function and, in the case of the E. coli WCM, genes yet to be implemented at the 
time of writing. Despite not having all well-annotated genes implemented, the E. coli WCM 
represents a vital progression in WCM creation, comprising of tenfold more parameter values than 
the M. genitalium WCM, and completing simulations in a fraction of the time while including 50 
times the number of molecules as its predecessor (Macklin et al., 2020). The M. genitalium WCM has 
also permitted the discovery of novel in silico minimal genomes, including the most reduced genome 
to date (Rees-Garbutt et al., 2020c), a feat which could be replicated, and experimentally verified, 
when the E. coli WCM is complete. Custom genome design of a genome-reduced industrially useful 




Figure 1.1. The two extant whole-cell models (WCMs) and some of their defining features (adapted 
from Rees-Garbutt et al., 2020a). 
To achieve genome-driven engineering of cells, it is necessary to marry metabolic and genomic 
engineering to control a large proportion of cellular processes, enacting change in both specific 
metabolite yields and in the genome of the cell (Landon et al., 2019). As WCMs represent an in silico 
medium for modelling metabolism as well as cellular behaviour in response to genetic alterations, 
they provide a unique solution to streamline the production of genome-engineered cells. The E. coli 
WCM will permit the first attempts to engineer genomes in vivo with strategy informed by in silico 
WCM simulations, reducing the trial-and-error nature of the work, saving researchers time and 
money. 
1.4 - Using whole-cell models 
To understand the research presented in this thesis, it is necessary to provide some background 
information about WCMs including how they function and how they can be interacted with to 
produce useful data. The M. genitalium WCM functions by the integration of 28 submodels that are 
responsible for cellular processes such as metabolism and transcription and are mathematically 
modelled (Karr et al., 2012). The model is run by using an algorithm that takes randomly initialised 
cell variables, which represent the complete configuration of the cell, and allocate them among the 
28 submodels. These submodels then operate for one second before the cell variables are updated 
repeatedly until the cell divides or the maximum simulation time (13.89 hours) is reached (Karr et 
al., 2012). The E. coli WCM is constructed from unified datasets defining cell parameters such as the 
numbers and types of RNA and protein molecules, upon which 19 algorithms comprising over 10,000 
mathematical equations are run to simulate a cell growing and dividing (Macklin et al., 2020). 
Macklin et al. (2020) analogise this process to the numerical integration of ordinary differential 
equations (ODEs), where the cellular states are analogous to the ODE state variables and the cellular 
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processes are analogous to the differential equations. In both WCMs growth is predicted by the 
continued feedback of the results of equations within biologically feasible bounds, which when met 
cause the cell to divide.  
As WCMs can model genes in their genomic context, it is possible to use them to construct and test 
potential minimal gene sets, whereby genes are removed to form a proposed genome that cannot 
have any more genes removed from it without incurring loss of viability (Glass et al., 2017). These 
gene sets have previously been proposed through protocell design (Tomita et al., 1999), comparative 
genomics (Huang et al., 2013), and single gene knockout studies (Karr et al., 2012). Gene sets are 
quantified by combining candidate genes identified in these studies into comprehensive groups 
capable of accounting for all essential genes within a cell. Minimal genomes have also been 
proposed by running genetic algorithms GAMA and Minesweeper on the M. genitalium WCM (Rees-
Garbutt et al., 2020c). These algorithms select possible non-essential gene deletions before 
simulating the genome of M. genitalium without those genes and then analyse the resulting cell to 
check for viability. Simulations that produce dividing cells proceed to the next cycle, progressively 
increasing the number of genes deleted. This has allowed the automated production of 58,071 M. 
genitalium genomes (Rees-Garbutt et al., 2020c) in a much more efficient manner than manual 
genome construction efforts. As individual gene analysis can impact the ability to meaningfully 
interpret results, researchers often use gene ontology (GO) terms, standardised labels that describe 
a gene’s function, to reconnect the genes disrupted back to the processes being impacted (Apweiler 
et al., 2004). GO terms are built from a structured, controlled vocabulary to create a network where 
each GO term is a node connected by the relationship between the terms, and as such can describe 
the relationships between genes and the processes they influence (Apweiler et al., 2004). Rees-
Garbutt et al. (2020c) utilise GO terms to analyse the minimal genomes produced by the GAMA and 
Minesweeper algorithms to identify the types of processes being dispensed with in the in silico cell. 
 
1.5 - E. coli and M. genitalium as model and minimal organisms 
Minimal genomes are sets of protein-coding genes that form a genome where no more genes can be 
removed without incurring loss of viability (Glass et al., 2017). Such genomes can only exist in rich 
growth media with no external stressors (Hutchison et al., 2016). The genes that cannot be 
dispensed with are therefore described as essential (Rancati et al., 2018). In recent years essentiality 
has undergone a complex redefinition, resulting in the understanding that multiple minimal 
genomes for individual bacterial species can exist, depending on factors such as environmental 
conditions and which redundant genetic pathways are selected in the cell (Landon et al., 2019; 
Xavier et al., 2014; Rees-Garbutt et al., 2020c). For example, low essential genes are dispensable in 
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most environmental and genetic contexts (Rancati et al., 2018). There is disparity between finding a 
local minimum genome for a specific species and searching for a global minimum genome, which 
would contain the smallest number of genes necessary for life. A notable example of the former is a 
38.9% gene reduction of E. coli (Iwadate et al., 2011) while the latter is best represented by the 
creation of JCVI-Syn3.0, a 50% gene reduction of Mycoplasma mycoides (M. mycoides), which 
possesses the smallest known genome to have ever autonomously produced a dividing cell 
(Hutchison et al., 2016). Herein lies the divergence in strategy when producing a minimal genome. A 
number of previous genome reduction efforts are presented in Table 1.1. Many minimal genome 
creation efforts involve top-down construction, where extant genomes are reduced (Iwadate et al., 
2011). JCVI-Syn3.0 has a synthetic genome built in Saccharomyces cerevisiae and cloned into a 
Mycoplasma cell, which progresses towards a bottom-up approach (Göpfrich et al., 2018). While 
routine bottom-up construction of an entire cell is currently infeasible due to complexity and costs, 
many synthetic biologists view this approach as an important way to construct the most minimal 
genomes (Forster & Church, 2006).  
Table 1.1. An incomplete history of notable genome reduction efforts reported in the literature. 
Year Organism & Strain Genome reduction Reference 
2002 E. coli MDS12 8% 
Kolisnychenko et 
al. 
2006 E. coli MDS43 15% Pósfai et al. 
2011 E. coli Δ33a 39% Iwadate et al. 
2013 E. coli DGF-298 35% Hirokawa et al. 
 
Corynebacterium glutamicum 
MB001 6% Baumgart et al. 
2014 E. coli MS56 23% Park et al. 
 Pseudomonas putida EM383 4% 
Martinez-Garcia et 
al. 
2016 M. mycoides JCVI-syn3.0 50% Hutchison et al. 
 E. coli MGE-syn1.0 in S. cerevisiae 77% Zhou et al. 
 E. coli MDS69 20% Karcagi et al. 
 rE.coli-57 57-codon genome Ostrov et al. 
2017 B. subitilis PG10 and PS38 36% Reuß et al. 
2019 E. coli Syn61 synthetic 61-codon genome Fredens et al. 
 
It is important to note that reducing a genome to a state with the fewest genes is not the sole way of 
creating a minimal genome. Minimising the total genome size, including non-coding elements such 
as pseudogenes (Roberts & Morris, 2013) may provide avenues to further reduce a genome when no 
more genes are dispensable. Codon replacement research (Fredens et al., 2019) has reduced the 
genome of E. coli, using an alternative metric to genes, by reducing the number of codons used to 
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synthesise proteins from DNA, providing us with another standard to measure minimality against. 
Mollicutes, of which Mycoplasma are a genus, have also been identified as candidates for the 
removal of non-essential enzymes (de Crécy-Lagard et al., 2007), which would further decrease the 
contents of the cell. Progress in protein engineering has led to improvements in enzyme activity and 
stability, including colocalization efforts which have allowed us to understand where proteins occur 
and how they function (Li et al., 2020). Theoretically, the ability to modify proteins and enzymes in 
this way could be scaled up to the entire proteome, streamlining cell metabolism and reducing 
complexity. A desirable direction for research could therefore be to combine efforts to reduce the 
genetic content of the cell with those to reduce the total number of components in the cell, 
producing the most minimal, least complex cell possible (Xavier et al., 2014). 
E. coli and M. genitalium serve as model and minimal organisms respectively (Taj et al., 2014; Fraser 
et al., 1995), and both organisms have been heavily used in minimisation efforts. The ease with 
which E. coli can be grown in the laboratory is a pertinent factor in its historical and continued use as 
a model organism for biological research, with quick doubling time, environmental resilience, and 
low cost of maintaining colonies all proving valuable characteristics (Blount, 2015). M. genitalium 
occupies an alternative niche in research, as it is notoriously difficult to culture effectively in the 
laboratory, with extremely slow reproduction frustrating research efforts (Hutchison et al., 2016). 
This has stifled in vivo progress with M. genitalium and researchers have instead investigated other 
Mycoplasmas, for example the J. Craig Venter Institute (JCVI) synthesising the M. mycoides genome 
(Gibson et al., 2010). Most recent research using M. genitalium has therefore been in silico (Rees-
Garbutt et al., 2020c). 
The differing characteristics of E. coli and M. genitalium have prompted distinct avenues for genome 
design and minimisation. As an organism of specific interest to industry, utilised for large-scale 
biosynthesis of molecules such as terpenoids (Choi et al., 2010), many previous attempts at 
minimising the genome of E. coli have focused on the removal of genes and metabolic pathways 
which do not overly diminish the rate of cellular growth and division on economically viable growth 
media (Hirokawa et al., 2013). An example of such a minimised strain of E. coli is MDS42, 
representing a 14.3% genomic reduction compared to E. coli MG1655 without reducing growth rate 
(Pósfai et al., 2006). This type of minimisation, while undeniably useful and representing progress in 
genome minimisation, is applied to an industrial setting where the goals are centred around the 
creation of chassis cells and does not explore the limits of genome minimisation investigated in 
other studies (Landon et al., 2019). The genomes of Mycoplasmas have undergone minimisation in 
its purest form; research efforts have created a strain of M. genitalium with the fewest genes 
possible for cell growth on ideal media, despite extended doubling time (Hutchison et al., 2016). The 
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crowning achievement of this branch of research comes in the form of JCVI-syn3.0, a reduction of a 
previously synthesised M. mycoides genome which had been transplanted into M. genitalium and 
reduced to 473 genes (Hutchison et al., 2016). This organism represents the most genome-reduced 
cell produced to date, with a doubling time of ~180 minutes and providing exciting avenues for 
research regarding minimal gene sets, as well as further progress concerning universal core 
functions for life. JCVI-syn3A was subsequently developed by the JCVI, comprising 493 genes and 
producing a more robust cell which was easier to grow in the laboratory, with a doubling time of 
~120 minutes (Hutchison et al., 2016; Glass, 2017; Breuer et al., 2019). Recent progress has been 
reported in JCVI-syn3A, as a reverse genetics approach revealed the seven genes required for normal 
cell division in this organism (Pelletier et al., 2021). 
1.6 - CRISPR-Cas9 and no-SCAR for bacterial genome engineering 
Genome engineering has undergone huge revolutions in recent years, with the development of 
powerful technologies facilitating ever-growing control over our ability to manipulate the genomes 
of organisms (Khalil, 2020). Preceded by technologies such as zinc finger nucleases (ZFNs) and 
transcription activator-like effector nucleases (TALENs) (Kim et al., 1996; Boch et al., 2009), CRISPR-
Cas9 technology represents arguably our most vital step forward in genome engineering (Jinek et al., 
2012). By utilising elements of the bacterial adaptive immune system, it is possible to target and edit 
genes with precision once thought impossible, enabling the vast editing of entire genomes to the 
accuracy of a few base pairs (Hsu et al., 2014). This precision has significantly contributed to genetic 
studies conducted in eukaryotes, with achievements such as increasing rice grain yield through 
targeted gene knockouts (Lu et al., 2018).  
As prokaryotes such as E. coli lack the ability to repair double-strand breaks (DSBs) in DNA by 
homologous recombination (HR), λ Red technology remains the premier method to conduct genome 
editing in E. coli (Murphy, 1998). Pioneered in 1998, λ Red recombineering for bacteria uses the 
bacteriophage λ Red proteins, Exo, Bet, and Gam to construct gene knockout mutants through HR of 
a double-stranded DNA (dsDNA) polymerase chain reaction (PCR) product with bacterial 
chromosomes (Murphy, 1998). Exo degrades dsDNA from 5’ ends to reveal the single-stranded DNA 
(ssDNA) which is targeted by Bet and HR takes place to insert the desired DNA, while Gam prevents 
the digestion of λ phage DNA so recombination can occur (Datsenko & Wanner, 2000). This 
revolutionary technique permitted the construction of the Keio collection, a single gene knockout 
library of E. coli K-12, amongst other achievements (Baba et al., 2006; Mosberg et al., 2010).  
While previously frustrating the attempts of microbiologists to edit the genome of E. coli, the ability 
of CRISPR-Cas9 to induce cell death by creating DSBs now provides a way to optimise the process of 
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recombineering through counterselection. If a colony has not undergone successful transformation 
Figure 1.2. An outline of the no-SCAR method. Day 1: the pCas9-CR4 plasmid is transformed 
into electrocompetent E. coli and plated on LB + chloramphenicol at 37°C. Day 2: the 
pKDsgRNA-xxx plasmid (-xxx denotes the targeted gene) is transformed into cells and plated 
on LB + spectinomycin and chloramphenicol at 30°C. Day 3: cells are grown to OD ~0.5 in SOB 
then 50mM L-arabinose is added to induce λ Red. Cells are then made electrocompetent and 
transformed with ss/dsDNA to confer the desired mutation. Once recovered, cells are plated 
on LB + spectinomycin, chloramphenicol, and anhydrotetracycline at 30°C. Day 4: colonies 
are screened by PCR and grown at 37°C to cure the pKDsgRNA-xxx plasmid. Day 5: transform 
mutant cells with the next pKDsgRNA-xxx plasmid and repeat the process. Day 5*-8 curing: 
transform electrocompetent mutant cells with curing plasmid pKDsgRNA-p15 and recover 
cells in SOC at 30°C, add 100µg/L anhydrotetracycline at 30°C. Plate cells on LB + 
spectinomycin and anhydrotetracycline at 30°C. Screen colonies by patching on LB and LB + 
chloramphenicol at 37°C (adapted from Reisch & Prather, 2015).  
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and editing, then the wild-type cells will be successfully targeted by CRISPR and Cas9 will produce an 
irreparable DSB resulting in cell death (Bowater & Doherty, 2006). This phenomenon was capitalised 
upon to improve recombination efficiency in bacteria first by Jiang et al. (2013), and then by Reisch 
& Prather (2015). The latter reported the Scarless Cas9 Assisted Recombineering (no-SCAR) method 
of creating genomic edits in E. coli using λ Red recombineering, partnered with CRISPR-Cas9, to 
create scarless edits in a single step with relative ease (Reisch & Prather, 2015) (Figure 1.2). No-SCAR 
recombination works by employing two plasmids, one encoding single guide RNA (sgRNA) and λ Red 
machinery for recombineering by HR (pKDsgRNA-ack) and the other encoding a Cas9 nuclease to 
facilitate the creation of DSBs, thus inducing death in cells in which editing has not occurred (pCas9-
CR4). A third, curing plasmid, is used to remove pCas9-CR4 from bacterial cells once all rounds of 
recombineering are complete, through introducing DSBs by Cas9 cleavage (pKDsgRNA-p15).  
To target the desired genomic loci, pKDsgRNA-ack must be retargeted by Circular Polymerase 
Extension Cloning (CPEC) or round the horn cloning (Quan & Tian, 2011; Ochman et al., 1988). To 
achieve cloning by CPEC, PCR is used to produce linear DNA fragments which have short overlapping 
sequences on both ends. The regions of overlap can be modified to target the desired genomic loci 
by changing the primers used for PCR. Once amplified, the products undergo DpnI digestion and are 
run on an agarose gel, before undergoing excision, purification, and further PCR cycling. The 
retargeted pKDsgRNA-ack is then transformed into electrocompetent E. coli by electroporation. The 
desired host strain can then be sequentially transformed with pCas9-CR4 and pKDsgRNA-ack, before 
transforming with linear DNA to create the desired deletion, insertion, or mutation in the bacterial 
genome. Here the λ Red machinery can be induced by L-arabinose to facilitate HR. Recovery and 
incubation after the editing takes place, alongside colony PCR and Sanger sequencing, will reveal 
whether editing was successful, as tetracycline-induced CRISPR-Cas9 mediated counterselection 
occurs. This system of recombineering can produce cyclical genome modifications with every 
iteration of editing increasing the amount of time saved, as pCas9-CR4 remains in cells. As such, it is 
possible to carry out three mutations in a cell and cure the plasmids used in 14 days, a method 
which is four days faster than SceI counter-selection (Reisch & Prather, 2015; Kim et al., 2014). 
Reisch & Prather (2015) also reported high transformation efficiency, and low escape rate of 
counterselection by cells avoiding death by Cas9-induced DSBs, increasing the viability of the no-
SCAR system for genome engineering.  
1.7 - Aims 
I set out to test the ability of the E. coli WCM to correctly predict the effect of gene knockouts. This 
would test how useful the model is for genome design. I also wanted to contribute to the research 
our group was conducting into M. genitalium minimal gene sets. I took three approaches: 
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1. To use the predictions of the E. coli WCM to inform and direct gene deletions in the 
laboratory using the no-SCAR system for genome editing (Reisch & Prather, 2015). 
2. To help to identify and test possible minimal gene sets using the M. genitalium WCM. 
3. To collaborate with the Covert group at Stanford University, the producers of both the M. 
genitalium and E. coli WCMs, to improve the E. coli WCM, which is still under development. 
Through this, I hope to increase the model’s fidelity to living E. coli cells, allowing for more 























Chapter 2 – Minimal gene sets in M. genitalium 
2.1 - Introduction 
M. genitalium has been a vital subject of minimal genome research (see Chapter 1 section 1.4). M. 
genitalium’s reduced metabolism and simplicity made it possible to create a WCM of it, that has 
allowed in silico investigation of its genome (Karr et al., 2012). Our research group has been working 
with the M. genitalium WCM for a number of years, with it being the target of the genome design 
algorithms GAMA and Minesweeper (Rees-Garbutt et al., 2020c). These algorithms permit the use of 
design-simulate-test cycles for genome design and they were first applied to genome minimisation 
in M. genitalium (Rees-Garbutt et al., 2020c). In addition to this work, members of our research 
group utilised their knowledge of the M. genitalium WCM to investigate the potential minimal gene 
set for life (Rees-Garbutt et al., 2020b). Many researchers have published gene sets that they claim 
should function as bacterial minimal gene sets, but these studies were based on removing one or at 
most a few genes at a time and then combining genes based on the results, assuming that there 
would be no cumulative effects of removing large numbers of genes simultaneously (Forster & 
Church, 2006; Gil, 2014; Glass et al., 2006; Huang et al., 2013; Hutchison et al., 1999; Karr et al., 
2012; Mushegian & Koonin, 1996; Tomita et al., 1999). Joshua Rees-Garbutt realised that we could 
test these gene sets in the M. genitalium WCM to see whether they could produce dividing cells in 
silico, as this would be practically impossible to investigate in vivo. Despite in silico research using 
the M. genitalium WCM being faster than in vivo research, there are significant time costs associated 
with the model’s use. The simulations which produced the data I analyse in this chapter each took 
between 5 – 12 hours, increasing the proportion of time for my project which was dedicated to this 
work. Joshua Rees-Garbutt discovered that none of the minimal gene sets chosen for investigation 
produced dividing in silico cells, with each set requiring reintroduction of specific essential and low-
essential genes to enable cellular division (Rees-Garbutt et al., 2020b).  
Table 2.1 details which minimal gene sets were investigated and what they were called for our 
research. The processes used to design the gene sets are also given (e.g. protocell creation, 
comparative genomics, and single gene deletions). Protocells are collections of biomolecules 
encapsulated in a membrane and are capable of self-replication (Dzieciol & Mann, 2012). 
Comparative genomics computationally and experimentally compares the genomes of different 
species to identify common genes (Koonin, 2003). Table 2.2 is a summary of results from Rees-
Garbutt et al. (2020b), identifying the sizes of the initial and final in silico genomes for the minimal 
gene sets investigated. The classes of genes (see Chapter 1 section 1.4) which had to be 
reintroduced are also presented. Rees-Garbutt et al. (2020c) previously published M. genitalium 
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genomes in silico with sizes of 256 (Minesweeper_256) and 236 (GAMA_236) genes, which remain 
the most minimal genomes shown to divide in silico to date. 
 
My contribution to this research was to analyse the minimal gene sets to try to identify biological 
functions that could be dispensed with while still producing a dividing cell. To do this I took the in 
silico simulations and grouped genes according to function using GO terms. I also performed GO 
term analysis of the genes Joshua Rees-Garbutt reintroduced to the gene sets sourced from the 
literature in order to produce cells which successfully divided in silico. This work is currently 
undergoing review after submission for potential publication in ACS Synthetic Biology.  
 
Table 2.1. Comparing minimal gene sets with M. genitalium in vivo and the M. genitalium whole-
cell model. Predicted in silico genome size is the size of gene sets once adapted for use in the M. 
genitalium WCM, with unmodelled genes removed and 42 RNA coding genes added. * = protein-
coding genes. M. genitalium has 42 RNA-coding genes that are not included in this column. ^ = due 




2.2 - Methods 
2.2.1 - Data sources 
The M. genitalium WCM is publicly available at: https://github.com/CovertLab/WholeCell. The 




2.2.2 - Procedures 
2.2.2.1 - GO term analysis of minimal gene sets 
Having received the gene sets from Joshua Rees-Garbutt, I created .txt files of the genes present in 
each gene set. This resulted in the creation of eight .txt files, one for each minimal gene set: 
ChurchMGS.txt (Forster & Church, 2006), GilMGS.txt (Gil, 2014), GlassMGS.txt (Glass et al., 2006), 
HuangMGS.txt (Huang et al., 2013), HutchisonMGS.txt (Hutchison et al., 1999), KarrMGS.txt (Karr et 
al., 2012), KooninMGS.txt (Mushegian & Koonin, 1996), and TomitaMGS.txt (Tomita et al., 1999). 
These files are collectively referred to as AuthorNameMGS.txt. The GO terms were retrieved from 
UniProt by Joshua Rees-Garbutt (Apweiler et al., 2004) and I processed results using a script in 
Jupyter Notebooks created by Joshua Rees-Garbutt 
(https://github.com/squishybinary/Gene_Ontology_Comparison_for_Mycoplasma_genitalium_whol
e-cell_model/blob/master/165deletions_versus_GOBaseline.ipynb) which converted the list of 
genes (AuthorNameMGS.txt) knocked out from the model to create each minimal gene set into .csv 
Table 2.2. Minimal gene sets before and after the reintroduction of essential and low essential 
genes to produce dividing in in silico cells. The “Agreed” set contains 14 genes not included in all 
eight minimal gene sets. * = Final size of in silico genome includes members of the original 359 
protein-coding genes and the 42 RNA-coding genes in the M. genitalium whole-cell model, to 
realistically indicate the genome that might need to be built to produce living cells (adapted from 
Rees-Garbutt et al., 2020b). 
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files for analysis (AuthorNameMGSvsGOBaseline.txt). To create the .csv files I made the following 
changes to the code in file 165deletions_versus_GOBaseline.ipynb: 
1. Change line 4 to read in the gene set-specific .txt file (AuthorNameMGS.txt). 
df2 = pd.read_csv(‘165deletions.txt’, sep=”\t”) 
To 
df2 = pd.read_csv(‘AuthorNameMGS.txt’, sep=”\t”) 





This process involved reading in the GO baseline M. genitalium data which each minimal gene set 
would be compared to (GOBaseline.txt), then reading in the gene deletion list (AuthorNameMGS.txt) 
as a 1D vertical dataframe and converting it to a list. The deletion list for all eight minimal gene sets 
was read through repeatedly running the code (ChurchMGS.txt, GilMGS.txt, GlassMGS.txt, 
HuangMGS.txt, HutchisonMGS.txt, KarrMGS.txt, KooninMGS.txt, and TomitaMGS.txt). The baseline 
and deletion list would then be compared in a dataframe, with GeneIDs present in the baseline and 
not in the deletion list being kept in the new list. This list was then exported to a .csv file. I then 
manually organised GO terms by whether they were unaffected, reduced, or removed by gene 
deletions (Appendices 1-8). I proceeded to analyse the tables and synthesise information from 
across the gene sets to identify patterns and trends. 
2.2.2.2 - GO term reintroductions for minimal gene sets 
I repeated the process outlined in Section 2.2.2.1 for genes which when reintroduced produced 
minimal gene sets that divided in silico, with the only difference being GeneIDs present in both the 
baseline and the reintroduction list were kept in the new list, which was exported to a .csv file. 
Joshua Rees-Garbutt adapted the 165deletions_versus_GOBaseline.ipynb script to create 
Reintroductions_Protocells_versus_GOBaseline.ipynb (https://github.com/JJRightmyer/MGS-
processing/blob/main/Reintroductions_Protocells_versus_GOBaseline.ipynb) with the following 
changes: 
1. Change line 4 to read in the reintroduction gene list .txt file. 




df2 = pd.read_csv(‘reintroduction_authorName.txt’, sep=”\t”) 





3. Change lines 8 and 9 so the dataframe constructed compares the baseline and 
reintroduction lists, then export that list to a .csv file. 





df3 = df[df[‘GeneID’].isin(reintrolist)] 
df3.to_csv(‘reintroductionAuthorNameGOList.txt’, sep=’\t’) 
 
Once I had created the .csv files comparing the reintroduced GO terms to the baseline for M. 
genitalium by processing each of the eight gene reintroductions through 
Reintroductions_Protocells_versus_GOBaseline.ipynb, I manually produced tables to allow for easy 
comparison between the gene sets and looked for patterns across the data (Appendices 9-16). 
2.3 - Results 
2.3.1 - GO term reductions and removals 
Through grouping M. genitalium genes using GO terms, it was possible to reveal more about the 
cellular functions that were either being conserved or dispensed with in the different minimal gene 
sets. When compared to the baseline genome (all genes present, 347 GO term categories), the 
minimal gene sets each provided a unique combination of GO term reductions and removals (Table 
2.3). For brevity, the complete tables of GO terms for all eight gene sets are included in Appendices 






Table 2.3. A summary of minimal gene set (MGS) GO term reductions and removals from the 
baseline 155 GO terms. The minimal gene set names correspond to the publications identified in 
Table 2.1. 
MGS GO terms reduced GO terms removed 
Church 22 40 
Gil 21 30 
Glass 17 14 
Huang 24 36 
Hutchison 15 8 
Karr 18 29 
Koonin 19 18 
Tomita 22 39 
 
The Church MGS (Appendix 1) represented one of the most reduced genomes, with reductions and 
removals in GO categories across the entire genome. Processes affected included: DNA (replication, 
topology, transcription, recombination, repair, catabolism, nucleotide synthesis), RNA (processing, 
modification, compound salvage, pseudouridine synthesis), ATP and important biomolecule 
metabolism and regulation (carbohydrates, sugars, lipids, carboxylic acids, ATP coupled proton 
transport, coenzyme A biosynthesis, fructose 1,6-bisphosphate metabolic process), environmental 
interactions (pathogenesis, cell adhesion, cytoadherence to microvasculature, protein secretion, 
heterophilic cell-cell adhesion), cell cycle (cell division, chromosome segregation & separation), 
protein-related processes (transport, lipoylation, ribosome biogenesis, lipoprotein, catabolism, 
import repair, modification), and homeostasis (response to oxidative stress, cellular phosphate ion 
homeostasis). These reductions and removals represented a system-wide reduction in 
environmental interaction, damage repair, energy production, and process regulation. The removal 
of various molecule transport mechanisms would also lead to increased generation time, as 
reactions would be slowed down. It is likely that a cell with this genome would be very susceptible to 
environmental change as well as deleterious mutations, as four of its DNA repair systems have been 
heavily reduced or removed. 
The Gil MGS (Appendix 2) had significant reduction, but not to the same degree as MGSs Church, 
Tomita, and Huang. Processes conserved include RNA processes, processes involved in the 
production of ATP, and processes related to proteins such as transport and folding. Otherwise, the 
reductions were very similar to MGSs Church, Tomita, and Huang, with genes involved in DNA 
processes, environmental interaction, cell cycle, and homeostatic processes identical to the Huang 
MGS. This set would possibly have increased protein availability and functionality over other gene 
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sets due to tRNA processing and protein folding being unchanged, as well as increased ATP 
production in the cell. While the Gil MGS introduces no unique reductions or removals of GO terms, 
its composition aids in identifying a general base for the biological functions which can be dispensed 
with whilst still producing a dividing in silico cell. Decreases in the cell’s ability to interact with its 
environment were generally tolerated by gene sets produced by protocell and comparative genomic 
studies (MGSs Church, Tomita, Huang, Gil, and Koonin) but not by gene sets produced by single gene 
deletions (MGSs Karr, Glass, and Hutchison). 
The Glass MGS (Appendix 3) had significant conservation of processes across the genome, 
comparable to that of the Hutchison set. While all GO categories were still reduced, only the cell 
cycle was reduced a significant amount, with reductions equal to MGSs Koonin, Karr, and Gil. The 
gene set also showed reduction to four DNA repair processes, possibly reducing the cell’s ability to 
tolerate genetic damage. However, it retained full interaction with the environment, with the DNA 
restriction-modification system being the only process removed. This is also the only gene set apart 
from MGS Hutchison to conserve cellular phosphate ion homeostasis, with all others either reducing 
or removing the process.  
Another heavily reduced genome, the Huang MGS (Appendix 4) was very similar to MGSs Church 
and Tomita, including protein folding while excluding fructose 1,6-bisphosphate metabolism and 
some other protein-related processes. The Huang MGS also removed sister chromatid cohesion and 
chromosome condensation, both with consequences for cell division. This could increase generation 
time as it becomes harder to package chromosome copies into daughter cells. 
The Hutchison MGS (Appendix 5) showed the capacity for the reduction of GO categories including 
DNA (repair, transcription, recombination), RNA (tRNA processing, mRNA catabolic, pseudouridine 
synthesis), ribosome biogenesis (with consequences for gene translation), environmental interaction 
(pathogenesis, cell adhesion, cytoadherence to microvasculature), cell cycle (division, chromosome 
segregation), and ATP generation including metabolism and regulation of important biomolecules 
(carbohydrates, sugars, lipids, coenzyme A biosynthetic process, phosphate ion transmembrane 
transport). In many cases analogous pathways exist to compensate for the removal of certain 
processes, as well as the ideal growth environment negating the need for some environmental 
interaction processes. While the gene set would remove redundancies, it is also important to note 
the removal of multiple DNA repair mechanisms may impact the survival of cells across generations 
as deleterious mutations accumulate. 
The Karr MGS (Appendix 6) had GO term process reduction which fell between the heavily reduced 
sets and the lightly reduced. While maintaining reductions in ATP and important biomolecule 
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metabolism comparable to MGSs Huang and Tomita, as well as cell cycle reductions identical to 
MGSs Huang and Gil, the Karr MGS saw significant process conservation across RNA processes, 
environmental interactions, and protein-related processes. This represented a prominent set of 
environmental interaction processes, which have often been either reduced or removed in other 
gene sets. This would likely create a cell that is more adaptable to environmental change, as well as 
being able to produce more functional proteins, as relatively few protein-related processes are 
affected. 
The Koonin MGS (Appendix 7) was relatively lightly reduced, with significant process conservation 
compared to the heavily reduced sets in DNA, RNA, ATP and important biomolecule metabolism, and 
protein-related processes. Its interactions with the environment, cell cycle, and homeostatic 
processes were as reduced as the most minimal gene sets. Uniquely, this gene set only reduced one 
DNA repair process, making the cell relatively robust to genetic damage.  
The Tomita MGS (Appendix 8) was very similar to the Church MGS, with only the inclusion of protein 
folding and refolding and the exclusion of glycolytic process, carboxylic acid metabolism, and 
fructose 1,6-bisphosphate metabolic process setting them apart. This would result in the cell 
behaving in much the same way as the Church MGS, with low tolerance to environmental or genetic 
stress. By impacting protein folding and refolding, it is likely that this cell will have reduced rates of 
cellular reactions, due to enzymes not having the correct active site. 
2.3.2 - Gene reintroductions 
GO term analysis of the genes reintroduced to M. genitalium gene sets was also successful, clarifying 
which cellular functions the in silico cells could not dispense with when simulated using the M. 
genitalium WCM. The variation in required GO term reintroductions to produce dividing in silico cells 
was immediately apparent, with the Karr MGS requiring the fewest reintroductions by far (Table 
2.4). This result is unsurprising as the Karr MGS was proposed by the same authors who developed 
the M. genitalium WCM. Complete tables of all the GO terms reintroduced to produce functioning in 







Table 2.4. A summary of minimal gene set (MGS) GO term reintroductions. Both the number of 
categories reintroduced and the number of processes that make up those categories are included. 
MGS GO term categories reintroduced GO term processes reintroduced 
Church 91 153 
Gil 50 73 
Glass 14 15 
Huang 65 115 
Hutchison 12 13 
Karr 1 2 
Koonin 25 35 
Tomita 80 130 
 
Of the GO terms which had to be reintroduced to produce dividing in silico cells, translation, 
transport, tRNA processing, and glycolytic process were most common, with at least one appearing 
in each of the gene sets. DNA replication, transcription DNA-templated, and carbohydrate metabolic 
process were also reintroduced often. The Karr MGS was notable for only requiring the 
reintroduction of genes which were involved in transport to produce a dividing in silico cell. The 
trends of functions restored to the gene sets once genes were reintroduced are discussed in more 
detail by Rees-Garbutt et al. (2020b), where common cellular functions which required 
reintroduction are identified. Reintroduced cellular functions identified by Rees-Garbutt et al. 
(2020b) included: DNA (polymerase subunits, thymidine insertion, recycling of pyrimidine, 
chromosome segregation; RNA (polymerase subunit, tRNA modification, the 50S and 30S ribosomal 
subunits); transporters (cobalt, phosphonate, potassium); production (NAD, flavin, NADP, fatty 
acid/phospholipids); and dehydrogenation (glycerol and alpha-keto acids). The reintroduction of 
phosphonate transport (MG_291) was vital to produce dividing in silico cells, as this process was 
removed in all MGSs bar Koonin, depriving in silico cells of phosphate. Phosphonate transport had to 
be reintroduced to ensure in silico cells divided for the other seven MGSs. 
2.4 - Discussion 
These results clarify which biological functions should be included in any minimal gene set for M. 
genitalium. They identify which mistakes previous authors had made when proposing their own 
gene sets and provide useful information for future genome designers. GO term analysis permits 
contextualisation of the genes that are both conserved and dispensed with to produce a viable 
minimal genome for M. genitalium, assigning cellular processes to each gene in question, allowing us 
to understand how the in silico cell is being impacted when its genome is reduced. As published in 
Rees-Garbutt et al. (2020b), MGSs Church and Tomita are the smallest in silico genomes shown to 
function behind Minesweeper_256 and GAMA_236 (Rees-Garbutt et al., 2020c), which is largely 
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reflected by the GO term analysis of these gene sets (Table 2.3). These gene sets needed the most 
gene reintroductions to produce dividing in silico cells, and reintroduction of the most GO terms 
(Table 2.4). Through the identification of cellular processes deemed essential to produce viable M. 
genitalium cells, for example the necessity of having processes in place to provide cells with 
sufficient phosphate (section 2.3.2), we can provide a more comprehensive blueprint to direct future 
in vivo construction of minimal genomes. While WCM M. genitalium cannot perfectly replicate a 
cell’s response to genetic manipulation (see Chapter 1 section 1.3), this research nonetheless 
progresses minimal genome design by improving upon potential MGSs presented in the literature 
and providing a clear direction for future research. With the development of more efficient 
technologies permitting reconstruction of Mycoplasma genomes in yeast cells (Benders et al., 2010; 
Karas et al., 2013; Tsarmpopoulos et al., 2016), synthetic biologists have the necessary tools to begin 



















Chapter 3 – Laboratory work informed by WCM 
predictions 
3.1 - Introduction 
To comprehensively assess the accuracy of WCMs, we must test their predictions in vivo. Only 
through in vivo investigation is it possible to determine how genome design methodologies can be 
improved by using WCMs. The development of the E. coli WCM provides us with the chance to 
investigate WCM predictions in vivo in an efficient and cost-effective manner, as E. coli is much 
easier to work with in the laboratory than M. genitalium (see Chapter 1 section 1.4). By 
implementing a system for genome editing of E. coli in our laboratories, we would be able to test the 
in silico predictions of the E. coli WCM to better understand how accurately it relates to in vivo cells. 
While our group had access to the E. coli WCM, it was designed to run on Stanford University’s 
SHERLOCK supercomputer cluster, so was initially incompatible with the University of Bristol’s 
BlueCrystal supercomputer cluster. To get it running successfully required assistance from the 
Advanced Computing Research Centre team at the University of Bristol. Whilst other team members 
worked on this and to make efficient use of time, I decided to set up the no-SCAR protocol (see 
Chapter 1 section 1.5) in our laboratory and trial a proof-of-concept deletion so that the protocol 
would be ready to use for in vivo investigations of in silico results once we could produce them 
(Reisch & Prather, 2015). When fully implemented, the no-SCAR protocol allows for an initial 
genomic edit to be created in less than a week, with consequent iterations possible to complete in 
three or four days, assuming an efficient workflow with plasmid retargeting and oligonucleotide 
creation. This is one of the fastest methods for iterative, low error rate genome engineering, which is 
ideal as the laboratory work would likely be the limiting step on data collection, as in silico results 
with the E. coli WCM can be produced in as little as 15 minutes. 
3.2 - Methods 
Here I document the laboratory methods I undertook as I attempted to implement the no-SCAR 
method of genome engineering (Figure 1.2). I also detail the steps I would have taken if the effects 
of the Covid-19 pandemic had not caused our laboratories to close. 
3.2.1 - Strains and constructs 
E. coli K-12 substrain MG1655 (Genotype: F- λ- ilvG- rfb-50 rph-1; Blattner et al., 1997) was obtained 
as frozen stocks from Thomas Gorochowski, University of Bristol. Frozen bacterial stocks were stored 
in an equal volume of 50% glycerol solution (VWR, 444485B) gently mixed with overnight culture 
and stored at -80°C. 
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I received plasmids pCas9-CR4, pKDsgRNA-ack, and pKDsgRNA-p15 from Addgene in the form of E. 
coli DH5-α (Genotype: F– endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG purB20 φ80dlacZΔM15 
Δ(lacZYA-argF)U169, hsdR17(rK–mK+), λ–; Hanahan, 1985) bacterial stabs, from which I made glycerol 
stocks and stored at -80°C. The no-SCAR plasmids pKDsgRNA-ack (Addgene plasmid # 62654 ; 
http://n2t.net/32ristol:62654 ; RRID:Addgene_62654), pCas9-CR4 (Addgene plasmid # 62655 ; 
http://n2t.net/32ristol:62655 ; RRID:Addgene_62655), and pKDsgRNA-p15 (Addgene plasmid # 
62656 ; http://n2t.net/32ristol:62656 ; RRID:Addgene_62656) were gifts from Kristala Prather 
(Reisch & Prather, 2015). Plasmid maps for plasmids pCas9-CR4 (https://www.addgene.org/62655/), 
pKDsgRNA-ack (https://www.addgene.org/62654/), and pKDsgRNA-p15 
(https://www.addgene.org/62656/) are available at Addgene. Cultures containing pCas9-CR4 were 
grown on spectinomycin at 37°C while those containing pKDsgRNA-ack and pKDsgRNA-p15 were 
grown on chloramphenicol at 30°C.  
3.2.2 - Bacterial cultures 
Fresh bacterial cultures were prepared by streaking from frozen stocks to single colonies on Luria-
Bertani (Miller) broth (LB) (Supelco, L3027-250G) 1% agar plates (Sarstedt, 82.1472). Plates were 
sealed with parafilm and incubated at 37°C overnight. Duplicate liquid cultures were prepared by 
inoculating 5ml LB media (Applichem, A6666.0500G) in a 15ml Falcon tube, with a single picked 
colony from the LB agar plates. A duplicate tube of medium was set up but not inoculated as a 
control to check the quality of my aseptic technique. The Falcon tubes were incubated overnight at 
37°C and 250rpm. 
3.2.3 - Preparing electrocompetent cells 
Overnight culture was diluted into 5ml of fresh LB media in a 15ml Falcon culture tube to an OD600 of 
0.1, then incubated it at 37°C and 250rpm until an OD600 of 0.6 was reached. Cells were harvested by 
centrifugation at 4°C, 4100 x g for 20 minutes, the supernatant discarded and the pellet resuspended 
in 5ml ice-cold, sterile MilliQ water before centrifuging again at 4°C, 4100 x g for 10 minutes. This 
was repeated three times to wash the cells, followed by a fourth wash of the pellet with 5ml ice-
cold, sterile 10% glycerol, centrifuged at 4°C, 4100 x g for 10 minutes. The supernatant was 
discarded and the electrocompetent cells were resuspended in 50µl ice-cold, sterile 10% glycerol, 
divided into two 25µl aliquots and frozen at -80°C. 
3.2.4 - Confirming plasmid structure 
Plasmid structures were checked by culturing them in host bacteria under the appropriate antibiotic 
selection, isolating plasmid DNA and digesting using restriction enzymes. 
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3.2.4.1 - Antibiotics 
Antibiotic stock solutions were made by diluting 50mg chloramphenicol powder (Sigma-Aldrich, 
C0378-25G) in 2ml ethanol (VWR, MFCD00003568) to produce a stock solution with a concentration 
of 25mg/ml, and diluting 100mg spectinomycin powder (Cambridge Bioscience, S016-5g) in 2ml 
dH2O to produce a stock solution with a concentration of 50mg/ml.  
3.2.4.2 - Selective growth 
Chloramphenicol and spectinomycin stock solutions (section 3.2.4.1) were diluted to 25µg/ml and 
50µg/ml respectively in 1% LB agar solution to make six plates (section 3.2.2). Three plates contained 
chloramphenicol and the other three spectinomycin. Cultures containing plasmids pCas9-CR4, 
pKDsgRNA-ack, and pKDsgRNA-p15 were grown on the antibiotic they were resistant to (section 
3.2.1) alongside duplicate cultures as negative controls. 
3.2.4.3 - Restriction digests 
Restriction digests were conducted using restriction enzymes EcoRI (Promega, R6011) and XhoI 
(Promega, R6161) following the Promega Assembly of Restriction Enzyme Digestions manual 
(https://www.promega.com/-/media/files/resources/protocols/technical-manuals/101/restriction-
enzymes-protocol.pdf). Plasmids were first miniprepped using the QIAprep Spin Miniprep Kit (50) 
(QIAGEN, 27104), then digested before undergoing electrophoresis on 1% agarose gel. Uncut 
plasmids were run alongside digested plasmids as a control to check the success of restriction 
digests. 
3.2.4.4 - Agarose gel electrophoresis 
1% agarose gels (Fisher Scientific, 13478388) were prepared for electrophoresis using MidoriGreen 
dye (Nippon Genetics, MG05), NEB Quick-Load® Purple 1 kb Plus DNA Ladder (NEB, N0550S) and 
Quick-Load® 100 bp DNA Ladder (NEB, N0467S). The gels ran for 120 minutes at 80V.  
3.3 - Results 
3.3.1 - Plasmid validation by selective growth 
To validate the plasmids pCas9-CR4, pKDsgRNA-ack, and pKDsgRNA-p15, I grew cultures containing 
plasmids on selective media (section 3.2.4.2). Three plates contained chloramphenicol as a selective 
agent, of which two were used to grow cells containing pKDsgRNA-ack and pKDsgRNA-p15 plasmids, 
which confer chloramphenicol resistance. The other served as a control for growing cells containing 
the pCas9-CR4 plasmid, which confers spectinomycin resistance. The other three plates contained 
spectinomycin, one to select for cells containing the pCas9-CR4 plasmid, and the others to act as 
controls for the pKDsgRNA-ack and pKDsgRNA-p15 plasmids. The cultures all grew on the media they 
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had respective resistances to, and the negative controls were all successful, indicating presence of 
the correct plasmids. 
3.3.2 - Plasmid validation by restriction digestion 
I wanted to further clarify the structures of the no-SCAR plasmids, as to be certain of their effects 
when used in recombineering. I achieved this by restriction digest (section 3.2.4.3). I used Addgene’s 
Sequence Analyser tool to find the cut sites of enzymes on all three plasmids when using restriction 
enzymes EcoRI and XhoI. For plasmids pKDsgRNA-ack and pKDsgRNA-p15, EcoRI cuts at 1215bp, 
2724bp, and 5275bp, while XhoI cuts once at 5816bp 
(https://www.addgene.org/browse/sequence/258350/; 
https://www.addgene.org/browse/sequence/228332/). For plasmid pCas9-CR4, EcoRI cuts at 739bp 
and 2111bp, while XhoI cuts once at 4912bp 
(https://www.addgene.org/browse/sequence/212888/). Once extracted and clean, I separately 
incubated the plasmids with both EcoRI and XhoI (section 3.2.4.3). EcoRI should produce bands of 
1509bp, 2551bp, and 2868bp for plasmids pKDsgRNA-ack and pKDsgRNA-p15, and bands of 1372bp 
and 5398bp for plasmid pCas9-CR4. XhoI should produce bands of 6959bp and 6928bp for plasmids 
pKDsgRNA-ack and pKDsgRNA-p15 respectively and produce a 6770bp band for plasmid pCas9-CR4. I 
made and ran two 1% agarose gels with wells for electrophoresis (section 3.2.4.4). This digest 
proved problematic, with no clear bands being produced by any restriction enzymes, while the uncut 
plasmid produced clear bands of the expected size. 
3.3.3 - Restriction digest troubleshooting 
I proceeded to troubleshoot this digest through individually altering reagents and conditions to 
discover what was causing the digest to behave unexpectedly. The dH2O I was using in the restriction 
digestion reaction (Table 3.1) could have been contaminated with DNases which were completely 
digesting the plasmids. I autoclaved Milli-Q water before attempting another restriction digest, but 
again the digests produced no clear bands when run on 1% agarose gel. As suggested by Colin 
Lazarus, University of Bristol, I also tried incubating my miniprepped DNA at 70°C for 10 minutes 
before the addition of restriction enzymes to denature exonucleases which may have been present 
and interfering with the digest, but this did not help. Further research suggested that using enzymes 
at a concentration which was too high would result in errant digestion of plasmid DNA, producing 
fragments of unexpected sizes (https://www.thermofisher.com/uk/en/home/life-
science/cloning/cloning-learning-center/34ristol34en-school-of-molecular-biology/molecular-
cloning/restriction-enzymes/restriction-enzyme-key-considerations.html). I tried reducing the 
volume of restriction enzyme in solution to 0.2µl. As this did not produce clear banding on 1% 
agarose gel, I decided to closely analyse the concentrations of the entire restriction enzyme solution. 
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Using a nanodrop to discern the exact concentration of plasmid DNA produced by miniprepping the 
plasmids, I took the minipreps with the highest concentrations (pCas9-CR4: 91.40ng/µl, pKDsgRNA-
ack: 51.70ng/µl, pKDsgRNA-p15: 48.50ng/µl) of DNA to be digested. This was to ensure there was 
enough DNA in the digestion so that it would both be visible on a 1% agarose gel and to avoid 
nonspecific degradation of DNA by star activity. To ensure I achieved the correct ratio of DNA to 
restriction enzyme to maximise the chance of a successful restriction digest, I adjusted the volumes 
of the DNA solution and restriction enzyme solution in the reaction, also changing the volume of 
dH2O I used. The changes I made are summarised in Table 3.1. 
Table 3.1. The composition of restriction digestion reactions, comparing my initial unsuccessful 
effort to the subsequently adjusted, and successful effort below. DNA concentrations for the 
successful run were: pCas9-CR4: 91.40ng/µl, pKDsgRNA-ack: 51.70ng/µl, pKDsgRNA-p15: 48.50ng/µl. 
  
 This restriction digest was largely successful, with agarose gel electrophoresis producing bands of 
the expected size for many combinations of restriction enzyme. Digestion of plasmid pCas9-CR4 with 
EcoRI produced a band consistent with the prediction of 5398bp but produced a band larger than 
the expected 1372bp. I would have investigated this further if I had more time in the laboratory. 
Digestion with XhoI produced a band consistent with the 6770bp prediction. Digestion of plasmid 
pKDsgRNA-p15 with EcoRI produced bands consistent with predicted bands of 1509bp, 2551bp, and 
2868bp, while digestion with XhoI produced a band consistent with the 6928bp prediction (Figure 
3.1). Unfortunately, the capture of the agarose gel showing the restriction digest of plasmid 
pKDsgRNA-ack did not successfully download and due to Covid-19 closing our laboratories, I could 














Enzyme (µl) dH2O (µl) Result 
       
pCas9-CR4 2.00 0.20 1.00 0.50 16.30 Unsuccessful 
pKDsgRNA-
ack 2.00 0.20 1.00 0.50 16.30 Unsuccessful 
pKDsgRNA-
p15 2.00 0.20 1.00 0.50 16.30 Unsuccessful 
       
pCas9-CR4 2.00 0.20 3.00 0.12 14.68 Successful 
pKDsgRNA-
ack 2.00 0.20 4.84 0.12 12.84 Successful 
pKDsgRNA-
p15 2.00 0.20 5.16 0.12 12.52 Successful 
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electrophoresis and saw that digestion with EcoRI produced bands consistent with the predicted 
sizes of 1509bp, 2551bp, and 2868bp for plasmid pKDsgRNA-ack, as well as a 6959bp band when 
digested with XhoI. 
 
Figure 3.1. Digital image of 1% agarose gel electrophoresis of restriction digests. Results include 
digestion of plasmids pCas9-CR4 (CR4) and pKDsgRNA-p15 (p15) by restriction enzymes XhoI and 
EcoRI. Uncut, circular versions of both plasmids were also run as controls (C). Ladders used were NEB 
Quick-Load® Purple 1 kb Plus DNA Ladder (1kb Ladder) and NEB Quick-Load® 100 bp DNA Ladder 
(100bp ladder). 
3.3.4 - Design of proof-of-concept deletion 
With the structure of the no-SCAR plasmids confirmed, I was ready to produce a proof-of-concept 
deletion to establish the no-SCAR system would function as desired in our laboratory. I decided to 
reproduce the ack gene deletion carried out by Reisch & Prather (2015) which I could validate by 
colony PCR and Sanger sequencing. Reproducing a deletion previously created would allow for 
simple comparison of my results to those of Reisch & Prather (2015), quickly providing the means to 
assess the success of my attempt to implement the no-SCAR system. To produce the ack deletion, I 
designed: an oligonucleotide for homologous recombination around the deletion site, and primers 
for CPEC, colony PCR, sgRNA retargeting, PCR, and Sanger sequencing. Using the Benchling software 
(https://www.benchling.com/) to carry out my DNA design, with FASTA sequence for E. coli K-12 
MG1655 retrieved from NCBI (https://www.ncbi.nlm.nih.gov/nuccore/545778205) and using Sigma-
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Aldrich (https://www.sigmaaldrich.com/catalog/product/sigma/oligo?lang=en&region=GB) to order 
the primers and oligonucleotides, I produced the following primers and oligonucleotides: gamR, 
CPEC2F, pKDseq5, sgrnaR, sgrnaA, ackCD, sgRNA-ack-F, sgRNA-ack-R, ackF-PCR, ackR-PCR, and ackF-
seq. Table 3.2 summarises the sequences and intended uses of the synthesised DNA. The processes 
in which these primers and oligonucleotides are used are outlined below. My DNA design was 
performed in accordance with the no-SCAR protocol published by Reisch & Prather (2017).  
3.3.5 - ack gene deletion 
I deemed the replication of the 1095bp deletion of the ack gene performed by Reisch & Prather 
(2015) to be a useful method of confirming I had successfully implemented the no-SCAR system. By 
having results which I could directly compare my deletion to, I would accelerate the process of 
troubleshooting and fine-tuning to efficiently set up no-SCAR for subsequent recombineering. The 
no-SCAR system has been found to be very efficient when producing gene deletions of several 
hundred base pairs, with efficiency reducing but still possible with deletions up to 45kbp (Reisch & 
Prather, 2015). The ack gene was therefore an ideal candidate for a proof-of-concept deletion. As 
the ack gene is located on replichore 2 of E. coli and its coding sequence is on the negative strand of 
DNA, I had to produce an oligonucleotide which had the same sequence as the positive strand 
sequence of E. coli, ensuring that the lagging strand of genomic DNA was targeted when performing 
recombineering. I designed the 71bp ackCD oligonucleotide identical to the published sequence 
(Reisch & Prather, 2015) (Table 3.2) to target the ack gene for deletion, while locating the mutation 
site within 15bp of a PAM site (2413504bp – 2413506bp CCN on the forward strand corresponding 
to NGG on the reverse strand) to disrupt Cas9 binding, thus facilitating Cas9-mediated 
counterselection of mutants. I checked the secondary structure of the oligonucleotide with mfold 
(http://www.unafold.org/mfold/applications/rna-folding-form.php) using default parameters, 
confirming the delta G was higher than -12.5kcal/mol, then added 2-4 phosphorothioate bonds at 
the 5’ end of the oligonucleotide to resist degradation.  
3.3.6 - sgRNAs to target ack 
Having identified a PAM site which could be used to facilitate Cas9-mediated counterselection of 
cells, I had to determine Cas9 target specificity by modifying the 20bp sgRNA sequence on the 
plasmid pKDsgRNA-ack. This is achieved by CPEC using target-specific primers which program the 
pKDsgRNA-ack plasmid to target different genomic loci. As the PAM site identified was on the 
reverse strand of genomic DNA (section 3.3.5), it was necessary to copy the reverse complement of 
the 20bp following the PAM on the forward strand, as this sequence was the target site. Taking this 
sequence and adding gttttagagctagaaatagcaag to the 3’ end of it resulted in the creation of sgRNA-
ack-F. Taking the reverse complement of the 20bp sequence identified above and adding 
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Table 3.2. Primers and oligonucleotides designed for no-SCAR recombineering of E. coli. * indicates added 2-4 phosphorothioate bonds. All primers were 
constructed to have sufficient melting points, GC content, and GC clamp for successful PCR, with secondary structure checked. 
Name DNA Type Sequence 5’ – 3’ Process 
gamR Primer tttataacctccttagagctcga CPEC 
CPEC2F Primer cggcgtcacactttgctat CPEC 
pKDseq5 Primer cagtgaatgggggtaaatgg Colony PCR 
sgrnaR Primer gcctgcagtctagactcgag Colony PCR 
sgrnaA Sequencing Primer agctttcgctaaggatgattt DNA Sequencing  
ackCD Oligonucleotide G*T*TAGTACTGGTTCTGAACTGCGGTAGTTCTTCACTGGTTATCCCAACCAACGAAGAACTGG TTATCGC*G*C Recombineering 








ackF-PCR Primer CATGCGCTACGCTCTATGG PCR 
ackR-PCR Primer CGCCTTTGCGTTCCATTGC PCR 
ackF-seq Sequencing Primer TTCCATACCCACTATCAGGTATCC DNA sequencing  
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gtgctcagtatctctatcactga to the 3’ end led to the creation of primer sgRNA-ack-R. Using the Cas-
OFFinder software (http://www.rgenome.net/cas-offinder/) I confirmed the target site only targeted 
a single genomic locus. For “PAM Type” I selected “SPCas9: 5’-NRG”, for the “Target Genome” I 
selected Escherichia coli (K-12, MG1655), into the query sequence box I entered the 20bp target 
identified above, and for “Mismatch Number” I selected “3”.  I ordered primers sgRNA-ack-F and 
sgRNA-ack-R from Sigma-Aldrich with standard desalting and 0.025µmol synthesis. While Reisch & 
Prather (2015) carried out the deletion in E. coli DH5α cells, it was possible to design an ack deletion 
in E. coli MG1655 using the same oligonucleotides and with primer design unaffected. 
I also had the opportunity to observe and practise electroporation of electrocompetent E. coli cells 
to prepare myself to carry out my own transformation of electrocompetent cells. This training was 
provided by Beth Eldridge, University of Bristol. 
3.3.7 - Covid-19 and beyond 
It was after I received electroporation training that our laboratories were shut in response to the 
growing Covid-19 outbreak in the United Kingdom. This meant that despite having designed and 
ordered reagents and materials for the rest of the proof-of-concept ack gene deletion, I was unable 
to carry it out. Below I outline the steps I would have taken, had our laboratories remained open, as 
a record of the plans I had made, which could be helpful for future lab members. 
3.3.8 - Retargeting plasmids for recombineering 
I would have set up two PCR reactions of volume 50µl, the first with primers gamR and sgRNA-ack-F, 
with the second using primers CPEC2F and sgRNA-ack-R. In 0.2ml PCR tubes at room temperature I 
would combine 10µl 5X Colourless GoTaq Flexi Buffer (Promega, M890A), 4µl MgCl2 solution 
(Promega, A351B), 1µl PCR nucleotide mix (Promega, C1141), 1µl each primer, 0.25µl GoTaq Hot 
Start Polymerase (Promega, M5001), 2µl plasmid pKDsgRNA-ack as DNA template, and 30.75µl 
dH2O. I would then set a PCR reaction to run for an initial denaturation cycle at 95°C for 120s, then 
30 cycles of 95°C for 8s, 64°C for 8s, and 72°C for 180s. I would then DpnI (Thermo Fisher Scientific, 
ER1701) digest the template, adding 10 units per 50µl to the reaction tube, incubating at 37°C for 15 
minutes. Following this, I would run the PCR products on a 0.8% agarose gel (section 3.2.4.4). I would 
excise the bands produced at 3kb and 4kb, followed by gel purifying the PCR products using the 
QIAquick Gel Extraction Kit (Qiagen, 28704) and eluting in 1µl of dH2O. I would then perform CPEC 
cloning by mixing both PCR products together in a single 0.2ml PCR tube as above, removing the 
DNA template and adding 32.75µl dH2O instead. The PCR products serve as the DNA template and 
primers here. I would then set a PCR reaction to run for an initial denaturation cycle at 95°C for 120s, 
then 15 cycles of 95°C for 8s, 57°C for 15s, and 72°C for 180s.  
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3.3.9 - Transforming bacterial cells by electroporation 
I would transform 5µl of the PCR reaction (section 3.3.8) into 50µl electrocompetent E. coli (section 
3.2.3), pulsing using an electroporator with standard settings for a 1 mm cuvette of 1.8 kV, 200 Ω, 
and 25mF. These cells would recover in 500µl SOC medium (Merck, S1797-10X5ML) for 60 minutes 
at 30°C, and then I would plate 200µl of the solution on LB agar with 50 mg/L spectinomycin, 
incubating overnight at 30°C.  
3.3.10 - Sanger sequencing sgRNAs 
To confirm that the sgRNA was retargeted, I would pick an isolated colony with a sterile pipette tip 
and suspend in 100µl dH2O, before transferring 10µl of the cell suspension to a 0.2ml PCR tube for 
PCR (section 3.3.8). Altered reagents include: 1µl primer pKDseq5, 1µl primer sgRNAR, and 22.75µl 
dH2O. I would then set a PCR reaction to run for an initial denaturation cycle at 95°C for 120s, then 
30 cycles of 95°C for 15s, 57°C for 15s, and 68°C for 60s. I would then Sanger sequence the PCR 
products using a BigDye Terminator v3.1 Cycle Sequencing Kit (ThermoFisher, 4337454). This 
involves combining in a lidded 0.2ml PCR tube 2µl BigDye Sequencing Reaction Mix, 1µl 5x 
Sequencing buffer, 3µl PCR product, 1µl sequencing primer sgrnaA, and 3µl dH2O. Using a thermal 
cycler, I would initially cycle the solution at 94°C for 30s, then 30 cycles of 96°C for 10s, 50°C for 5s, 
and 60°C for 240s. To purify the sequencing products, I would transfer 10µl of the sequencing 
products to a clean 1.5ml microcentrifuge tube, before adding 10µl dH2O, 5µl 125mM EDTA (Fisher 
Scientific, 10618973), and 60µl 100% ethanol. I would first vortex the microcentrifuge tube and then 
centrifuge at 13,000rpm for 10 minutes. I would then remove the supernatant and rinse the pellet 
with 100µl 75% ethanol, before again centrifuging at 13,000rpm for 10 minutes. Removing the 
supernatant again, I would dry the pellet in a vacuum, before resuspending in 15µl formamide 
loading buffer (Geneflow, B9-0028) and transferring to a microtiter plate for sequencing. Finally, I 
would recover the cloned E. coli cells in LB media with 50mg/L spectinomycin at 30°C. 
3.3.11 - Recombineering 
Once I had established that the sgRNA was successfully retargeted, I would implement 
recombineering and Cas9 counterselection in E. coli MG1655. I would prepare a liquid culture of E. 
coli DH5α containing plasmid pCas9-CR4 with 30µg/L chloramphenicol (section 3.2.2). I would then 
miniprep pCas9-CR4 using QIAprep Spin Miniprep Kit (50) (QIAGEN, 27104). Next, I would transform 
5µl pCas9-CR4 into 50µl electrocompetent MG1655 E. coli using an electroporator with settings for a 
1 mm cuvette of 2.5kV, 200 Ω, and 25mF. Transformed cells would recover in SOC for 60 minutes, 
before being plated on LB agar with 30µg/L chloramphenicol at 37°C. The next day I would pick a 
colony and prepare electrocompetent cells (section 3.2.3), before transforming cells with plasmid 
pKDsgRNA-ack using the same electroporator settings as for pCas9-CR4. I would recover cells again 
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in SOC for 60 minutes, then plate 200µl of the solution on LB agar with 30mg/L chloramphenicol and 
50mg/L spectinomycin, incubating overnight at 30°C.  
Once both plasmids required for recombineering and Cas9 counterselection were successfully 
transformed into E. coli MG1655, it would then have been possible to begin editing the bacteria’s 
genome. I would achieve this by first inoculating a colony from the chloramphenicol/spectinomycin 
LB plate into 4ml of SOB (Fisher Scientific, 11337689) with 30mg/L chloramphenicol and 50mg/L 
spectinomycin, incubating at 30°C until the OD600 reaches 0.4. I would then induce λ Red by addition 
of L-arabinose (VWR, 1B1473-25G) to 0.2% and incubate for 15 minutes at 30°C. Next, I would place 
the culture on ice for 5 minutes to chill the cells, and then centrifuge at 3000 x g for 10 minutes to 
pellet the cells, before removing the supernatant. I would resuspend the cells in 1ml ice-cold dH2O 
and pipette 1ml glycerol-mannitol solution (Fisher Scientific, 15351791) underneath the cells. I 
would centrifuge the cells at 3000 x g for 10 minutes before removing both layers of supernatant in 
turn. I would then finally resuspend the cells in 400µl glycerol-mannitol solution. 
3.3.12 - Linear DNA transformation 
To achieve homologous recombination-mediated genetic engineering of E. coli MG1655, I would 
take 50µl of the electrocompetent cells prepared (section 3.3.11) and add the ackCD oligonucleotide 
to a concentration of 2µM, using a nanodrop to inform DNA concentration. After mixing gently and 
transmitting to an ice-cold 1mm electroporation cuvette (Geneflow, E6-0062), I would transform the 
donor DNA into the cells by electroporation (section 3.3.9). One can provide a control here by 
transforming cells with an oligonucleotide which is untargeted by the sgRNA, which would not 
prevent Cas9 from binding and as such would result in cell death. I would then recover the cells in 
1ml of SOC at room temperature, before incubating at 30°C and shaking at 250rpm.  
3.3.13 - Serial dilution  
Following culture growth, I would perform a serial dilution of five tenfold dilutions of the cell culture, 
spotting 8µl onto LB agar plates with 30mg/L chloramphenicol, 50mg/L spectinomycin, and 100µg/L 
anhydrotetracycline (aTc) (Stratech Scientific, C4291-APE-25mg). I would seal these plates with 
parafilm and incubate at 30°C. If I were to do the control experiment alongside the on-target 
oligonucleotide transformation, I would expect to see colonies about three orders of magnitude 
higher on the experimental plates. 
3.3.14 - Genotyping colonies 
I would genotype the experimental colonies by Sanger sequencing (section 3.3.10). I would pick an 
isolated colony (section 3.3.13) with a sterile pipette tip and suspend in 100µl dH2O, before 
transferring 10µl of the cell suspension to a 0.2ml PCR tube for PCR (section 3.3.8). Altered reagents 
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include: 1µl primer ackF-PCR, 1µl primer ackR-PCR, and 22.75µl dH2O. I would then set a PCR 
reaction to run for an initial denaturation cycle at 95°C for 120s, then 30 cycles of 95°C for 15s, 52°C 
for 15s, and 68°C for 60s. I would then Sanger sequence the PCR products (section 3.3.10). Altered 
reagents include: 1µl sequencing primer ackF-seq. Thermal cycling, purification and sequencing of 
products remain unchanged (section 3.3.10).  
3.3.15 - pKDsgRNA-ack curing 
From the serial dilution plate (section 3.3.13) I would prepare liquid culture with a single colony 
inoculated (section 3.2.2). I would then streak the cell culture on a LB agar plate with 30mg/L 
chloramphenicol and incubate overnight at 42°C. To test for spectinomycin resistance, I would patch 
isolated colonies onto both LB agar plates and LB agar with 50mg/L spectinomycin and incubate until 
I could see growth. Colonies which cannot grow on the LB agar with spectinomycin plate have 
therefore been cured of plasmid pKDsgRNA-ack, as it confers spectinomycin resistance. These 
colonies can then be used for transformation with a retargeted target plasmid for subsequent no-
SCAR recombineering, enabling multiple genomic edits in the same cell line by repeating the 
processes outlined above. I deemed it possible, and of biological interest, to perform iterative cycles 
of deletions on the same cell lines, informed by the in silico predictions of the E. coli WCM, with the 
long-term goal of discovering a potentially novel minimal gene set for E. coli. Once established, the 
no-SCAR method of genome engineering would be able to rapidly produce gene deletions in a way 
which hopefully, when guided by the predictions of the WCM, would produce viable cells with a 
significant portion of their genome removed. 
3.3.16 - pCas9-CR4 curing 
When I had achieved my desired number of iterative genomic edits in each E. coli MG1655 cell line, I 
would remove plasmid pCas9-CR4, leaving the cells plasmid-free. I would miniprep pKDsgRNA-p15 
using the QIAprep Spin Miniprep Kit (50), then transform the plasmid into the electrocompetent 
cells by electroporation (section 3.3.9). I would then recover the cells in 1ml SOC at 30°C for 2-3 
hours. I would add 100µg/L aTc to induce cas9 and the p15 targeting sgRNA. After incubating for two 
hours at 30°C, I would plate the cells on LB agar with 50mg/L spectinomycin and 100ng/L aTc, 
incubating again at 30°C overnight. Finally, I would screen 10-20 colonies by patching onto both LB 
agar and LB agar with 30mg/L chloramphenicol, incubating at 37°C to confirm the loss of 
chloramphenicol resistance.  
3.3.17 - Post proof-of-concept deletion 
Identifying gene targets to pursue beyond a proof-of-concept deletion was a very involved process 
that was a point of continuous discussion among members of our group. An ambitious goal was to 
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begin deletions in genome-reduced E. coli strains such as DGF-298 (Hirokawa et al., 2013) and 
MDS42 (Pósfai et al., 2006), with the aim of creating further genome reduction. This would be 
achieved by iterative cycles of gene deletions using the no-SCAR system described above, deleting 
gene after gene as directed by the single gene knockout simulations performed using the E. coli 
WCM. In this way, we would successfully combine in silico and in vivo research by streamlining the 
process of selecting candidate genes for deletion while maintaining viable cells. With an initial five-
day duration for an initial no-SCAR mutation, with a subsequent three-day turnaround for each 
mutation thereon, this process would still be time-consuming. Assuming perfect conditions, it would 
have been possible to produce ~40 deletions using the no-SCAR method in the time I had allocated 
myself for laboratory research. Subsequent mutations would have been beyond the scope of this 
project. Furthermore, when modifying E. coli MDS42, it is necessary to question the accuracy of the 
E. coli WCM’s predictions, as the model is a hybrid of E. coli strains MG1655, B/r, and BW25113 
(Figure 1.1). Mutations in E. coli MDS42 could behave very differently to the in silico predictions. The 
process of acquiring E. coli MDS42 also proved difficult, with the vendor I contacted responding 
slowly to enquiries. 
3.3.18 - General troubleshooting 
I had to solve various problems in the laboratory, including having LB media which was being 
contaminated with bacterial growth multiple times. This was despite me following aseptic technique 
to the best of my ability. The crucial change I made was to cease working in a laminar airflow hood, 
which may have had filters that needed changing amongst other problems. I instead reverted to 
work on the bench with a Bunsen burner, which I believe reduced the number of variables in my 
workspace that could lead to contamination. As explained above, I also overcame the challenges 
posed by the restriction digests of plasmids which allowed me to eventually confirm their structure 
(section 3.3.3). 
3.4 - Discussion 
While not being able to complete a proof-of-concept deletion due to factors beyond my control, the 
steps I took in implementing the no-SCAR protocol in our lab shall serve as a springboard for 
subsequent researchers who are interested in doing similar work. We have organised the delivery of 
E. coli MG1655 and DHα stocks containing plasmids pCas9-CR4, pKDsgRNA-ack, and pKDsgRNA-p15 
which I prepared to Rayane Nunes Lima, a collaborator in Brazil, showing that the progress I made is 
having a useful impact. Through the construction of this thesis and the outlining of the methodology 
that I followed, any subsequent researchers in our lab should be able to implement the no-SCAR 
system more efficiently, as I attempted to make the methods as explicit and reproducible as 
possible. This includes processes which are alluded to vaguely by Reisch & Prather (2017), for 
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example “genotype the colonies…by Sanger sequencing” which fails to detail the PCR reactions 
required for such a process. Through trying to establish this method of genome engineering, we also 
put into place useful systems for future use by our research group. This includes setting up the pre-
purchased RapidRED card, which permits easy ordering of synthesised oligonucleotides and primers 
from Merck (https://www.sigmaaldrich.com/content/dam/sigma-
aldrich/docs/promo_NOT_INDEXED/General_Information/1/edoc13-order-rapidred-card.pdf). If 
members of the lab group want to carry out genome editing as I intended, they will be able to do so 






















Chapter 4 – E. coli WCM single gene knockout analysis 
4.1 - Introduction 
WCMs permit in silico investigation of the literature published on the organism that they simulate. 
The M. genitalium and the E. coli WCMs have been used for this research (Karr et al., 2012; Macklin 
et al., 2020). It is necessary to compare WCMs against data from the literature that was not used to 
construct them, to understand how accurately these models can predict phenotypes. The Covert 
Lab, Stanford, gave us pre-publication access to their E. coli WCM and I hoped to test the model’s 
ability to predict the effects of creating single gene knockouts on the in silico cell’s growth, which I 
would use to inform in vivo genome recombineering (see Chapter 3). Essentiality (see Chapter 1 
section 1.4) provides a simple means of assessing the impact of single gene knockout studies on a 
cell: if the cell can undergo division when a gene is deleted, the gene is “non-essential” (Rancati et 
al., 2018). If cell division is prevented, the gene is instead “essential”.  
Once the E. coli WCM was successfully adapted for use on the BlueCrystal supercomputer cluster 
(see Chapter 3 section 3.1), a process which took several months, we were presented with the first 
chance to test WCM results in vivo. The Keio collection (Baba et al., 2006) is a single gene knockout 
library created by targeting 4288 E. coli K-12 genes with single gene knockouts. Of the 4288 targeted 
genes, 3985 mutants were obtained, indicating the majority of genes had non-essential phenotypes 
when knocked out. Most of the 303 genes which did not produce mutants when deleted are 
candidates for essential genes (Baba et al., 2006). Baba et al. (2006) produced essentiality scores for 
the 4288 genes investigated, combining their assessment of essentiality with those of previous 
researchers. As the output of the E. coli WCM produces data on growth and cell division, I would be 
able to assign essentiality labels to each gene deleted in silico and compare them with the Keio 
collection to assess whether the E. coli WCM could accurately predict the effect of removing both 
non-essential and essential genes from the E. coli genome. To organise and conduct simulations, the 
E. coli WCM uses FireWorks. This open-source tool was designed for managing high-throughput 
workflows using supercomputers (Jain et al., 2015). FireWorks uses an online MongoDB database to 
store workflows which can be retrieved by a supercomputer, executed, and have the results 
uploaded to the online database. FireWorks allows for workflows to be run in parallel on multiple 
supercomputers and for failures to be automatically rectified, increasing the efficiency with which 
simulations can be conducted. 
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4.2 - Methods 
4.2.1 - Data sources 
I downloaded the E. coli WCM from GitHub (https://github.com/CovertLab/WholeCellEcoliRelease). I 
followed installation instructions for the E. coli WCM created by Dianaimh Greene, of the Advanced 
Computing Research Centre, and Joshua Rees-Garbutt 
(https://github.com/squishybinary/Ecoli_whole-cell_model_analysis). I adapted the script 
FireWorksBox_5.sh produced by Joshua Rees-Garbutt 
(https://github.com/squishybinary/Ecoli_whole-
cell_model_FireWorksBoxes/blob/master/FireWorksBox_5.sh). I accessed the essentiality scores for 
the Keio collection published by Baba et al. (2006) at 
(https://www.embopress.org/doi/full/10.1038/msb4100050) – Supplementary Table 3 contained 
data for Keio collection deletion mutants.  
4.2.2 - Procedures 
4.2.2.1 - Setting up the E. coli WCM 
Having downloaded and installed the E. coli WCM on the University’s BlueCrystal supercomputer 
(section 4.2.1), I used the WinSCP client (https://winscp.net/eng/index.php) for File Transfer 
Protocol (FTP) and the PuTTY client 
(https://www.chiark.greenend.org.uk/~sgtatham/putty/latest.html) for Secure Shell (SSH) 
interfacing with the supercomputer.  
4.2.2.2 - Using FireWorks to run the E. coli WCM 
I followed a methodology outlined by Joshua Rees-Garbutt (https://research-
information.bris.ac.uk/ws/portalfiles/portal/254360018/Joshua_Rees_Garbutt_Thesis.pdf) to run 
the FireWorks workflow tool, allowing multiple supercomputers to work in parallel and execute jobs 
rapidly. I created three .yaml files and uploaded them via FTP to 
/newhome/jr16196/wholecell2/wcEcoli/wholecell/fireworks using the file my_fworker.yaml. A 
second file, my_launchpad.yaml, was changed to access my desired online database and read: 


















The third file, my_qadapter.yaml, was adapted to correspond with my supercomputer account and 





















4.2.2.3 - Using FireWorks to create single gene knockout simulations 
I created the bash script FireWorksBox_3.sh 
(https://github.com/JJRightmyer/SingleGeneKO/blob/main/FireWorksBox_3.sh) and uploaded it via 
FTP to /newhome/jr16196/wholecell2/wcEcoli/wholecell/fireworks. This script provides a 
description of the simulation to the script fw_queue.py which translates it into a workflow. My 
FireWorksBox_3.sh script was adapted from: https://github.com/squishybinary/Ecoli_whole-
cell_model_FireWorksBoxes/blob/master/FireWorksBox_5.sh. FireWorksBox_3.sh was created to 
produce 1214 simulations, each knocking out a single gene and running the resulting model for two 
generations. I then created a directory in 
/newhome/jr16196/wholecell2/wcEcoli/wholecell/fireworks, called /logs, in which I created two 
subdirectories called /launchpad and /qadapter. To set the supercomputer to fetch and launch 
FireWorks I ran the following command: 
qlaunch -r -l my_launchpad.yaml -w my_fworker.yaml -q my-




I then made FireWorksBox_3.sh executable and ran it using commands: 
cd /newhome/jr16196/wholecell2/wcEcoli/wholecell/fireworks 
chmod u+x FireWorksBox_3.sh 
./FireWorksBox_3.sh 
From the simulation output, the massFractionSummary.png and histogramDoublingTime.png files 
were of interest as they provided graphs of changing cellular components and cell division 
respectively as the simulation proceeded. I manually analysed the massFractionSummary.png graphs 
to assess the essentiality of each knocked-out gene in the simulation. 
4.2.2.4 - Using FireWorks to create wild-type simulations 
I altered FireWorksBox_3.sh to produce a script which described 30 wild-type simulations, which 
were run in the E. coli WCM for two generations. I named this script FireWorksBox_4.sh 
(https://github.com/JJRightmyer/SingleGeneKO/blob/main/FireWorksBox_4.sh) and it was run using 
the same methodology as outlined in Section 4.2.2.3. Due to time constraints, Ioana Gherman kindly 
ran these simulations for me on BlueCrystal. 
4.2.2.5 - Keio collection 
I downloaded Supplementary Table 3 from Baba et al. (2006) (section 4.2.1) and manually compared 
their assessment of essentiality against the output of the E. coli WCM.  
4.2.3 - Data storage 
The data I produced from two runs of 1214 single gene knockout simulations using the E. coli WCM 
can be found at the University of Bristol Advanced Computing Research Centre Research Data 
Storage Facility (https://data.bris.ac.uk/data/dataset/1v58mpokwp9927bf6s36osb5k). The growth 
data for 30 wild-type simulations performed by me and Ioana Gherman can also be found here 
(https://data.bris.ac.uk/data/dataset/2uymxzuikvnc526gu3b44gvxht). 
4.3 - Results 
4.3.1 - Issues with running gene knockout simulations 
An initial run of 1214 single gene knockout simulations produced massFractionSummary.png files 
with inaccurate labels (Figure 4.1). The GeneID label attributed to the graphed data was different to 
the GeneID in the graph’s title, with the mismatch being inconsistent across the simulations 
(between 2-4 genes off each time). Our team thought that the issue, despite requiring manual fixing 
due to its inconsistent nature, was superficial. We thought that we had still knocked out our 
intended gene targets. I discovered this was not the case and we had unintentionally knocked out 
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360 unmodelled genes. Joshua Rees-Garbutt identified a mistake within the rnas.tsv file in directory 
./reconstruction/ecoli/flat which caused the first entry (EG30099) in rnas.tsv to be ignored, shifting 
the gene index down by one. This caused all subsequent gene knockouts to be inaccurate. Joshua 
Rees-Garbutt proceeded to fix the mistake in the rnas.tsv file which caused the simulations to knock 
out unmodelled genes and my next run of simulations was successful. This took two weeks.  
4.3.2 - 1214 single gene knockouts 
Having set up the E. coli WCM (Section 4.2.2.1), I conducted the second set of 1214 single gene 
knockout simulations for two generations. I used two generations due to computational space 
restrictions while requiring multiple generations to assess gene essentiality. Of the 1214 modelled 
genes which were knocked out in individual in silico cells, 899 genomes successfully produced output 
of massFractionSummary.png, histogramDoublingTime.png, and short_name files. The file named 
massFractionSummary.png details growth metrics for the simulations including: dry mass, protein 
mass, rRNA mass, mRNA mass, and DNA mass (Figure 4.1). The histogramDoublingTime.png file 
shows if the in silico cell has divided, which is also shown by massFractionSummary.png. The 
Figure 4.1. The graphed output of a single gene knockout using the E. coli WCM. Each line 
represents a single generation of the cell growing. Changes in the cell’s mass, protein, rRNA, mRNA, 
and DNA are plotted over time. This simulation was supposed to knock out frmA (EG50010) but 
instead knocked out the unmodelled gene ffs (FFS-RNA[c]_KO). The first generation of the cell is 




short_name file details which gene was knocked out in the model. The genes that were knocked out 
in these 899 genomes were non-essential, as cell division occurred. 313 genes produced no output 
when knocked out, as in silico cells did not divide and therefore produced no automated graphs. This 
could imply that these genes were essential or could mean there was a problem with the code when 
producing these knockouts. Genes gltX (EG10407) and gor (EG10412) produced 
histogramDoublingTime.png and short_name files when knocked out but failed to produce a 
massFractionSummary.png file. This was due to a computational error and while the in silico cells did 
divide, I could not analyse the cellular components which underlay the cell’s behaviour. I decided 
against their inclusion in my analysis of the simulations.  
4.3.3 - Keio collection issues 
Comparing the results of the single gene knockouts produced by the E. coli WCM to the essentiality 
score given by Baba et al. (2006) in the Keio collection demanded an unexpected step in data 
analysis. Supplementary Table 3 (https://www.embopress.org/doi/full/10.1038/msb4100050) 
contained the raw data Baba et al. (2006) used to define gene essentiality, which they accomplished 
by calculating a score based on essentiality data from Gerdes et al. (2003), Hashimoto et al. (2005), 
Kang et al. (2004), and their own data. This was done to allow comparison with other E. coli gene 
essentiality studies. The only way to separate the data produced by Baba et al. (2006) from the 
essentiality score they provide was to manually calculate and deduct the scores attributed to 
essentiality data from Gerdes et al. (2003), Hashimoto et al. (2005), and Kang et al. (2004). I chose to 
separate the data from Baba et al. (2006) from those of the other researchers as Baba et al. (2006) 
were the only group to publish results of a single gene knockout experiment. The other researchers 
employed strategies such as genetic footprinting and transposon mutagenesis, to which “striking 
differences” could be attributed (Baba et al., 2006). I believed a direct comparison between my own 
single gene knockout experiment and one found in the literature would produce the most 
interesting result. Once I found the score Baba et al. (2006) gave their own data, I could assign the 
gene essentiality result they discovered from their in vivo experiments. This was a time consuming 
process which highlighted the importance of clear data presentation to me. The difficulty I 
experienced was exacerbated by the website used by Baba et al. (2006) to distribute the Keio 
collection (http://ecoli.aist-nara.ac.jp/), which was down for the duration of my project. 
4.3.4 - Comparing Keio collection essentiality to model output 
Once I had interpreted the in vivo gene essentiality result from Baba et al. (2006), I was able to 
compare this to the results of the single gene knockout experiment outlined in Section 4.3.2. I 
manually constructed a table to compare the model output to the Keio collection, first inputting the 
Keio collection assessment of essentiality, then comparing that to the E. coli WCM output and 
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assigning a key to document the agreement or disagreement of the two (Appendix 17). A challenge 
of this was reconciling the gene codes the Keio collection and the E. coli WCM had used, as they 
were different and required manual fixing (e.g. the alr gene had an ID of EG10001 in the model but 
ECK4045 in the Keio collection). I then created a summary table for the results of this comparison 
(Table 4.1). Of the 1212 modelled genes I analysed, 834 agreed with the Keio collection, with 727 
non-essential genes producing graphs of standard growth and 64 essential genes not producing 
output, and 43 non-essential genes producing graphs of impacted growth.  
Table 4.1. A summary of the E. coli whole-cell model (WCM) single gene knockouts output when 
compared to essentiality data published in the Keio collection. A breakdown of each result is 
provided with reasons for agreement and disagreement. In bold are the total numbers of genes in 
the E. coli WCM which agree and disagree with the Keio collection, alongside genes whose 
essentiality could not be assessed. 
Gene phenotype in 
the Keio collection 
Phenotype in the E. 
coli WCM 
Agreement between 
the Keio collection 
and the E. coli WCM 
Genes 
Non-essential  Standard growth Agree 727 
Non-essential  Impacted growth Agree 43 
Essential  No output Agree 64 
   834 
Essential  Standard growth Disagree 115 
Essential  Impacted growth Disagree 7 
Non-essential  No output Disagree 249 
   371 
Uncertain essentiality Standard growth Uncertain 7 
 
30 wild-type simulations (section 4.2.2.4) provided values of growth for cells showing a standard 
growth phenotype (Table 4.2). If any of the cell’s dry, protein, rRNA, mRNA or DNA mass values were 
lower than the final growth range values at the end of the second generation of a simulated cell, I 
deemed the knockout to have produced the impacted growth phenotype. Of the 371 genes which 
disagreed with the Keio collection when simulated, 115 were genes that Baba et al. (2006) showed 
were essential in vivo, which produced graphs of standard growth when knocked out in the model, 
seven were essential genes which produced graphs of impacted growth when knocked out, and 249 
were non-essential genes which did not produce output. Seven genes also produced graphs of 
normal growth but were given uncertain essentiality by Baba et al. (2006), so they could neither 
agree nor disagree with the simulation results. This highlights that the E. coli WCM currently has no 
designated output for in silico cells which fail to divide. Instead, we assumed that because the 
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knocked out gene caused the model to produce no output, it may be essential to the cell’s growth. 
This is now being investigated more carefully by other members of our group. 
Table 4.2. The ranges for Y-axis values of 30 wild-type simulations at the end of two generations of 

















Of the single gene knockouts described above, seven (EG10088, EG10205, EG10206, EG10207, 
EG10208, EG11314, EG11539) were essential genes which successfully produced output, indicating 
they were non-essential to the in silico cell’s growth and disagreeing with the Keio collection. The 
massFractionSummary.png files produced by these simulations were impacted compared to the 
standard output graphs, with dry mass, protein mass, rRNA mass, mRNA mass, and DNA mass lower 
than the ranges which indicate the standard growth phenotype (Figure 4.2). This was also the case 
for 43 non-essential single gene knockouts which agreed with the Keio collection, with 
massFractionSummary.png files different to the standard output graphs (Figure 4.2). The 
inconsistent axes of the graphs produced by the E. coli WCM made visual interpretation and 
comparison of the outputs difficult 
(https://data.bris.ac.uk/data/dataset/1v58mpokwp9927bf6s36osb5k). As these graphs are produced 
automatically by the model, modifying them requires familiarity with details of the model, which are 
time-consuming to obtain. The graphs I present in Figure 4.2 were manually reconstructed to allow 
comparison between the model outputs. Nevertheless, the deviation of these cells from the 
standard growth pattern warrants further investigation, for example repeating these single gene 
knockouts over more generations to see if cells will continue to divide beyond two generations. This 
may resolve the issue as the model’s creators suggested that initial metabolite pools may sustain the 
cell for two generations even when an essential gene is removed (personal correspondence). 
It may be possible to investigate why 313 single gene knockouts produced no output when run using 
the E. coli WCM through gene knockdown experiments. Ioana Gherman of our research group has 
since shown that creating 90% knockdowns allows most of the simulated cells to divide and is 
continuing to investigate 97% and 100% knockdowns. As high percentage gene knockdowns should 
produce cells with similar phenotypes to gene knockouts, this should reveal if there is an issue with 







Figure 4.2. Plots of four E. coli WCM simulation outputs for cells grown for two generations with axes 
adjusted to enable comparison. Dry, protein, rRNA, mRNA, and DNA mass of cells were plotted over time. 
The first generation is plotted in black and the second in yellow. a) a wild-type simulation from which the 
standard growth phenotype was established. b) a single gene knockout simulation of alr (EG10001) 
showing the standard growth phenotype. c) a single gene knockout simulation of aroE (EG10077) showing 
the impacted growth phenotype in the second generation. d) a single gene knockout simulation of asd 
(EG10088) showing the impacted growth phenotype in both generations. 
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4.4 - Discussion 
This work represents the first study of gene essentiality that combines the E. coli WCM and the 
literature. Comparing the 1214 modelled genes in the E. coli WCM to the Keio collection, a single 
gene deletion library deemed the gold standard for identifying essential genes (Goodall et al., 2018), 
has allowed us to assess the model’s predictive capabilities when creating single gene knockouts. My 
preliminary results suggest the E. coli WCM produces single gene knockouts which agree with at 
least 68.8% of the Keio collection over two generations. This figure is promising, but there is also 
much room for improvement. Conversations with the model’s creators have revealed that 
computational bugs could have caused 313 single gene knockouts to produce no output. This is not 
unexpected as they have not yet explored how the model responds to gene knockouts. The results 
of Ioana Gherman’s 90% knockdown experiment suggest that there are problems in the model when 
responding to gene knockouts, as opposed to knockdowns. This probably indicates that my results 
are caused by problems with the model’s code not working the way it was intended when producing 
gene knockouts, which I have relayed to the model’s creators. This has already led to better 
procedures for modelling gene function modifications in the E. coli WCM, which will make it much 
more useful for future research that uses the model to investigate the effects of modifying gene 
functions. 
My results also establish gene targets for no-SCAR recombineering (see Chapter 3) where there is 
both agreement and disagreement between the E. coli WCM output and the Keio collection. Seven 
genes (EG10052, EG10053, EG10055, EG10527, EG11006, EG11866, EG11868) which were not 
required for cell division in my simulations, were labelled as possessing uncertain essentiality (Baba 
et al., 2006) and therefore are strong candidates for investigation using the no-SCAR method. This 
research could help provide more data regarding the essentiality of these genes, for example araA 
(EG10052) and rhaD (EG11866) whose essentialities have proved inconclusive (Gerdes et al., 2003; 
Baba et al., 2006; Goodall et al., 2018). The no-SCAR method also permits the simple creation of 
multiple gene deletions in a cell, which would aid our understanding of possible effects of genomic 
context on the essentiality of these genes (Rancati et al., 2018). As a cell’s need for specific genes 
changes with the presence or absence of other genes in its genome, it could be the case that these 
genes of uncertain essentiality are dependent on their genomic context (Rees-Garbutt et al., 2020c). 
Further in vivo investigation of the E. coli WCM’s predictions, accurate or otherwise, will help 
establish how useful this model can be when designing genetic edits in E. coli. This work, alongside 
repeating the single gene knockouts with more generations, repeating the simulations to test for 
consistency between the simulations, and potentially performing multiplex gene knockout in silico 
will give further indication of the E. coli WCM’s ability to usefully inform E. coli genome research. 
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Chapter 5 – Improving the E. coli WCM 
5.1 - Introduction 
Despite severely impacting my project’s progress in the laboratory, the Covid-19 pandemic sparked 
further collaboration between our research group and that of Markus Covert at Stanford University, 
who created both the E. coli and M. genitalium WCMs which have served as focal points of my 
research. The collaboration was designed to develop the E. coli WCM beyond its release snapshot, 
utilising the skillsets of researchers outside Stanford to help propel the E. coli WCM towards being a 
true WCM, able to account for the function of all well-annotated E. coli genes. This would create a 
model which shows greater fidelity to in vivo E. coli. This would permit cross-evaluation of E. coli 
datasets in the literature beyond what the Covert Lab has already achieved (Macklin et al., 2020) and 
provide an increasingly useful model for genome design in silico. 
Initial communication with the Covert Lab was focused on deciding which elements of the E. coli 
WCM could be usefully improved by researchers who were relatively unfamiliar with the inner 
workings of the model. Conversations with Markus Covert, Travis Horst, Gwanggu Sun, Joshua Rees-
Garbutt, and Sophie Landon led me to begin investigating how cellular metabolism was 
implemented in the E. coli WCM. The metabolic model of the E. coli WCM has detailed quantitative 
parameters for 380 metabolic reactions (Macklin et al., 2020) and is a reconstruction of the E. coli K-
12 model published by Weaver et al. (2014), which was in turn based on the Orth et al. (2011) 
metabolic model of E. coli. The metabolic model is also able to adjust to time-dependent/cell cycle-
dependent behaviour from other simulated processes while maintaining homeostasis, representing 
a significant improvement over the M. genitalium WCM (Karr et al., 2012). Macklin et al. (2020) 
incorporate kinetics-based and FBA-based approaches to make use of the many reported parameter 
values for E. coli without additional model fitting to ensure metabolism is readily integrable with the 
rest of the WCM. However, there is scope to add parameters for many more metabolic reactions, 
with 1913 metabolic reactions published to the EcoCyc database for E. coli MG1655 (Keseler et al., 
2017). My goal was to successfully implement metabolic reactions which I found interesting and 
could direct the development of the E. coli WCM towards unique applications. 
 I also worked with Travis Horst to improve transcriptional regulation within the E. coli WCM. The 
quantitative model of transcriptional regulation in the E. coli WCM incorporates the function of 22 
transcription factors regulating 355 genes, in turn describing 438 regulatory interactions (Macklin et 
al., 2020). Implementing transcriptional regulation requires modelling the activation or inhibition of 
a transcription factor and once it is active, modelling its effect on RNA polymerase recruitment to a 
promoter site. Macklin et al. (2020) separated transcription factors into three classes based on their 
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mechanism of activation. The first, one-component systems, are transcription factors that are 
directly activated or inhibited by a small molecule ligand. The second, two-component systems, are 
transcription factors that are paired with a separate sensing protein that responds to an 
environmental stimulus. The sensing protein phosphorylates the cognate transcription factor in this 
case. The third, zero-component systems, are transcription factors that are active whenever they are 
expressed. This includes transcription factors modulated by complex feedback loops which are 
simplified in the model to be always active to compensate for lack of understanding. There is 
capacity for implementing further transcriptional regulation in the E. coli WCM, as the EcoCyc 
database details 204 transcription factors describing 6399 regulatory interactions (Keseler et al., 
2017). My goal was to enhance the representation of transcriptional regulation within the E. coli 
WCM to improve the model’s ability to respond to a range of environmental conditions. 
5.2 - Methods  
5.2.1 - Data sources 
I downloaded the version of the E. coli WCM under development from the Covert Lab’s private 
GitHub repository (https://github.com/CovertLab/wcEcoli). I used the EcoCyc database for analysing 
metabolic reactions (https://ecocyc.org/). I obtained gene regulation data for Lrp from Supplemental 
file 4 published by Kroner et al. (2019) (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349092/). 
5.2.2 - Procedures 
5.2.2.1 - Setting up the E. coli WCM 
I followed installation instructions created by Sophie Landon to install and run the current version of 
the E. coli WCM on BlueCrystal. I used the PuTTy software to run the following code: 
module add tools/git-2.22.0 
 





git clone https://github.com/CovertLab/wcEcoli 
cd wholecell3/ 
 
git clone https://github.com/pyenv/pyenv.git ~/.pyenv 
echo 'export PYENV_ROOT="$HOME/.pyenv"' >> ~/.bash_profile 
echo 'export PATH="$PYENV_ROOT/bin:$PATH"' >> ~/.bash_profile 
echo -e 'if command -v pyenv 1>/dev/null 2>&1; then\n eval "$(pyenv 
init -)"\nfi' >> ~/.bash_profile 
source ~/.bash_profile 
 




echo 'eval "$(pyenv virtualenv-init -)"' >> ~/.bash_profile 




PYTHON_CONFIGURE_OPTS="--enable-shared" pyenv install 3.6.12 
 
cd wcEcoli/ 
pyenv local 3.6.12 
pyenv virtualenv wcEcoli3 
pyenv local wcEcoli3 
 





git clone https://github.com/xianyi/OpenBLAS 
cd OpenBLAS 






FC=/cm/shared/languages/GCC-7.1.0/bin/gfortran make -j 8 
 









libraries = openblas 
library_dirs = /newhome/jr16196/Software/wholecell3/install/lib 






##Install in this order## 
 
pip install scipy==1.5.2 --no-binary --force-reinstall 
pip install numpy==1.19.2 --no-binary --force-reinstall 
 
CPATH=/usr/include/glpk CVXOPT_BUILD_GLPK=1 pip install -r 
requirements.txt --no-binary scipy,cvxopt 
export PYTHONPATH="$PWD:$PYTHONPATH" 
 








python runscripts/manual/runParca.py --cpus 8 
 
5.2.2.2 - Metabolism 
In the file wcEcoli/reconstruction/ecoli/dataclasses/process/metabolism.py 
(https://github.com/JJRightmyer/PrivateWCMEcoli/blob/main/metabolism.py) I changed line 41 
from: 
VERBOSE = False 
To 
VERBOSE = True 
This would create an output from the parameter calculator (ParCa) of all successful and unsuccessful 
metabolic reactions, which I could then analyse. 
I then ran the parameter ParCa with the following command to reveal any metabolic reactions which 
could be implemented: 
python runscripts/manual/runParca.py 
I copied the ParCa output into a file I named Parca_output.txt 
(https://github.com/JJRightmyer/AddingToWCMEcoli/blob/main/Parca_output.txt) and identified 
the missing metabolic reactions, copying them into a file called Metabolism_targets.txt 
(https://github.com/JJRightmyer/AddingToWCMEcoli/blob/main/Metabolism_targets.txt).  
To implement the thiosulfate sulfurtransferase reaction (THIOSULFATE-SULFURTRANSFERASE-RXN in 
reactions.tsv) I used the EcoCyc database to find a stoichiometrically balanced reaction 
(https://ecocyc.org/ECOLI/NEW-IMAGE?type=REACTION&object=THIOSULFATE-
SULFURTRANSFERASE-RXN). I then added this reaction to the file 
wcEcoli/reconstruction/ecoli/flat/reactions.tsv 
(https://github.com/JJRightmyer/PrivateWCMEcoli/blob/main/reactions.tsv) to read: 
"THIOSULFATE-SULFURTRANSFERASE-RXN" {"S2O3[p]": -1, "HCN[p]": -1, 
"HSCN[p]": 1, "SO3[p]": 1, "PROTON[p]": 2} false ["CPLX0-8219", 
"EG11600-MONOMER", "EG10780-MONOMER", "CPLX0-242"]  
This reaction indicates that S2O3 + HCN → HSCN + SO3 + 2H
+, with all reactants and products 
occurring in the periplasm ([p]) in a non-reversible reaction (false) and being catalysed by four 
enzymes (CPLX0-8219, EG11600-MONOMER, EG10780-MONOMER, CPLX0-242).  
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I then uploaded the updated reactions.tsv file to BlueCrystal and ran the ParCa again using the 
following command: 
python runscripts/manual/runParca.py 
I copied the output from the PuTTy command console into a file called Thiosulfate_implemented.txt 
(https://github.com/JJRightmyer/AddingToWCMEcoli/blob/main/Thiosulfate_implemented.txt) 
where line 71 indicates successful implementation of the thiosulfate transferase reaction. I sent my 
updated wcEcoli/reconstruction/ecoli/flat/reactions.tsv file to Travis Horst for inclusion in the E. coli 
WCM. 
5.2.2.3 - Transcriptional regulation 
I downloaded fold change data for the transcription factor Lrp from Supplemental file 4 published by 
Kroner et al. (2019).  I calculated the mean fold change for each gene from the log2_expr_ratio 
across the Log, Trans, and Stat sheets on minimal media (MIN). I calculated standard deviation for 
each value. I assigned a reaction direction based on whether the average expression ratio was 
positive or negative (either 1 or -1 respectively). I inputted this data into a file called 
Lrp_fold_changes.tsv 
(https://github.com/JJRightmyer/AddingToWCMEcoli/blob/main/lrp_fold_changes.tsv), ensuring it 
matched the formatting of the foldChanges.tsv file in the model and sent it to Travis Horst for 
inclusion in the E. coli WCM.  
5.2.3 - Data availability 
The data I produced while implementing the thiosulfate sulfurtransferase reaction and adding the 
transcriptional regulation by Lrp are available on GitHub 
(https://github.com/JJRightmyer/AddingToWCMEcoli). Where I have used or edited files which 
appear in the Covert Lab’s private GitHub repository for the E. coli WCM, I have uploaded these files 
to a private GitHub repository of my own so I can share my work whilst protecting their work 
(https://github.com/JJRightmyer/PrivateWCMEcoli). 
5.3 - Results  
5.3.1 - Improving the metabolic model in the E. coli WCM 
I successfully implemented the thiosulfate sulfurtransferase reaction into the E. coli WCM. This 
reaction is a pathway for the metabolism of cyanide, which has been observed in E. coli isolated 
from gold extraction circuit liquids (Figueira et al., 1996). By adding the thiosulfate sulfurtransferase 
reaction, the E. coli WCM should be able to simulate growth in response to cyanide exposure and 
may be of interest to scientists researching bioleaching for less harmful valuable metal extraction, as 
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sodium cyanide solution used to leach gold from ore is toxic to wildlife (Eisler & Wiemeyer, 2004). As 
all the metabolites the reaction needed to be carried out were already present in the 
metabolites.tsv file, the process of adding a balanced chemical equation to implement the 
thiosulfate sulfurtransferase reaction into the E. coli WCM was simple. The thiosulfate 
sulfurtransferase reaction is also involved in the transfer of sulfur from thiosulfate to thiophilic 
acceptors (Ray et al., 2000), but the specific physiological role that this reaction serves is unclear 
(Libiad et al., 2018). To make more rapid progress in expanding the E. coli WCM’s representation of 
metabolism efficiently, we would have to move towards automated inclusion of metabolic reactions 
from published databases, as opposed to manual curation. Sophie Landon decided to pursue this 
further, as she had experience with metabolic models. The manual analysis of the E. coli WCM’s 
metabolic model I performed also revealed a discrepancy with the EcoCyc data that the model was 
based on. In the reactions.tsv 
(https://github.com/JJRightmyer/PrivateWCMEcoli/blob/main/reactions.tsv) file, the xylonate 
dehydratase reaction (XYLONATE-DEHYDRATASE-RXN) was defined as reversible, contradicting the 
EcoCyc database (https://ecocyc.org/gene?orgid=ECOLI&id=G7910-MONOMER#tab=RXNS). I was 
able to inform the model’s creators of this inconsistency and they addressed it.  
5.3.2 - Implementing transcriptional regulation by Lrp 
I worked with Travis Horst to improve transcriptional regulation in the E. coli WCM to make it closer 
to that of an in vivo cell. We identified the transcription factor Lrp as a strong candidate for inclusion 
in the model, as Lrp regulates 38% of E. coli genes (Kroner et al., 2019). I was able to download and 
process the chromatin-immunoprecipitation sequencing (ChIP-seq) and RNA sequencing (RNA-seq) 
data for 2844 E. coli genes published by Kroner et al. (2019) into a .tsv file which matched the format 
of the foldChanges.tsv file 
(https://github.com/JJRightmyer/PrivateWCMEcoli/blob/main/foldChanges.tsv) in the E. coli WCM. 
This was compatible with the way in which the model calculates transcriptional regulation (Macklin 
et al., 2020). By calculating the mean of the fold changes in genes across the logarithmic phase (Log), 
transition point (Trans), and stationary phase (Stat) I was able to provide an average figure for the 
fold change of each gene regulated by Lrp in an E. coli cell grown on minimal media. I then sent the 
lrp_fold_changes.tsv file I had created to Travis Horst for implementation in the E. coli WCM. 
5.4 - Discussion 
Through collaboration with the creators of the E. coli WCM, I was able to contribute to the metabolic 
model and transcriptional regulation model, implementing the thiosulfate sulfurtransferase reaction 
and fold change data for 2844 genes regulated by the transcription factor Lrp respectively. 
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While the addition of a single metabolic reaction to the metabolic model in the E. coli WCM 
represents a small amount of progress, with automated addition of large amounts of data preferred, 
I increased my familiarity with the model and identified cyanide removal in bioleaching as an 
enhancement that could increase the potential applications of the model. Manual analysis of the 
reactions.tsv file also revealed an inconsistency with the EcoCyc database upon which the E. coli 
WCM was based, prompting the model’s creators to review data which they had automatically 
curated. The process of onboarding members of our research group by the Covert Lab was also 
helpful to them in implementing protocols to make the E. coli WCM more accessible to external 
researchers as they continue to expand their collaborations with external research groups. 
My curation of fold change data for 2844 genes by the transcription factor Lrp shall hopefully 
advance transcriptional regulation within the E. coli WCM. Expanding the number of genes in the E. 
coli WCM Lrp regulates from 16 (in foldChanges.tsv) to 2844 should improve the E. coli WCM’s ability 
to regulate metabolism and motility in response to changing environmental conditions (Kroner et al., 
2019) as the model is developed further. While I was unable to implement the data I curated myself, 
I gained an understanding of how transcriptional regulation is represented in the E. coli WCM and 
















Chapter 6 - General Discussion 
6.1 - Results Summary 
Prior to this Masters project, the M. genitalium WCM had been available for use in research since 
2012 (Karr et al., 2012), prompting production of algorithms for genome design, resulting in the 
publication of a new in silico minimal genome (Rees-Garbutt et al., 2020c). The difficulty of working 
with M. genitalium in the lab has stifled further progress in vivo, leading to researchers investigating 
other organisms such as M. mycoides, creating JCVI-syn3.0 (Hutchison et al., 2016) and JCVI-syn3A 
(Glass, 2017). M. pneumoniae has also been identified as a more suitable organism for in vivo 
research; Piñero-Lambea et al. (2020) have developed an oligonucleotide recombineering and Cas-9 
mediated counterselection system for genome editing in M. pneumoniae, with the intention of 
making a chassis strain. CRISPR-Cas9 gene editing technology was also well-established in both 
prokaryotes and eukaryotes (Jinek et al., 2012; Jiang et al., 2013; Hsu et al., 2014), and when 
combined with λ Red machinery, produced genomic edits in bacteria with relative ease (Reisch & 
Prather, 2015). Through our group’s collaboration with the Covert Lab, we had access to the E. coli 
WCM before its publication in July 2020 (Macklin et al., 2020). Here lay the opportunity to test the in 
silico predictions of a whole-cell model in vivo, as E. coli is much easier to work with in the laboratory 
than M. genitalium (Hutchison et al., 2016). However, laboratory work was curtailed by the Covid-19 
pandemic. 
During my Masters project, I was able to: analyse GO terms to provide biological insights into in silico 
minimal gene sets simulated in the M. genitalium WCM (Chapter 2), establish the no-SCAR protocol 
for scarless recombineering of E. coli in our laboratory (Chapter 3), compare 1214 single gene 
knockouts over two generations in the E. coli WCM to the essentiality data presented in the Keio 
collection (Chapter 4), and begin to implement improvements to the current version of the E. coli 
WCM, adding the thiosulfate sulfurtransferase reaction to the metabolic model and transcriptional 
regulation data by Lrp for 2844 genes (Chapter 5).  
Since starting my project, the E. coli WCM was published and used to evaluate the literature, which 
agreed with the majority of curated data and highlighted discrepancies that were investigated, 
which led to new biological insights (Macklin et al., 2020). The single gene knockout simulations I 
conducted using the model (Chapter 4) shall help the model’s creators understand how well the E. 
coli WCM can predict the effects of gene knockouts and whether the model is fit for purpose for 
gene essentiality and genome design studies. The addition of the thiosulfate sulfurtransferase 
reaction and Lrp transcriptional regulation data by me should bring the E. coli WCM closer to the 
representation of an E. coli cell in vivo and may generate interest in the model by researchers 
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interested in processes such as bioleaching. Progress has also been reported in JCVI-syn3A, as a 
reverse genetics approach revealed the seven genes required for normal cell division in this 
organism (Pelletier et al., 2021). This research took seven years to accomplish, highlighting the 
incremental nature of progress in synthetic biology. I believe we should adopt in silico approaches 
such as the work described in this thesis using the M. genitalium WCM to guide and support in vivo 
research conducted in organisms like JCVI-syn3A, as there is the opportunity to streamline research 
efforts. This will become more applicable as more WCMs are published (Whole-Cell Modelling; 
https://www.wholecell.org/models/). 
6.2 - Limitations  
The progress I made towards implementing the no-SCAR system for genomic editing of E. coli was 
severely limited by the Covid-19 pandemic. I had hoped to test predictions of the E. coli WCM in 
vivo, providing an indication of the model’s suitability to inform E. coli genome engineering. While 
access to our laboratories has not yet returned to the level we experienced pre-pandemic, I hope 
this will change over the coming months, permitting implementation of the no-SCAR system to 
achieve rapid genome editing in E. coli (Reisch & Prather, 2015). The methodology I prepared to 
produce a 1095bp deletion in the ack gene reported in this thesis can be readily adapted to permit 
efficient testing of the E. coli WCM’s predictions in vivo. This work may be continued by Rayane 
Nunes Lima, a post doc in our collaborator Elibio Rech’s laboratory in Brazil, or by future Masters 
and PhD students joining our research group. 
The research I conducted using the E. coli WCM was also accompanied by many limitations. It took 
our research group six months to get simulations running on the E. coli WCM due to complications of 
installing and running the model on the BlueCrystal supercomputer cluster. This has limited the 
amount of progress we can report from using the model. Supercomputer storage capabilities also 
limited our research of single gene knockouts using the E. coli WCM to two generations, preventing 
further investigation into some essential genes which produced dividing cells when knocked out. 
These results can be linked to sub-generational gene expression or large initial metabolite pools 
sustaining cells despite essential knockouts, but this will have to be investigated. The remote nature 
of using the E. coli WCM has allowed continued research through the Covid-19 pandemic by new 
PhD and Masters students in our group, enhancing the prospect of further progress being made. 
6.3 - Future work 
Our group’s discovery of MGS Church and Tomita as some of the most minimal M. genitalium 
genomes shown to function so far in silico (Rees-Garbutt et al., 2020b) should prompt in vivo 
investigation of these results. As these genomes, along with all other genomes investigated, did not 
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produce dividing in silico cells until genes were reintroduced, it is important that in vivo research is 
conducted (Rees-Garbutt et al., 2020b). This will clarify whether any of the discrepancies are caused 
by errors in the M. genitalium model, aid in understanding the mistakes previous researchers made 
when designing minimal gene sets, and provide useful information for genome designers in the 
future. However, M. genitalium’s unsuitability for laboratory research shall obstruct these efforts 
(Hutchison et al., 2016). Coupled with the M. genitalium WCM’s limitations, including long 
simulation times, using data from other organisms, and ability to only produce single generations of 
cells, it is difficult to visualise researchers engaging with this work further, as progress will be slow. 
The publication of a whole-cell biochemical network for M. genitalium and the framework used to 
construct the network could yet rejuvenate interest in this organism (Burke et al., 2020). 
Despite only modelling 43% of well-annotated genes in E. coli, the E. coli WCM represents a vital 
progression in whole-cell modelling and should be adopted for use in genome-scale research. 
Macklin et al. (2020) used the E. coli WCM for comparison of the literature against itself, identifying 
areas of contradiction which were subsequently investigated. Retrospective analysis of the literature 
is important to improving our understanding of E. coli, but the E. coli WCM must provide tangible 
benefits to reduce the costs associated with in vivo E. coli research for its use to be sustained. The 
accuracy with which the E. coli WCM can predict in vivo phenotypes must therefore be tested before 
researchers can begin to optimise design-build-test cycles using the model. An immediate avenue for 
research may be to simulate 99% knockdowns on all genes in the E. coli WCM, as the simulation’s 
phenotype should be very similar to gene knockouts. This will help us understand if the model 
struggles to compute gene knockouts as opposed to gene knockdowns, despite their similar 
phenotypes.  
Accessibility in the use of the M. genitalium and E. coli WCMs is key to their continued use among 
researchers. The data outputs from both models require difficult analysis to extract key information, 
with machine learning approaches desired but complicated by the nature of the data produced. The 
onboarding time for new researchers has greatly reduced from the M. genitalium to the E. coli 
WCM, due to simpler construction (Macklin et al., 2020), yet the models remain difficult to set up on 
different supercomputer clusters and remain familiar largely to the teams who develop models, as 
opposed to the microbiologists, geneticists, and synthetic biologists who could gain from their use.  
The complex nature of gene essentiality must also be considered, as the essentiality of some genes is 
contextual, depending on both the environmental conditions present and their genomic context 
(Rees-Garbutt et al., 2020c). To accurately reflect the behaviour of genes in vivo and provide useful 
predictions for gene knockout studies, the E. coli WCM must be improved to take these factors into 
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account. The Vivarium Project begins to address the effects of environmental conditions by 
modelling chemotaxis in E. coli and improving the in silico cell’s ability to interact with heterogenous 
environments (Agmon & Spangler, 2020). Gene essentiality studies remain relevant when validating 
cellular models and have featured in recent publications (Macklin et al., 2020; Burke et al., 2020). 
As the costs of gene editing, sequencing, and synthesis technologies continue to fall, the fields of 
genetics and synthetic biology shall continue to enjoy investment and success. CRISPR-Cas9 has been 
used to produce megabase-sized synthetic genomes (Zhou et al., 2016) and appears to be the 
premier technology for future genome engineering. While sgRNA design to reduce off-target effects 
is complex and requires further understanding (Lino et al., 2018), the development of computational 
tools has simplified this process (Bradford & Perrin, 2019). 
The cost of synthesising genomes is also set to decrease, with predictions that synthesising the 
human genome would cost significantly less than the ~$40,000,000 cost of producing JCVI-syn1.0 
(Pennisi, 2010; Schindler et al., 2018). However, the cost of synthesis projects of this scale is still 
likely to remain obstructive to all but the largest institutes with significant financial support. 
Despite costs reducing across synthetic biology, it is possible that the field of whole-cell modelling 
may stagnate. As new WCMs take years to develop and in vivo genome design is restricted to 
institutions with the greatest funding, the field may become inaccessible to most researchers, with 
research output too slow and expensive to compete for funding. Multiple reviews have been 
published addressing these concerns and proposing solutions to keep whole-cell modelling 
competitive and current. Solutions include: the curation of normalised data for inclusion in WCMs 
without obtrusive manual effort (Marucci et al., 2020), the improvement of experimental data to 
build models from (Szigeti et al., 2018), and systematic and streamlined construction of WCMs, 
especially when progressing towards more complex cells such as human (Goldberg et al., 2016). The 
publication of Datanator by the Karr Lab (Roth et al., 2021) may begin to alleviate the lengthy 
manual process of WCM data curation and eventually work towards the development of automated 
WCM construction tools similar to ModelSEED (Seaver et al., 2021) and CarveME (Machado et al., 
2018) which already exist for metabolic models. The publication of a Saccharomyces cerevisiae WCM 
(Münzner et al., 2019), alongside WCMs for M. pneumoniae, H1 human embryonic stem cell and an 
archetypal bacterium in development (Whole-Cell Modelling; https://www.wholecell.org/models/), 
may galvanise further parts of the biological scientific community around these WCMs, securing the 
future of the field. 
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6.4 - Conclusions 
We are drawing closer to the complete integration of in silico and in vivo research for custom 
genome design. The publication of the E. coli WCM is important for this goal, providing a WCM for 
an organism that is both easy to work with in the laboratory and of industrial interest. Before the E. 
coli WCM can be adopted for ubiquitous use by synthetic biologists, its development must be 
completed, with the remaining 57% of well-annotated genes modelled and missing submodels 
implemented. I believe a complete E. coli WCM will provide us with greater opportunity to 
investigate the literature as Macklin et al. (2020) have done, as it was possible to identify 
discrepancies within the literature despite the majority of E. coli genes being unmodelled. If this 
progress is achieved and the E. coli WCM can accurately predict in vivo phenotypes to inform the in 
vivo construction of a genome, we may experience a shift in genome design methodology towards 
WCM use. This may form the unifying progress whole-cell modelling requires to warrant more 
widespread use among synthetic biologists.  
Tools for in vivo genome engineering are suitable and ready for complete design and construction of 
genomes. The work of the Chin Lab and the JCVI has greatly evidenced this (Fredens et al., 2019; 
Hutchison et al., 2016). The opportunity to provide genome engineers with accurate data for 
genome construction is held by the whole-cell modelling community. When WCMs are improved to 
the point where their use shall streamline genome design in a cost-effective manner, we could 
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Appendix 1. A summary of gene ontology (GO) term reductions and removals from the baseline M. genitalium genome to produce the minimal gene set proposed 
by Forster & Church (2006). Baseline = the unchanged genome of M. genitalium in the M. genitalium WCM. The number of GO term categories either Unaffected, 
Reduced, or Removed is listed below the respective columns. 
Unaffected Baseline ChurchMGS Reduced Baseline ChurchMGS Removed Baseline ChurchMGS 
translation 56 56 glycolytic process 11 10 
ATP synthesis coupled 
proton transport 8 0 
protein folding 5 5 DNA replication 10 9 
cytoadherence to 
microvasculature mediated 
by symbiont protein  6 0 
cell redox homeostasis 3 3 tRNA processing 5 4 SOS response 6 0 
acetyl-CoA biosynthetic 
process 2 2 DNA topological change 5 4 DNA recombination 4 0 
AMP salvage 2 2 
transcription DNA-
templated  9 7 pathogenesis 4 0 
CDP-diacylglycerol 




system 4 3 nucleotide-excision repair 3 0 
gluconeogenesis 2 2 protein transport 6 4 base-excision repair 2 0 
glycine biosynthetic 
process 2 2 
fatty acid biosynthetic 
process 3 2 lipid metabolic process 2 0 
NAD biosynthetic process 2 2 
regulation of 
transcription DNA-
templated  3 2 protein secretion 2 0 
nucleoside metabolic 
process 2 2 transport 10 6 response to oxidative stress 2 0 
nucleotide biosynthetic 
process 2 2 
carbohydrate metabolic 
process 5 3 
SRP-dependent 
cotranslational protein 
targeting to membrane 2 0 
one-carbon metabolic 
process 2 2 cell cycle 4 2 
tRNA 
threonylcarbamoyladenosine 




aminoacylation 2 2 
glycerol metabolic 
process 4 2 
ATP hydrolysis coupled 
proton transport 1 0 
purine ribonucleoside 
salvage 2 2 biosynthetic process 2 1 carbohydrate transport 1 0 
5-phosphoribose 1-
diphosphate biosynthetic 
process 1 1 
DNA-templated 
transcription initiation  2 1 
carboxylic acid metabolic 
process 1 0 
adenine salvage 1 1 protein lipoylation 2 1 cell adhesion 1 0 
adhesion of symbiont to 
host cell 1 1 UMP salvage 2 1 
cellular phosphate ion 
homeostasis 1 0 
alanyl-tRNA aminoacylation 1 1 cell division 5 2 
cellular protein modification 
process 1 0 
arginyl-tRNA 
aminoacylation 1 1 ribosome biogenesis 5 2 chromosome segregation 1 0 
asparaginyl-tRNA 
aminoacylation 1 1 pseudouridine synthesis 3 1 chromosome separation 1 0 
chromosome condensation 1 1 rRNA processing 3 1 
coenzyme A biosynthetic 
process 1 0 
CTP salvage 1 1 DNA repair 8 1 
deoxyribonucleotide 
catabolic process 1 0 
cysteinyl-tRNA 
aminoacylation 1 1 22   
deoxyribose phosphate 
catabolic process 1 0 
de novo' CTP biosynthetic 
process 1 1    
DNA restriction-modification 
system 1 0 
deoxyribonucleotide 
biosynthetic process 1 1    dTMP biosynthetic process 1 0 
DNA biosynthetic process 1 1    dTTP biosynthetic process 1 0 
DNA replication initiation 1 1    
fructose 1,6-bisphosphate 
metabolic process  1 0 
DNA replication synthesis 
of RNA primer  1 1    
heterophilic cell-cell 
adhesion via plasma 
membrane cell adhesion 
molecules 1 0 
DNA-templated 
transcription termination  1 1    
lipoprotein biosynthetic 
process 1 0 





process 1 1    
negative regulation of 
phosphate metabolic 
process 1 0 
FAD biosynthetic process 1 1    
phosphate ion 
transmembrane transport 1 0 
FMN biosynthetic process 1 1    protein catabolic process 1 0 
fructose 6-phosphate 
metabolic process 1 1    protein import 1 0 
galactose metabolic 
process 1 1    
protein insertion into 
membrane 1 0 
glucose catabolic process 1 1    protein repair 1 0 
glucose metabolic process 1 1    protein targeting 1 0 
glutamyl-tRNA 
aminoacylation 1 1    
regulation of carbohydrate 
metabolic process 1 0 
glycerol catabolic process 1 1    RNA processing 1 0 
glycerol ether metabolic 
process 1 1    uracil salvage 1 0 
glycerol-3-phosphate 
metabolic process 1 1    40   
glycyl-tRNA aminoacylation 1 1       
guanosine tetraphosphate 
biosynthetic process 1 1       
histidine biosynthetic 
process 1 1       
histidyl-tRNA 
aminoacylation 1 1       
IMP salvage 1 1       
isoleucyl-tRNA 
aminoacylation 1 1       
leucyl-tRNA aminoacylation 1 1       
lysyl-tRNA aminoacylation 1 1       
membrane lipid biosynthetic 
process 1 1       




process 1 1       
methionyl-tRNA 
aminoacylation 1 1       
mRNA processing 1 1       
NAD metabolic process 1 1       
NADP biosynthetic process 1 1       
organic acid metabolic 
process 1 1       
pentose-phosphate shunt 1 1       
pentose-phosphate shunt 
non-oxidative branch  1 1       
phosphate-containing 
compound metabolic 
process 1 1       
phosphatidylglycerol 
biosynthetic process 1 1       
phospholipid biosynthetic 
process 1 1       
potassium ion transport 1 1       
prolyl-tRNA aminoacylation 1 1       
protein refolding 1 1       
purine nucleotide 
biosynthetic process 1 1       
pyrimidine nucleobase 
metabolic process 1 1       
pyrimidine nucleoside 
metabolic process 1 1       
regulation of DNA 
replication 1 1       
regulation of DNA-
templated transcription 
elongation  1 1       
regulation of translation 1 1       
regulation of translational 
fidelity 1 1       
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removal of superoxide 
radicals 1 1       
response to heat 1 1       
riboflavin biosynthetic 
process 1 1       
rRNA catabolic process 1 1       
S-adenosylmethionine 
biosynthetic process 1 1       
selenocysteinyl-tRNA(Sec) 
biosynthetic process 1 1       
seryl-tRNA aminoacylation 1 1       
sister chromatid cohesion 1 1       
tetrahydrofolate 
interconversion 1 1       
thiamine biosynthetic 
process 1 1       
thiamine diphosphate 
biosynthetic process 1 1       
threonyl-tRNA 
aminoacylation 1 1       
transcription antitermination 1 1       
tRNA aminoacylation for 
protein translation 1 1       
tRNA modification 1 1       
tRNA thio-modification 1 1       
tRNA wobble uridine 
modification 1 1       
tryptophanyl-tRNA 
aminoacylation 1 1       
tyrosyl-tRNA 
aminoacylation 1 1       
UDP-glucose metabolic 
process 1 1       
valyl-tRNA aminoacylation 1 1       




Appendix 2. A summary of gene ontology (GO) term reductions and removals from the baseline M. genitalium genome to produce the minimal gene set proposed 
by Gil (2014). Baseline = the unchanged genome of M. genitalium in the M. genitalium WCM. The number of GO term categories either Unaffected, Reduced, or 
Removed is listed below the respective columns. 
Unaffected Baseline GilMGS Reduced Baseline GilMGS Removed Baseline GilMGS 
translation 56 56 DNA replication 10 9 
cytoadherence to 
microvasculature 
mediated by symbiont 
protein  6 0 
glycolytic process 11 11 DNA topological change 5 4 SOS response 6 0 
ATP synthesis coupled proton 
transport 8 8 transcription DNA-templated  9 7 DNA recombination 4 0 
protein transport 6 6 
phosphoenolpyruvate-
dependent sugar 
phosphotransferase system 4 3 pathogenesis 4 0 
protein folding 5 5 
fatty acid biosynthetic 
process 3 2 
nucleotide-excision 
repair 3 0 
tRNA processing 5 5 
regulation of transcription 
DNA-templated  3 2 lipid metabolic process 2 0 
cell redox homeostasis 3 3 rRNA processing 3 2 
response to oxidative 
stress 2 0 
acetyl-CoA biosynthetic 
process 2 2 transport 10 6 carbohydrate transport 1 0 
AMP salvage 2 2 
carbohydrate metabolic 
process 5 3 
carboxylic acid 
metabolic process 1 0 
CDP-diacylglycerol 
biosynthetic process 2 2 ribosome biogenesis 5 3 cell adhesion 1 0 
gluconeogenesis 2 2 cell cycle 4 2 
cellular phosphate ion 
homeostasis 1 0 
glycine biosynthetic process 2 2 glycerol metabolic process 4 2 
cellular protein 
modification process 1 0 
NAD biosynthetic process 2 2 biosynthetic process 2 1 
chromosome 
condensation 1 0 
nucleoside metabolic process 2 2 
DNA-templated transcription 
initiation  2 1 
chromosome 




process 2 2 protein lipoylation 2 1 
chromosome 
separation 1 0 
one-carbon metabolic process 2 2 base-excision repair 2 1 
deoxyribonucleotide 
catabolic process 1 0 
phenylalanyl-tRNA 
aminoacylation 2 2 protein secretion 2 1 
deoxyribose phosphate 
catabolic process 1 0 
purine ribonucleoside salvage 2 2 
tRNA 
threonylcarbamoyladenosine 
modification 2 1 
DNA restriction-
modification system 1 0 
SRP-dependent 
cotranslational protein 
targeting to membrane 2 2 cell division 5 2 
dTMP biosynthetic 
process 1 0 
UMP salvage 2 2 pseudouridine synthesis 3 1 
dTTP biosynthetic 
process 1 0 
5-phosphoribose 1-
diphosphate biosynthetic 
process 1 1 DNA repair 8 2 
heterophilic cell-cell 
adhesion via plasma 
membrane cell 
adhesion molecules 1 0 
adenine salvage 1 1 21   
lipoprotein biosynthetic 
process 1 0 
adhesion of symbiont to host 
cell 1 1    
mRNA catabolic 
process 1 0 
alanyl-tRNA aminoacylation 1 1    
negative regulation of 
phosphate metabolic 
process 1 0 
arginyl-tRNA aminoacylation 1 1    
phosphate ion 
transmembrane 
transport 1 0 
asparaginyl-tRNA 
aminoacylation 1 1    
protein catabolic 
process 1 0 
ATP hydrolysis coupled proton 
transport 1 1    protein repair 1 0 
coenzyme A biosynthetic 
process 1 1    
regulation of 
carbohydrate metabolic 
process 1 0 
CTP salvage 1 1    RNA processing 1 0 
cysteinyl-tRNA aminoacylation 1 1    
sister chromatid 
cohesion 1 0 
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de novo' CTP biosynthetic 
process 1 1    30   
deoxyribonucleotide 
biosynthetic process 1 1       
DNA biosynthetic process 1 1       
DNA replication initiation 1 1       
DNA replication synthesis of 
RNA primer  1 1       
DNA-templated transcription 
termination  1 1       
dTDP biosynthetic process 1 1       
enterobacterial common 
antigen biosynthetic process 1 1       
FAD biosynthetic process 1 1       
FMN biosynthetic process 1 1       
fructose 1,6-bisphosphate 
metabolic process  1 1       
fructose 6-phosphate 
metabolic process 1 1       
galactose metabolic process 1 1       
glucose catabolic process 1 1       
glucose metabolic process 1 1       
glutamyl-tRNA aminoacylation 1 1       
glycerol catabolic process 1 1       
glycerol ether metabolic 
process 1 1       
glycerol-3-phosphate 
metabolic process 1 1       
glycyl-tRNA aminoacylation 1 1       
guanosine tetraphosphate 
biosynthetic process 1 1       
histidine biosynthetic process 1 1       
histidyl-tRNA aminoacylation 1 1       
IMP salvage 1 1       
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isoleucyl-tRNA aminoacylation 1 1       
leucyl-tRNA aminoacylation 1 1       
lysyl-tRNA aminoacylation 1 1       
membrane lipid biosynthetic 
process 1 1       
metabolic process 1 1       
methionine biosynthetic 
process 1 1       
methionyl-tRNA 
aminoacylation 1 1       
mRNA processing 1 1       
NAD metabolic process 1 1       
NADP biosynthetic process 1 1       
organic acid metabolic process 1 1       
pentose-phosphate shunt 1 1       
pentose-phosphate shunt non-
oxidative branch  1 1       
phosphate-containing 
compound metabolic process 1 1       
phosphatidylglycerol 
biosynthetic process 1 1       
phospholipid biosynthetic 
process 1 1       
potassium ion transport 1 1       
prolyl-tRNA aminoacylation 1 1       
protein import 1 1       
protein insertion into 
membrane 1 1       
protein refolding 1 1       
protein targeting 1 1       
purine nucleotide biosynthetic 
process 1 1       
pyrimidine nucleobase 




metabolic process 1 1       
regulation of DNA replication 1 1       
regulation of DNA-templated 
transcription elongation  1 1       
regulation of translation 1 1       
regulation of translational 
fidelity 1 1       
removal of superoxide radicals 1 1       
response to heat 1 1       
riboflavin biosynthetic process 1 1       
rRNA catabolic process 1 1       
S-adenosylmethionine 
biosynthetic process 1 1       
selenocysteinyl-tRNA(Sec) 
biosynthetic process 1 1       
seryl-tRNA aminoacylation 1 1       
tetrahydrofolate 
interconversion 1 1       
thiamine biosynthetic process 1 1       
thiamine diphosphate 
biosynthetic process 1 1       
threonyl-tRNA aminoacylation 1 1       
transcription antitermination 1 1       
tRNA aminoacylation for 
protein translation 1 1       
tRNA modification 1 1       
tRNA thio-modification 1 1       
tRNA wobble uridine 
modification 1 1       
tryptophanyl-tRNA 
aminoacylation 1 1       




process 1 1       
uracil salvage 1 1       
valyl-tRNA aminoacylation 1 1       










Appendix 3. A summary of gene ontology (GO) term reductions and removals from the baseline M. genitalium genome to produce the minimal gene set proposed 
by Glass et al. (2006). Baseline = the unchanged genome of M. genitalium in the M. genitalium WCM. The number of GO term categories either Unaffected, 
Reduced, or Removed is listed below the respective columns. 
Unaffected Baseline GlassMGS Reduced Baseline GlassMGS Removed Baseline GlassMGS 
translation 56 56 DNA replication 10 9 DNA recombination 4 0 
glycolytic process 11 11 transport 10 9 lipid metabolic process 2 0 
transcription DNA-templated  9 9 
ATP synthesis coupled 
proton transport 8 7 
carboxylic acid metabolic 
process 1 0 
cytoadherence to 
microvasculature mediated 
by symbiont protein  6 6 
carbohydrate metabolic 
process 5 4 
cellular protein modification 
process 1 0 
protein transport 6 6 ribosome biogenesis 5 4 chromosome condensation 1 0 
DNA topological change 5 5 tRNA processing 5 4 chromosome segregation 1 0 
protein folding 5 5 
phosphoenolpyruvate-
dependent sugar 
phosphotransferase system 4 3 chromosome separation 1 0 
pathogenesis 4 4 cell cycle 4 3 
coenzyme A biosynthetic 
process 1 0 
cell redox homeostasis 3 3 glycerol metabolic process 4 3 
DNA restriction-modification 
system 1 0 
fatty acid biosynthetic 
process 3 3 pseudouridine synthesis 3 2 dTMP biosynthetic process 1 0 
regulation of transcription 
DNA-templated  3 3 nucleotide-excision repair 3 2 dTTP biosynthetic process 1 0 
rRNA processing 3 3 cell division 5 3 
phosphate ion 
transmembrane transport 1 0 
acetyl-CoA biosynthetic 
process 2 2 
DNA-templated 
transcription initiation  2 1 RNA processing 1 0 
AMP salvage 2 2 base-excision repair 2 1 sister chromatid cohesion 1 0 
biosynthetic process 2 2 SOS response 6 3 14   
CDP-diacylglycerol 
biosynthetic process 2 2 
response to oxidative 
stress 2 1    
gluconeogenesis 2 2 DNA repair 8 3    
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glycine biosynthetic process 2 2 17      
NAD biosynthetic process 2 2       
nucleoside metabolic 
process 2 2       
nucleotide biosynthetic 
process 2 2       
one-carbon metabolic 
process 2 2       
phenylalanyl-tRNA 
aminoacylation 2 2       
protein lipoylation 2 2       
protein secretion 2 2       
purine ribonucleoside 
salvage 2 2       
SRP-dependent 
cotranslational protein 
targeting to membrane 2 2       
tRNA 
threonylcarbamoyladenosine 
modification 2 2       
UMP salvage 2 2       
5-phosphoribose 1-
diphosphate biosynthetic 
process 1 1       
adenine salvage 1 1       
adhesion of symbiont to host 
cell 1 1       
alanyl-tRNA aminoacylation 1 1       
arginyl-tRNA aminoacylation 1 1       
asparaginyl-tRNA 
aminoacylation 1 1       
ATP hydrolysis coupled 
proton transport 1 1       
carbohydrate transport 1 1       
cell adhesion 1 1       
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cellular phosphate ion 
homeostasis 1 1       
CTP salvage 1 1       
cysteinyl-tRNA 
aminoacylation 1 1       
de novo' CTP biosynthetic 
process 1 1       
deoxyribonucleotide 
biosynthetic process 1 1       
deoxyribonucleotide 
catabolic process 1 1       
deoxyribose phosphate 
catabolic process 1 1       
DNA biosynthetic process 1 1       
DNA replication initiation 1 1       
DNA replication synthesis of 
RNA primer  1 1       
DNA-templated transcription 
termination  1 1       
dTDP biosynthetic process 1 1       
enterobacterial common 
antigen biosynthetic process 1 1       
FAD biosynthetic process 1 1       
FMN biosynthetic process 1 1       
fructose 1,6-bisphosphate 
metabolic process  1 1       
fructose 6-phosphate 
metabolic process 1 1       
galactose metabolic process 1 1       
glucose catabolic process 1 1       
glucose metabolic process 1 1       
glutamyl-tRNA 
aminoacylation 1 1       
glycerol catabolic process 1 1       
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glycerol ether metabolic 
process 1 1       
glycerol-3-phosphate 
metabolic process 1 1       
glycyl-tRNA aminoacylation 1 1       
guanosine tetraphosphate 
biosynthetic process 1 1       
heterophilic cell-cell adhesion 
via plasma membrane cell 
adhesion molecules 1 1       
histidine biosynthetic process 1 1       
histidyl-tRNA aminoacylation 1 1       
IMP salvage 1 1       
isoleucyl-tRNA 
aminoacylation 1 1       
leucyl-tRNA aminoacylation 1 1       
lipoprotein biosynthetic 
process 1 1       
lysyl-tRNA aminoacylation 1 1       
membrane lipid biosynthetic 
process 1 1       
metabolic process 1 1       
methionine biosynthetic 
process 1 1       
methionyl-tRNA 
aminoacylation 1 1       
mRNA catabolic process 1 1       
mRNA processing 1 1       
NAD metabolic process 1 1       
NADP biosynthetic process 1 1       
negative regulation of 
phosphate metabolic process 1 1       
organic acid metabolic 
process 1 1       




non-oxidative branch  1 1       
phosphate-containing 
compound metabolic process 1 1       
phosphatidylglycerol 
biosynthetic process 1 1       
phospholipid biosynthetic 
process 1 1       
potassium ion transport 1 1       
prolyl-tRNA aminoacylation 1 1       
protein catabolic process 1 1       
protein import 1 1       
protein insertion into 
membrane 1 1       
protein refolding 1 1       
protein repair 1 1       
protein targeting 1 1       
purine nucleotide 
biosynthetic process 1 1       
pyrimidine nucleobase 
metabolic process 1 1       
pyrimidine nucleoside 
metabolic process 1 1       
regulation of carbohydrate 
metabolic process 1 1       
regulation of DNA replication 1 1       
regulation of DNA-templated 
transcription elongation  1 1       
regulation of translation 1 1       
regulation of translational 
fidelity 1 1       
removal of superoxide 
radicals 1 1       




process 1 1       
rRNA catabolic process 1 1       
S-adenosylmethionine 
biosynthetic process 1 1       
selenocysteinyl-tRNA(Sec) 
biosynthetic process 1 1       
seryl-tRNA aminoacylation 1 1       
tetrahydrofolate 
interconversion 1 1       
thiamine biosynthetic 
process 1 1       
thiamine diphosphate 
biosynthetic process 1 1       
threonyl-tRNA 
aminoacylation 1 1       
transcription antitermination 1 1       
tRNA aminoacylation for 
protein translation 1 1       
tRNA modification 1 1       
tRNA thio-modification 1 1       
tRNA wobble uridine 
modification 1 1       
tryptophanyl-tRNA 
aminoacylation 1 1       
tyrosyl-tRNA aminoacylation 1 1       
UDP-glucose metabolic 
process 1 1       
uracil salvage 1 1       
valyl-tRNA aminoacylation 1 1       






Appendix 4. A summary of gene ontology (GO) term reductions and removals from the baseline M. genitalium genome to produce the minimal gene set proposed 
by Huang et al. (2013). Baseline = the unchanged genome of M. genitalium in the M. genitalium WCM. The number of GO term categories either Unaffected, 
Reduced, or Removed is listed below the respective columns. 
Unaffected Baseline HuangMGS Reduced Baseline HuangMGS Removed Baseline HuangMGS 
translation 56 56 DNA replication 10 9 
cytoadherence to 
microvasculature 
mediated by symbiont 
protein  6 0 
glycolytic process 11 11 protein transport 6 5 SOS response 6 0 
cell redox homeostasis 3 3 tRNA processing 5 4 DNA recombination 4 0 
acetyl-CoA biosynthetic 
process 2 2 protein folding 5 4 pathogenesis 4 0 
AMP salvage 2 2 DNA topological change 5 4 
nucleotide-excision 
repair 3 0 
CDP-diacylglycerol 
biosynthetic process 2 2 transcription DNA-templated  9 7 lipid metabolic process 2 0 
gluconeogenesis 2 2 
phosphoenolpyruvate-
dependent sugar 
phosphotransferase system 4 3 base-excision repair 2 0 
glycine biosynthetic process 2 2 
fatty acid biosynthetic 
process 3 2 protein secretion 2 0 
NAD biosynthetic process 2 2 
regulation of transcription 
DNA-templated  3 2 
response to oxidative 
stress 2 0 
nucleoside metabolic 
process 2 2 transport 10 6 
ATP hydrolysis coupled 
proton transport 1 0 
nucleotide biosynthetic 
process 2 2 
carbohydrate metabolic 
process 5 3 carbohydrate transport 1 0 
one-carbon metabolic 
process 2 2 ribosome biogenesis 5 3 
carboxylic acid metabolic 
process 1 0 
phenylalanyl-tRNA 
aminoacylation 2 2 cell cycle 4 2 cell adhesion 1 0 
purine ribonucleoside 
salvage 2 2 glycerol metabolic process 4 2 
cellular phosphate ion 





targeting to membrane 2 2 
DNA-templated transcription 
initiation  2 1 
cellular protein 
modification process 1 0 
5-phosphoribose 1-
diphosphate biosynthetic 
process 1 1 UMP salvage 2 1 
chromosome 
condensation 1 0 
adenine salvage 1 1 biosynthetic process 2 1 chromosome segregation 1 0 
adhesion of symbiont to host 
cell 1 1 protein lipoylation 2 1 chromosome separation 1 0 
alanyl-tRNA aminoacylation 1 1 
tRNA 
threonylcarbamoyladenosine 
modification 2 1 
coenzyme A biosynthetic 
process 1 0 
arginyl-tRNA aminoacylation 1 1 cell division 5 2 
deoxyribonucleotide 
catabolic process 1 0 
asparaginyl-tRNA 
aminoacylation 1 1 
ATP synthesis coupled 
proton transport 8 3 
deoxyribose phosphate 
catabolic process 1 0 
CTP salvage 1 1 pseudouridine synthesis 3 1 
DNA restriction-
modification system 1 0 
cysteinyl-tRNA 
aminoacylation 1 1 rRNA processing 3 1 
dTMP biosynthetic 
process 1 0 
de novo' CTP biosynthetic 
process 1 1 DNA repair 8 1 
dTTP biosynthetic 
process 1 0 
deoxyribonucleotide 
biosynthetic process 1 1 24   
heterophilic cell-cell 
adhesion via plasma 
membrane cell adhesion 
molecules 1 0 
DNA biosynthetic process 1 1    
lipoprotein biosynthetic 
process 1 0 
DNA replication initiation 1 1    mRNA catabolic process 1 0 
DNA replication synthesis of 
RNA primer  1 1    
negative regulation of 
phosphate metabolic 
process 1 0 
DNA-templated transcription 
termination  1 1    
phosphate ion 
transmembrane transport 1 0 
dTDP biosynthetic process 1 1    protein catabolic process 1 0 
enterobacterial common 
antigen biosynthetic process 1 1    
protein insertion into 
membrane 1 0 
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FAD biosynthetic process 1 1    protein repair 1 0 
FMN biosynthetic process 1 1    
regulation of 
carbohydrate metabolic 
process 1 0 
fructose 1,6-bisphosphate 
metabolic process  1 1    RNA processing 1 0 
fructose 6-phosphate 
metabolic process 1 1    
sister chromatid 
cohesion 1 0 
galactose metabolic process 1 1    uracil salvage 1 0 
glucose catabolic process 1 1    36   
glucose metabolic process 1 1       
glutamyl-tRNA 
aminoacylation 1 1       
glycerol catabolic process 1 1       
glycerol ether metabolic 
process 1 1       
glycerol-3-phosphate 
metabolic process 1 1       
glycyl-tRNA aminoacylation 1 1       
guanosine tetraphosphate 
biosynthetic process 1 1       
histidine biosynthetic process 1 1       
histidyl-tRNA aminoacylation 1 1       
IMP salvage 1 1       
isoleucyl-tRNA 
aminoacylation 1 1       
leucyl-tRNA aminoacylation 1 1       
lysyl-tRNA aminoacylation 1 1       
membrane lipid biosynthetic 
process 1 1       
metabolic process 1 1       
methionine biosynthetic 
process 1 1       
methionyl-tRNA 
aminoacylation 1 1       
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mRNA processing 1 1       
NAD metabolic process 1 1       
NADP biosynthetic process 1 1       
organic acid metabolic 
process 1 1       
pentose-phosphate shunt 1 1       
pentose-phosphate shunt 
non-oxidative branch  1 1       
phosphate-containing 
compound metabolic process 1 1       
phosphatidylglycerol 
biosynthetic process 1 1       
phospholipid biosynthetic 
process 1 1       
potassium ion transport 1 1       
prolyl-tRNA aminoacylation 1 1       
protein import 1 1       
protein refolding 1 1       
protein targeting 1 1       
purine nucleotide 
biosynthetic process 1 1       
pyrimidine nucleobase 
metabolic process 1 1       
pyrimidine nucleoside 
metabolic process 1 1       
regulation of DNA replication 1 1       
regulation of DNA-templated 
transcription elongation  1 1       
regulation of translation 1 1       
regulation of translational 
fidelity 1 1       
removal of superoxide 
radicals 1 1       




process 1 1       
rRNA catabolic process 1 1       
S-adenosylmethionine 
biosynthetic process 1 1       
selenocysteinyl-tRNA(Sec) 
biosynthetic process 1 1       
seryl-tRNA aminoacylation 1 1       
tetrahydrofolate 
interconversion 1 1       
thiamine biosynthetic 
process 1 1       
thiamine diphosphate 
biosynthetic process 1 1       
threonyl-tRNA 
aminoacylation 1 1       
transcription antitermination 1 1       
tRNA aminoacylation for 
protein translation 1 1       
tRNA modification 1 1       
tRNA thio-modification 1 1       
tRNA wobble uridine 
modification 1 1       
tryptophanyl-tRNA 
aminoacylation 1 1       
tyrosyl-tRNA aminoacylation 1 1       
UDP-glucose metabolic 
process 1 1       
valyl-tRNA aminoacylation 1 1       







Appendix 5. A summary of gene ontology (GO) term reductions and removals from the baseline M. genitalium genome to produce the minimal gene set proposed 
by Hutchison et al. (1999). Baseline = the unchanged genome of M. genitalium in the M. genitalium WCM. The number of GO term categories either Unaffected, 
Reduced, or Removed is listed below the respective columns. 
Unaffected Baseline HutchisonMGS Reduced Baseline HutchisonMGS Removed Baseline HutchisonMGS 
translation 56 56 
carbohydrate 
metabolic process 5 4 
lipid metabolic 
process 2 0 
glycolytic process 11 11 tRNA processing 5 4 cell adhesion 1 0 




system 4 3 
chromosome 
segregation 1 0 
transport 10 10 
glycerol metabolic 
process 4 3 
coenzyme A 
biosynthetic process 1 0 
transcription DNA-templated  9 9 DNA repair 8 6 
DNA restriction-
modification system 1 0 
ATP synthesis coupled 
proton transport 8 8 pathogenesis 4 3 
mRNA catabolic 
process 1 0 
protein transport 6 6 
cytoadherence to 
microvasculature 
mediated by symbiont 
protein  6 4 
phosphate ion 
transmembrane 
transport 1 0 
DNA topological change 5 5 SOS response 6 4 
regulation of 
carbohydrate 
metabolic process 1 0 
protein folding 5 5 
nucleotide-excision 
repair 3 2 8   
cell redox homeostasis 3 3 cell division 5 3    
fatty acid biosynthetic 
process 3 3 ribosome biogenesis 5 3    
regulation of transcription 
DNA-templated  3 3 cell cycle 4 2    
rRNA processing 3 3 
DNA-templated 





targeting to membrane 2 2 DNA recombination 4 2    
acetyl-CoA biosynthetic 
process 2 2 
pseudouridine 
synthesis 3 1    
AMP salvage 2 2 15      
base-excision repair 2 2       
biosynthetic process 2 2       
CDP-diacylglycerol 
biosynthetic process 2 2       
gluconeogenesis 2 2       
glycine biosynthetic process 2 2       
NAD biosynthetic process 2 2       
nucleoside metabolic 
process 2 2       
nucleotide biosynthetic 
process 2 2       
one-carbon metabolic 
process 2 2       
phenylalanyl-tRNA 
aminoacylation 2 2       
protein lipoylation 2 2       
protein secretion 2 2       
purine ribonucleoside 
salvage 2 2       
response to oxidative stress 2 2       
tRNA 
threonylcarbamoyladenosine 
modification 2 2       
UMP salvage 2 2       
5-phosphoribose 1-
diphosphate biosynthetic 
process 1 1       
adenine salvage 1 1       
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adhesion of symbiont to host 
cell 1 1       
alanyl-tRNA aminoacylation 1 1       
arginyl-tRNA aminoacylation 1 1       
asparaginyl-tRNA 
aminoacylation 1 1       
ATP hydrolysis coupled 
proton transport 1 1       
carbohydrate transport 1 1       
carboxylic acid metabolic 
process 1 1       
cellular phosphate ion 
homeostasis 1 1       
cellular protein modification 
process 1 1       
chromosome condensation 1 1       
chromosome separation 1 1       
CTP salvage 1 1       
cysteinyl-tRNA 
aminoacylation 1 1       
de novo' CTP biosynthetic 
process 1 1       
deoxyribonucleotide 
biosynthetic process 1 1       
deoxyribonucleotide 
catabolic process 1 1       
deoxyribose phosphate 
catabolic process 1 1       
DNA biosynthetic process 1 1       
DNA replication initiation 1 1       
DNA replication synthesis of 
RNA primer  1 1       
DNA-templated transcription 
termination  1 1       
dTDP biosynthetic process 1 1       
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dTMP biosynthetic process 1 1       
dTTP biosynthetic process 1 1       
enterobacterial common 
antigen biosynthetic process 1 1       
FAD biosynthetic process 1 1       
FMN biosynthetic process 1 1       
fructose 1,6-bisphosphate 
metabolic process  1 1       
fructose 6-phosphate 
metabolic process 1 1       
galactose metabolic process 1 1       
glucose catabolic process 1 1       
glucose metabolic process 1 1       
glutamyl-tRNA 
aminoacylation 1 1       
glycerol catabolic process 1 1       
glycerol ether metabolic 
process 1 1       
glycerol-3-phosphate 
metabolic process 1 1       
glycyl-tRNA aminoacylation 1 1       
guanosine tetraphosphate 
biosynthetic process 1 1       
heterophilic cell-cell 
adhesion via plasma 
membrane cell adhesion 
molecules 1 1       
histidine biosynthetic 
process 1 1       
histidyl-tRNA aminoacylation 1 1       
IMP salvage 1 1       
isoleucyl-tRNA 
aminoacylation 1 1       




process 1 1       
lysyl-tRNA aminoacylation 1 1       
membrane lipid biosynthetic 
process 1 1       
metabolic process 1 1       
methionine biosynthetic 
process 1 1       
methionyl-tRNA 
aminoacylation 1 1       
mRNA processing 1 1       
NAD metabolic process 1 1       
NADP biosynthetic process 1 1       
negative regulation of 
phosphate metabolic 
process 1 1       
organic acid metabolic 
process 1 1       
pentose-phosphate shunt 1 1       
pentose-phosphate shunt 
non-oxidative branch  1 1       
phosphate-containing 
compound metabolic 
process 1 1       
phosphatidylglycerol 
biosynthetic process 1 1       
phospholipid biosynthetic 
process 1 1       
potassium ion transport 1 1       
prolyl-tRNA aminoacylation 1 1       
protein catabolic process 1 1       
protein import 1 1       
protein insertion into 
membrane 1 1       
protein refolding 1 1       
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protein repair 1 1       
protein targeting 1 1       
purine nucleotide 
biosynthetic process 1 1       
pyrimidine nucleobase 
metabolic process 1 1       
pyrimidine nucleoside 
metabolic process 1 1       
regulation of DNA replication 1 1       
regulation of DNA-templated 
transcription elongation  1 1       
regulation of translation 1 1       
regulation of translational 
fidelity 1 1       
removal of superoxide 
radicals 1 1       
response to heat 1 1       
riboflavin biosynthetic 
process 1 1       
RNA processing 1 1       
rRNA catabolic process 1 1       
S-adenosylmethionine 
biosynthetic process 1 1       
selenocysteinyl-tRNA(Sec) 
biosynthetic process 1 1       
seryl-tRNA aminoacylation 1 1       
sister chromatid cohesion 1 1       
tetrahydrofolate 
interconversion 1 1       
thiamine biosynthetic 
process 1 1       
thiamine diphosphate 
biosynthetic process 1 1       
threonyl-tRNA 
aminoacylation 1 1       
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transcription antitermination 1 1       
tRNA aminoacylation for 
protein translation 1 1       
tRNA modification 1 1       
tRNA thio-modification 1 1       
tRNA wobble uridine 
modification 1 1       
tryptophanyl-tRNA 
aminoacylation 1 1       
tyrosyl-tRNA aminoacylation 1 1       
UDP-glucose metabolic 
process 1 1       
uracil salvage 1 1       
valyl-tRNA aminoacylation 1 1       















Appendix 6. A summary of gene ontology (GO) term reductions and removals from the baseline M. genitalium genome to produce the minimal gene set 
proposed by Karr et al. (2012). Baseline = the unchanged genome of M. genitalium in the M. genitalium WCM. The number of GO term categories either 
Unaffected, Reduced, or Removed is listed below the respective columns. 
Unaffected Baseline KarrMGS Reduced Baseline KarrMGS Removed Baseline KarrMGS 
translation 56 56 DNA replication 10 9 
ATP synthesis coupled proton 
transport 8 0 
glycolytic process 11 11 tRNA processing 5 4 SOS response 6 0 
cytoadherence to 
microvasculature mediated 
by symbiont protein  6 6 
transcription DNA-
templated  9 7 DNA recombination 4 0 




system 4 3 nucleotide-excision repair 3 0 
DNA topological change 5 5 cell cycle 4 3 base-excision repair 2 0 
protein folding 5 5 
fatty acid biosynthetic 
process 3 2 lipid metabolic process 2 0 
ribosome biogenesis 5 5 
regulation of transcription 
DNA-templated  3 2 response to oxidative stress 2 0 
pathogenesis 4 4 
carbohydrate metabolic 
process 5 3 
ATP hydrolysis coupled proton 
transport 1 0 
cell redox homeostasis 3 3 cell division 5 3 carbohydrate transport 1 0 
rRNA processing 3 3 transport 10 6 
carboxylic acid metabolic 
process 1 0 
acetyl-CoA biosynthetic 
process 2 2 
glycerol metabolic 
process 4 2 
cellular phosphate ion 
homeostasis 1 0 
AMP salvage 2 2 
DNA-templated 
transcription initiation  2 1 chromosome condensation 1 0 
CDP-diacylglycerol 
biosynthetic process 2 2 UMP salvage 2 1 chromosome segregation 1 0 
gluconeogenesis 2 2 biosynthetic process 2 1 chromosome separation 1 0 
glycine biosynthetic process 2 2 protein lipoylation 2 1 
coenzyme A biosynthetic 
process 1 0 
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NAD biosynthetic process 2 2 protein secretion 2 1 
deoxyribonucleotide catabolic 
process 1 0 
nucleoside metabolic 
process 2 2 pseudouridine synthesis 3 1 
deoxyribose phosphate 
catabolic process 1 0 
nucleotide biosynthetic 
process 2 2 DNA repair 8 1 
DNA restriction-modification 
system 1 0 
one-carbon metabolic 
process 2 2 18   dTMP biosynthetic process 1 0 
phenylalanyl-tRNA 
aminoacylation 2 2    dTTP biosynthetic process 1 0 
purine ribonucleoside 
salvage 2 2    lipoprotein biosynthetic process 1 0 
SRP-dependent 
cotranslational protein 
targeting to membrane 2 2    mRNA catabolic process 1 0 
tRNA 
threonylcarbamoyladenosine 
modification 2 2    
negative regulation of phosphate 
metabolic process 1 0 
5-phosphoribose 1-
diphosphate biosynthetic 
process 1 1    
phosphate ion transmembrane 
transport 1 0 
adenine salvage 1 1    protein repair 1 0 
adhesion of symbiont to host 
cell 1 1    
regulation of carbohydrate 
metabolic process 1 0 
alanyl-tRNA aminoacylation 1 1    RNA processing 1 0 
arginyl-tRNA aminoacylation 1 1    sister chromatid cohesion 1 0 
asparaginyl-tRNA 
aminoacylation 1 1    uracil salvage 1 0 
cell adhesion 1 1    29   
cellular protein modification 
process 1 1       
CTP salvage 1 1       
cysteinyl-tRNA 
aminoacylation 1 1       
de novo' CTP biosynthetic 




biosynthetic process 1 1       
DNA biosynthetic process 1 1       
DNA replication initiation 1 1       
DNA replication synthesis of 
RNA primer  1 1       
DNA-templated transcription 
termination  1 1       
dTDP biosynthetic process 1 1       
enterobacterial common 
antigen biosynthetic process 1 1       
FAD biosynthetic process 1 1       
FMN biosynthetic process 1 1       
fructose 1,6-bisphosphate 
metabolic process  1 1       
fructose 6-phosphate 
metabolic process 1 1       
galactose metabolic process 1 1       
glucose catabolic process 1 1       
glucose metabolic process 1 1       
glutamyl-tRNA 
aminoacylation 1 1       
glycerol catabolic process 1 1       
glycerol ether metabolic 
process 1 1       
glycerol-3-phosphate 
metabolic process 1 1       
glycyl-tRNA aminoacylation 1 1       
guanosine tetraphosphate 
biosynthetic process 1 1       
heterophilic cell-cell 
adhesion via plasma 
membrane cell adhesion 




process 1 1       
histidyl-tRNA aminoacylation 1 1       
IMP salvage 1 1       
isoleucyl-tRNA 
aminoacylation 1 1       
leucyl-tRNA aminoacylation 1 1       
lysyl-tRNA aminoacylation 1 1       
membrane lipid biosynthetic 
process 1 1       
metabolic process 1 1       
methionine biosynthetic 
process 1 1       
methionyl-tRNA 
aminoacylation 1 1       
mRNA processing 1 1       
NAD metabolic process 1 1       
NADP biosynthetic process 1 1       
organic acid metabolic 
process 1 1       
pentose-phosphate shunt 1 1       
pentose-phosphate shunt 
non-oxidative branch  1 1       
phosphate-containing 
compound metabolic 
process 1 1       
phosphatidylglycerol 
biosynthetic process 1 1       
phospholipid biosynthetic 
process 1 1       
potassium ion transport 1 1       
prolyl-tRNA aminoacylation 1 1       
protein catabolic process 1 1       
protein import 1 1       
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protein insertion into 
membrane 1 1       
protein refolding 1 1       
protein targeting 1 1       
purine nucleotide 
biosynthetic process 1 1       
pyrimidine nucleobase 
metabolic process 1 1       
pyrimidine nucleoside 
metabolic process 1 1       
regulation of DNA replication 1 1       
regulation of DNA-templated 
transcription elongation  1 1       
regulation of translation 1 1       
regulation of translational 
fidelity 1 1       
removal of superoxide 
radicals 1 1       
response to heat 1 1       
riboflavin biosynthetic 
process 1 1       
rRNA catabolic process 1 1       
S-adenosylmethionine 
biosynthetic process 1 1       
selenocysteinyl-tRNA(Sec) 
biosynthetic process 1 1       
seryl-tRNA aminoacylation 1 1       
tetrahydrofolate 
interconversion 1 1       
thiamine biosynthetic 
process 1 1       
thiamine diphosphate 
biosynthetic process 1 1       
threonyl-tRNA 
aminoacylation 1 1       
transcription antitermination 1 1       
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tRNA aminoacylation for 
protein translation 1 1       
tRNA modification 1 1       
tRNA thio-modification 1 1       
tRNA wobble uridine 
modification 1 1       
tryptophanyl-tRNA 
aminoacylation 1 1       
tyrosyl-tRNA aminoacylation 1 1       
UDP-glucose metabolic 
process 1 1       
valyl-tRNA aminoacylation 1 1       
















Appendix 7. A summary of gene ontology (GO) term reductions and removals from the baseline M. genitalium genome to produce the minimal gene set proposed 
by Mushegian & Koonin (1996). Baseline = the unchanged genome of M. genitalium in the M. genitalium WCM. The number of GO term categories either 
Unaffected, Reduced, or Removed is listed below the respective columns. 
Unaffected Baseline KooninMGS Reduced Baseline KooninMGS Removed Baseline KooninMGS 
translation 56 56 protein transport 6 5 
cytoadherence to 
microvasculature mediated by 
symbiont protein  6 0 
glycolytic process 11 11 
transcription DNA-
templated  9 7 pathogenesis 4 0 
DNA replication 10 10 
phosphoenolpyruvate-
dependent sugar 
phosphotransferase system 4 3 protein secretion 2 0 
ATP synthesis coupled 
proton transport 8 8 cell cycle 4 3 
tRNA 
threonylcarbamoyladenosine 
modification 2 0 
SOS response 6 6 glycerol metabolic process 4 3 
carboxylic acid metabolic 
process 1 0 
DNA topological 
change 5 5 DNA repair 8 6 cell adhesion 1 0 
protein folding 5 5 DNA recombination 4 3 
cellular phosphate ion 
homeostasis 1 0 
tRNA processing 5 5 pseudouridine synthesis 3 2 chromosome condensation 1 0 
cell redox homeostasis 3 3 
fatty acid biosynthetic 
process 3 2 chromosome segregation 1 0 
nucleotide-excision 
repair 3 3 
regulation of transcription 
DNA-templated  3 2 chromosome separation 1 0 
acetyl-CoA 
biosynthetic process 2 2 rRNA processing 3 2 
coenzyme A biosynthetic 
process 1 0 
AMP salvage 2 2 
carbohydrate metabolic 
process 5 3 
DNA restriction-modification 
system 1 0 
base-excision repair 2 2 cell division 5 3 
heterophilic cell-cell adhesion 
via plasma membrane cell 
adhesion molecules 1 0 
CDP-diacylglycerol 
biosynthetic process 2 2 
DNA-templated 
transcription initiation  2 1 mRNA catabolic process 1 0 
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gluconeogenesis 2 2 transport 10 5 
negative regulation of 
phosphate metabolic process 1 0 
glycine biosynthetic 
process 2 2 biosynthetic process 2 1 
protein insertion into 
membrane 1 0 
NAD biosynthetic 
process 2 2 lipid metabolic process 2 1 
regulation of carbohydrate 
metabolic process 1 0 
nucleoside metabolic 
process 2 2 response to oxidative stress 2 1 sister chromatid cohesion 1 0 
nucleotide biosynthetic 
process 2 2 ribosome biogenesis 5 2 18   
one-carbon metabolic 
process 2 2 19      
phenylalanyl-tRNA 
aminoacylation 2 2       
protein lipoylation 2 2       
purine ribonucleoside 
salvage 2 2       
SRP-dependent 
cotranslational protein 
targeting to membrane 2 2       
UMP salvage 2 2       
5-phosphoribose 1-
diphosphate 
biosynthetic process 1 1       
adenine salvage 1 1       
adhesion of symbiont 
to host cell 1 1       
alanyl-tRNA 
aminoacylation 1 1       
arginyl-tRNA 
aminoacylation 1 1       
asparaginyl-tRNA 
aminoacylation 1 1       
ATP hydrolysis 
coupled proton 
transport 1 1       




modification process 1 1       
CTP salvage 1 1       
cysteinyl-tRNA 
aminoacylation 1 1       
de novo' CTP 
biosynthetic process 1 1       
deoxyribonucleotide 
biosynthetic process 1 1       
deoxyribonucleotide 
catabolic process 1 1       
deoxyribose 
phosphate catabolic 
process 1 1       
DNA biosynthetic 
process 1 1       
DNA replication 
initiation 1 1       
DNA replication 
synthesis of RNA 
primer  1 1       
DNA-templated 
transcription 
termination  1 1       
dTDP biosynthetic 
process 1 1       
dTMP biosynthetic 
process 1 1       
dTTP biosynthetic 
process 1 1       
enterobacterial 
common antigen 
biosynthetic process 1 1       
FAD biosynthetic 
process 1 1       
FMN biosynthetic 





metabolic process  1 1       
fructose 6-phosphate 
metabolic process 1 1       
galactose metabolic 
process 1 1       
glucose catabolic 
process 1 1       
glucose metabolic 
process 1 1       
glutamyl-tRNA 
aminoacylation 1 1       
glycerol catabolic 
process 1 1       
glycerol ether 
metabolic process 1 1       
glycerol-3-phosphate 
metabolic process 1 1       
glycyl-tRNA 
aminoacylation 1 1       
guanosine 
tetraphosphate 
biosynthetic process 1 1       
histidine biosynthetic 
process 1 1       
histidyl-tRNA 
aminoacylation 1 1       
IMP salvage 1 1       
isoleucyl-tRNA 
aminoacylation 1 1       
leucyl-tRNA 
aminoacylation 1 1       
lipoprotein biosynthetic 
process 1 1       
lysyl-tRNA 




biosynthetic process 1 1       
metabolic process 1 1       
methionine 
biosynthetic process 1 1       
methionyl-tRNA 
aminoacylation 1 1       
mRNA processing 1 1       
NAD metabolic 
process 1 1       
NADP biosynthetic 
process 1 1       
organic acid metabolic 
process 1 1       
pentose-phosphate 
shunt 1 1       
pentose-phosphate 
shunt non-oxidative 
branch  1 1       
phosphate ion 
transmembrane 
transport 1 1       
phosphate-containing 
compound metabolic 
process 1 1       
phosphatidylglycerol 
biosynthetic process 1 1       
phospholipid 
biosynthetic process 1 1       
potassium ion 
transport 1 1       
prolyl-tRNA 
aminoacylation 1 1       
protein catabolic 
process 1 1       
protein import 1 1       
protein refolding 1 1       
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protein repair 1 1       
protein targeting 1 1       
purine nucleotide 
biosynthetic process 1 1       
pyrimidine nucleobase 
metabolic process 1 1       
pyrimidine nucleoside 
metabolic process 1 1       
regulation of DNA 
replication 1 1       
regulation of DNA-
templated transcription 
elongation  1 1       
regulation of 
translation 1 1       
regulation of 
translational fidelity 1 1       
removal of superoxide 
radicals 1 1       
response to heat 1 1       
riboflavin biosynthetic 
process 1 1       
RNA processing 1 1       
rRNA catabolic 
process 1 1       
S-adenosylmethionine 
biosynthetic process 1 1       
selenocysteinyl-
tRNA(Sec) 
biosynthetic process 1 1       
seryl-tRNA 
aminoacylation 1 1       
tetrahydrofolate 
interconversion 1 1       
thiamine biosynthetic 




biosynthetic process 1 1       
threonyl-tRNA 
aminoacylation 1 1       
transcription 
antitermination 1 1       
tRNA aminoacylation 
for protein translation 1 1       
tRNA modification 1 1       
tRNA thio-modification 1 1       
tRNA wobble uridine 
modification 1 1       
tryptophanyl-tRNA 
aminoacylation 1 1       
tyrosyl-tRNA 
aminoacylation 1 1       
UDP-glucose 
metabolic process 1 1       
uracil salvage 1 1       
valyl-tRNA 
aminoacylation 1 1       












Appendix 8. A summary of gene ontology (GO) term reductions and removals from the baseline M. genitalium genome to produce the minimal gene set proposed 
by Tomita et al. (1999). Baseline = the unchanged genome of M. genitalium in the M. genitalium WCM. The number of GO term categories either Unaffected, 
Reduced, or Removed is listed below the respective columns. 
Unaffected Baseline KooninMGS Reduced Baseline TomitaMGS Removed Baseline TomitaMGS 
translation 56 56 DNA replication 10 9 
ATP synthesis coupled 
proton transport 8 0 
glycolytic process 11 11 
carbohydrate metabolic 
process 5 4 
cytoadherence to 
microvasculature mediated 
by symbiont protein  6 0 
cell redox homeostasis 3 3 protein folding 5 4 SOS response 6 0 
acetyl-CoA biosynthetic 
process 2 2 DNA topological change 5 4 DNA recombination 4 0 
AMP salvage 2 2 tRNA processing 5 4 pathogenesis 4 0 
CDP-diacylglycerol 
biosynthetic process 2 2 
transcription DNA-
templated  9 7 nucleotide-excision repair 3 0 
gluconeogenesis 2 2 
phosphoenolpyruvate-
dependent sugar 
phosphotransferase system 4 3 base-excision repair 2 0 
glycine biosynthetic 
process 2 2 glycerol metabolic process 4 3 lipid metabolic process 2 0 
NAD biosynthetic process 2 2 
fatty acid biosynthetic 
process 3 2 protein secretion 2 0 
nucleoside metabolic 
process 2 2 
regulation of transcription 
DNA-templated  3 2 response to oxidative stress 2 0 
nucleotide biosynthetic 
process 2 2 protein transport 6 4 
SRP-dependent 
cotranslational protein 
targeting to membrane 2 0 
one-carbon metabolic 
process 2 2 transport 10 6 
tRNA 
threonylcarbamoyladenosine 
modification 2 0 
phenylalanyl-tRNA 
aminoacylation 2 2 cell cycle 4 2 
ATP hydrolysis coupled 
proton transport 1 0 
purine ribonucleoside 
salvage 2 2 
DNA-templated 





process 1 1 biosynthetic process 2 1 cell adhesion 1 0 
adenine salvage 1 1 UMP salvage 2 1 
cellular phosphate ion 
homeostasis 1 0 
adhesion of symbiont to 
host cell 1 1 protein lipoylation 2 1 
cellular protein modification 
process 1 0 
alanyl-tRNA 
aminoacylation 1 1 cell division 5 2 chromosome segregation 1 0 
arginyl-tRNA 
aminoacylation 1 1 ribosome biogenesis 5 2 chromosome separation 1 0 
asparaginyl-tRNA 
aminoacylation 1 1 pseudouridine synthesis 3 1 
coenzyme A biosynthetic 
process 1 0 
carboxylic acid metabolic 
process 1 1 rRNA processing 3 1 
deoxyribonucleotide 
catabolic process 1 0 
chromosome 
condensation 1 1 DNA repair 8 1 
deoxyribose phosphate 
catabolic process 1 0 
CTP salvage 1 1 22   
DNA restriction-modification 
system 1 0 
cysteinyl-tRNA 
aminoacylation 1 1    dTMP biosynthetic process 1 0 
de novo' CTP biosynthetic 
process 1 1    dTTP biosynthetic process 1 0 
deoxyribonucleotide 
biosynthetic process 1 1    
heterophilic cell-cell 
adhesion via plasma 
membrane cell adhesion 
molecules 1 0 
DNA biosynthetic process 1 1    
lipoprotein biosynthetic 
process 1 0 
DNA replication initiation 1 1    mRNA catabolic process 1 0 
DNA replication synthesis 
of RNA primer  1 1    
negative regulation of 
phosphate metabolic 
process 1 0 
DNA-templated 
transcription termination  1 1    
phosphate ion 
transmembrane transport 1 0 
dTDP biosynthetic 





process 1 1    protein import 1 0 
FAD biosynthetic process 1 1    
protein insertion into 
membrane 1 0 
FMN biosynthetic process 1 1    protein refolding 1 0 
fructose 1,6-bisphosphate 
metabolic process  1 1    protein repair 1 0 
fructose 6-phosphate 
metabolic process 1 1    protein targeting 1 0 
galactose metabolic 
process 1 1    
regulation of carbohydrate 
metabolic process 1 0 
glucose catabolic process 1 1    RNA processing 1 0 
glucose metabolic 
process 1 1    uracil salvage 1 0 
glutamyl-tRNA 
aminoacylation 1 1    39   
glycerol catabolic process 1 1       
glycerol ether metabolic 
process 1 1       
glycerol-3-phosphate 
metabolic process 1 1       
glycyl-tRNA 
aminoacylation 1 1       
guanosine tetraphosphate 
biosynthetic process 1 1       
histidine biosynthetic 
process 1 1       
histidyl-tRNA 
aminoacylation 1 1       
IMP salvage 1 1       
isoleucyl-tRNA 
aminoacylation 1 1       
leucyl-tRNA 
aminoacylation 1 1       




biosynthetic process 1 1       
metabolic process 1 1       
methionine biosynthetic 
process 1 1       
methionyl-tRNA 
aminoacylation 1 1       
mRNA processing 1 1       
NAD metabolic process 1 1       
NADP biosynthetic 
process 1 1       
organic acid metabolic 
process 1 1       
pentose-phosphate shunt 1 1       
pentose-phosphate shunt 
non-oxidative branch  1 1       
phosphate-containing 
compound metabolic 
process 1 1       
phosphatidylglycerol 
biosynthetic process 1 1       
phospholipid biosynthetic 
process 1 1       
potassium ion transport 1 1       
prolyl-tRNA 
aminoacylation 1 1       
purine nucleotide 
biosynthetic process 1 1       
pyrimidine nucleobase 
metabolic process 1 1       
pyrimidine nucleoside 
metabolic process 1 1       
regulation of DNA 
replication 1 1       
regulation of DNA-
templated transcription 
elongation  1 1       
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regulation of translation 1 1       
regulation of translational 
fidelity 1 1       
removal of superoxide 
radicals 1 1       
response to heat 1 1       
riboflavin biosynthetic 
process 1 1       
rRNA catabolic process 1 1       
S-adenosylmethionine 
biosynthetic process 1 1       
selenocysteinyl-
tRNA(Sec) biosynthetic 
process 1 1       
seryl-tRNA 
aminoacylation 1 1       
sister chromatid cohesion 1 1       
tetrahydrofolate 
interconversion 1 1       
thiamine biosynthetic 
process 1 1       
thiamine diphosphate 
biosynthetic process 1 1       
threonyl-tRNA 
aminoacylation 1 1       
transcription 
antitermination 1 1       
tRNA aminoacylation for 
protein translation 1 1       
tRNA modification 1 1       
tRNA thio-modification 1 1       
tRNA wobble uridine 
modification 1 1       
tryptophanyl-tRNA 




aminoacylation 1 1       
UDP-glucose metabolic 
process 1 1       
valyl-tRNA 
aminoacylation 1 1       



















Appendix 9. A summary of gene ontology (GO) terms reintroduced to the M. genitalium minimal gene 




translation 56 4 
glycolytic process 11 11 
DNA replication 10 8 
transport 10 6 
transcription DNA-templated  9 7 
DNA repair 8 1 
protein transport 6 4 
carbohydrate metabolic process 5 3 
cell division 5 2 
DNA topological change 5 4 
protein folding 5 4 
ribosome biogenesis 5 1 
tRNA processing 5 3 
cell cycle 4 2 
glycerol metabolic process 4 2 
phosphoenolpyruvate-dependent sugar phosphotransferase system 4 3 
cell redox homeostasis 3 3 
pseudouridine synthesis 3 1 
regulation of transcription DNA-templated  3 2 
rRNA processing 3 1 
acetyl-CoA biosynthetic process 2 2 
AMP salvage 2 1 
biosynthetic process 2 1 
CDP-diacylglycerol biosynthetic process 2 2 
fatty acid biosynthetic process 2 2 
gluconeogenesis 2 2 
glycine biosynthetic process 2 2 
NAD biosynthetic process 2 2 
nucleoside metabolic process 2 2 
nucleotide biosynthetic process 2 2 
one-carbon metabolic process 2 2 
protein lipoylation 2 1 
purine ribonucleoside salvage 2 2 
UMP salvage 2 1 
5-phosphoribose 1-diphosphate biosynthetic process 1 1 
adenine salvage 1 1 
adhesion of symbiont to host cell 1 1 
CTP salvage 1 1 
de novo' CTP biosynthetic process 1 1 
deoxyribonucleotide biosynthetic process 1 1 
DNA biosynthetic process 1 1 
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DNA replication initiation 1 1 
DNA replication synthesis of RNA primer  1 1 
DNA-templated transcription initiation  1 1 
DNA-templated transcription termination  1 1 
dTDP biosynthetic process 1 1 
enterobacterial common antigen biosynthetic process 1 1 
FAD biosynthetic process 1 1 
FMN biosynthetic process 1 1 
fructose 1,6-bisphosphate metabolic process  1 1 
fructose 6-phosphate metabolic process 1 1 
galactose metabolic process 1 1 
glucose catabolic process 1 1 
glucose metabolic process 1 1 
glycerol catabolic process 1 1 
glycerol ether metabolic process 1 1 
glycerol-3-phosphate metabolic process 1 1 
guanosine tetraphosphate biosynthetic process 1 1 
histidine biosynthetic process 1 1 
IMP salvage 1 1 
membrane lipid biosynthetic process 1 1 
metabolic process 1 1 
methionine biosynthetic process 1 1 
mRNA processing 1 1 
NAD metabolic process 1 1 
NADP biosynthetic process 1 1 
organic acid metabolic process 1 1 
pentose-phosphate shunt 1 1 
pentose-phosphate shunt non-oxidative branch  1 1 
phosphatidylglycerol biosynthetic process 1 1 
phospholipid biosynthetic process 1 1 
potassium ion transport 1 1 
purine nucleotide biosynthetic process 1 1 
pyrimidine nucleobase metabolic process 1 1 
pyrimidine nucleoside metabolic process 1 1 
regulation of DNA replication 1 1 
regulation of DNA-templated transcription elongation  1 1 
regulation of translational fidelity 1 1 
removal of superoxide radicals 1 1 
response to heat 1 1 
riboflavin biosynthetic process 1 1 
rRNA catabolic process 1 1 
S-adenosylmethionine biosynthetic process 1 1 
tetrahydrofolate interconversion 1 1 
thiamine biosynthetic process 1 1 
thiamine diphosphate biosynthetic process 1 1 
transcription antitermination 1 1 
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tRNA modification 1 1 
tRNA thio-modification 1 1 
tRNA wobble uridine modification 1 1 
































Appendix 10. A summary of gene ontology (GO) terms reintroduced to the M. genitalium minimal gene 




translation 56 6 
glycolytic process 11 4 
DNA replication 10 1 
transport 10 6 
transcription DNA-templated  9 2 
protein transport 6 4 
carbohydrate metabolic process 5 1 
cell division 5 1 
DNA topological change 5 2 
protein folding 5 1 
tRNA processing 5 1 
cell cycle 4 1 
glycerol metabolic process 4 2 
cell redox homeostasis 3 2 
fatty acid biosynthetic process 3 2 
pseudouridine synthesis 3 1 
regulation of transcription DNA-templated  3 1 
acetyl-CoA biosynthetic process 2 2 
AMP salvage 2 1 
biosynthetic process 2 1 
NAD biosynthetic process 2 2 
nucleoside metabolic process 2 1 
protein lipoylation 2 1 
purine ribonucleoside salvage 2 1 
UMP salvage 2 1 
adenine salvage 1 1 
CTP salvage 1 1 
de novo' CTP biosynthetic process 1 1 
DNA biosynthetic process 1 1 
DNA replication initiation 1 1 
enterobacterial common antigen biosynthetic process 1 1 
galactose metabolic process 1 1 
glycerol catabolic process 1 1 
glycerol-3-phosphate metabolic process 1 1 
guanosine tetraphosphate biosynthetic process 1 1 
membrane lipid biosynthetic process 1 1 
NAD metabolic process 1 1 
NADP biosynthetic process 1 1 
organic acid metabolic process 1 1 
phosphatidylglycerol biosynthetic process 1 1 
phospholipid biosynthetic process 1 1 
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potassium ion transport 1 1 
pyrimidine nucleobase metabolic process 1 1 
pyrimidine nucleoside metabolic process 1 1 
regulation of DNA replication 1 1 
regulation of translational fidelity 1 1 
thiamine biosynthetic process 1 1 
thiamine diphosphate biosynthetic process 1 1 
tRNA thio-modification 1 1 





























Appendix 11. A summary of gene ontology (GO) terms reintroduced to the M. genitalium minimal gene 




glycolytic process 11 1 
DNA replication 10 1 
transport 10 2 
carbohydrate metabolic process 5 1 
cell division 5 1 
protein folding 5 1 
cell cycle 4 1 
cell redox homeostasis 3 1 
rRNA processing 3 1 
CDP-diacylglycerol biosynthetic process 2 1 
metabolic process 1 1 
mRNA processing 1 1 
phosphatidylglycerol biosynthetic process 1 1 






















Appendix 12. A summary of gene ontology (GO) terms reintroduced to the M. genitalium minimal gene 




translation 56 25 
glycolytic process 11 6 
DNA replication 10 4 
transcription DNA-templated  9 3 
protein transport 6 4 
carbohydrate metabolic process 5 2 
cell division 5 1 
DNA topological change 5 2 
protein folding 5 2 
ribosome biogenesis 5 1 
tRNA processing 5 2 
cell cycle 4 1 
glycerol metabolic process 4 2 
phosphoenolpyruvate-dependent sugar phosphotransferase system 4 2 
cell redox homeostasis 3 2 
fatty acid biosynthetic process 3 2 
pseudouridine synthesis 3 1 
regulation of transcription DNA-templated  3 2 
acetyl-CoA biosynthetic process 2 2 
AMP salvage 2 1 
biosynthetic process 2 1 
CDP-diacylglycerol biosynthetic process 2 2 
glycine biosynthetic process 2 1 
NAD biosynthetic process 2 2 
nucleoside metabolic process 2 1 
nucleotide biosynthetic process 2 1 
one-carbon metabolic process 2 1 
protein lipoylation 2 1 
purine ribonucleoside salvage 2 2 
UMP salvage 2 1 
adenine salvage 1 1 
CTP salvage 1 1 
de novo' CTP biosynthetic process 1 1 
deoxyribonucleotide biosynthetic process 1 1 
DNA biosynthetic process 1 1 
enterobacterial common antigen biosynthetic process 1 1 
fructose 1,6-bisphosphate metabolic process  1 1 
fructose 6-phosphate metabolic process 1 1 
galactose metabolic process 1 1 
glucose catabolic process 1 1 
glycerol catabolic process 1 1 
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glycerol-3-phosphate metabolic process 1 1 
glycyl-tRNA aminoacylation 1 1 
guanosine tetraphosphate biosynthetic process 1 1 
histidine biosynthetic process 1 1 
IMP salvage 1 1 
membrane lipid biosynthetic process 1 1 
methionine biosynthetic process 1 1 
NAD metabolic process 1 1 
NADP biosynthetic process 1 1 
organic acid metabolic process 1 1 
pentose-phosphate shunt non-oxidative branch  1 1 
phosphate-containing compound metabolic process 1 1 
phosphatidylglycerol biosynthetic process 1 1 
phospholipid biosynthetic process 1 1 
purine nucleotide biosynthetic process 1 1 
pyrimidine nucleobase metabolic process 1 1 
pyrimidine nucleoside metabolic process 1 1 
regulation of translational fidelity 1 1 
thiamine biosynthetic process 1 1 
thiamine diphosphate biosynthetic process 1 1 
threonyl-tRNA aminoacylation 1 1 
tRNA thio-modification 1 1 
tRNA wobble uridine modification 1 1 



















Appendix 13. A summary of gene ontology (GO) terms reintroduced to the M. genitalium minimal gene 




translation 56 1 
transport 10 1 
tRNA processing 5 2 
pseudouridine synthesis 3 1 
glycine biosynthetic process 2 1 
isoleucyl-tRNA aminoacylation 1 1 
pyrimidine nucleobase metabolic process 1 1 
pyrimidine nucleoside metabolic process 1 1 
tetrahydrofolate interconversion 1 1 
thiamine biosynthetic process 1 1 
thiamine diphosphate biosynthetic process 1 1 























Appendix 14. A summary of gene ontology (GO) terms reintroduced to the M. genitalium minimal gene 



































Appendix 15. A summary of gene ontology (GO) terms reintroduced to the M. genitalium minimal gene 
set proposed by Mushegian & Koonin (1996) to produce a dividing in silico cell. 
GOTerms Baseline Koonin Reintroduction 
translation 56 5 
DNA replication 10 3 
transport 10 1 
transcription DNA-templated  9 2 
carbohydrate metabolic process 5 1 
tRNA processing 5 1 
glycerol metabolic process 4 1 
phosphoenolpyruvate-dependent sugar phosphotransferase system 4 3 
fatty acid biosynthetic process 3 1 
regulation of transcription DNA-templated  3 2 
NAD biosynthetic process 2 1 
DNA biosynthetic process 1 1 
enterobacterial common antigen biosynthetic process 1 1 
membrane lipid biosynthetic process 1 1 
NAD metabolic process 1 1 
NADP biosynthetic process 1 1 
pentose-phosphate shunt non-oxidative branch  1 1 
phospholipid biosynthetic process 1 1 
potassium ion transport 1 1 
pyrimidine nucleobase metabolic process 1 1 
pyrimidine nucleoside metabolic process 1 1 
regulation of translational fidelity 1 1 
thiamine biosynthetic process 1 1 
thiamine diphosphate biosynthetic process 1 1 















Appendix 16. A summary of gene ontology (GO) terms reintroduced to the M. genitalium minimal gene 




translation 56 7 
glycolytic process 11 4 
DNA replication 10 8 
transport 10 6 
transcription DNA-templated  9 3 
DNA repair 8 1 
protein transport 6 4 
carbohydrate metabolic process 5 3 
cell division 5 2 
DNA topological change 5 4 
protein folding 5 4 
ribosome biogenesis 5 1 
tRNA processing 5 4 
cell cycle 4 2 
glycerol metabolic process 4 1 
cell redox homeostasis 3 3 
fatty acid biosynthetic process 3 2 
pseudouridine synthesis 3 1 
regulation of transcription DNA-templated  3 1 
rRNA processing 3 1 
acetyl-CoA biosynthetic process 2 2 
AMP salvage 2 2 
biosynthetic process 2 1 
CDP-diacylglycerol biosynthetic process 2 1 
glycine biosynthetic process 2 2 
NAD biosynthetic process 2 2 
nucleoside metabolic process 2 2 
nucleotide biosynthetic process 2 2 
one-carbon metabolic process 2 2 
phenylalanyl-tRNA aminoacylation 2 1 
protein lipoylation 2 1 
purine ribonucleoside salvage 2 2 
UMP salvage 2 1 
5-phosphoribose 1-diphosphate biosynthetic process 1 1 
adenine salvage 1 1 
CTP salvage 1 1 
de novo' CTP biosynthetic process 1 1 
deoxyribonucleotide biosynthetic process 1 1 
DNA biosynthetic process 1 1 
DNA replication initiation 1 1 
DNA replication synthesis of RNA primer  1 1 
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DNA-templated transcription termination  1 1 
dTDP biosynthetic process 1 1 
enterobacterial common antigen biosynthetic process 1 1 
FAD biosynthetic process 1 1 
FMN biosynthetic process 1 1 
galactose metabolic process 1 1 
glycerol ether metabolic process 1 1 
guanosine tetraphosphate biosynthetic process 1 1 
histidine biosynthetic process 1 1 
IMP salvage 1 1 
membrane lipid biosynthetic process 1 1 
metabolic process 1 1 
methionine biosynthetic process 1 1 
mRNA processing 1 1 
NAD metabolic process 1 1 
NADP biosynthetic process 1 1 
organic acid metabolic process 1 1 
pentose-phosphate shunt non-oxidative branch  1 1 
phospholipid biosynthetic process 1 1 
potassium ion transport 1 1 
purine nucleotide biosynthetic process 1 1 
pyrimidine nucleobase metabolic process 1 1 
pyrimidine nucleoside metabolic process 1 1 
regulation of DNA replication 1 1 
regulation of DNA-templated transcription elongation  1 1 
regulation of translational fidelity 1 1 
removal of superoxide radicals 1 1 
response to heat 1 1 
riboflavin biosynthetic process 1 1 
rRNA catabolic process 1 1 
S-adenosylmethionine biosynthetic process 1 1 
tetrahydrofolate interconversion 1 1 
thiamine biosynthetic process 1 1 
thiamine diphosphate biosynthetic process 1 1 
transcription antitermination 1 1 
tRNA modification 1 1 
tRNA thio-modification 1 1 
tRNA wobble uridine modification 1 1 








Appendix 17. Analysis of 1214 single gene knockouts by comparison with the Keio collection. Gene index: Gene index in the E. coli WCM, KO number: the 
corresponding number to knock out a certain gene in the E. coli WCM, GeneID: the EcoCyc ID used to identify genes within the E. coli WCM, Accession ID: 
the gene ID used to identify genes within the Keio collection, Gene name: the genes modelled in the E. coli WCM (synonyms and identification of 
pseudogenes are included), Output: a description of whether the single gene knockout simulation produced output (Y = Standard growth output, X = No 
output, O = Impacted growth output, - = Missing massFractionSummary.png file), Keio essentiality: the essentiality result published by Baba et al. (2006) 
once separated from values published by Gerdes et al. (2003), Hashimoto et al. (2005), and Kang et al. (2004) (* = weaker confidence in essentiality label by 
Baba et al. (2006)), Conflicts: whether the output of the single gene knockout conflicts the assessment of essentiality published by Baba et al. (2006) (Y = 
Conflicts, N = No conflict, X = Unable to assess, Y! = Conflicts but shows impacted growth output, N! = No conflict but shows impacted growth output), 
Disagreement reason: categorisation of single gene knockouts which conflict the Keio collection (1 = Essential gene produced standard growth output, 2 = 
Essential gene produced impacted growth output, 3 = Uncertain essentiality gene produced standard growth output, 4 = Non-essential gene produced no 




Number GeneID AccessionID Gene name Output Keio essentiality Conflicts  Disagreement reason 
15 16 EG10001 ECK4045 alr Y N N - 
18 19 EG10004 ECK3629 dfp Y E* Y 1 
19 20 EG10006 ECK4116 dcuB Y N N - 
20 21 EG10007 ECK2301 hisM Y N N - 
24 25 EG10012 ECK0877 cydC Y E Y 1 
28 29 EG10016 ECK3114 garL Y N N - 
29 30 EG10017 ECK3176 ispB Y E Y 1 
35 36 EG10024 ECK0113 aceE Y N N - 
36 37 EG10025 ECK0114 aceF Y N N - 
38 39 EG10027 ECK2290 ackA Y N N - 
41 42 EG10030 ECK1618 add Y N N - 
42 43 EG10031 ECK1235 adhE Y N N - 
43 44 EG10032 ECK0468 adk X E N - 
45 46 EG10034 ECK2692 alaS Y N N - 
46 47 EG10035 ECK1408 aldA Y N N - 
47 48 EG10036 ECK1295 puuC Y N N - 
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49 50 EG10039 ECK1977 amn Y N N - 
53 54 EG10043 ECK4210 cysQ O N N! - 
55 56 EG10045 ECK1765 ansA Y N N - 
56 57 EG10046 ECK2952 ansB Y N N - 
58 59 EG10048 ECK0050 apaH Y N N - 
59 60 EG10049 ECK0971 appA Y N* N - 
61 62 EG10051 ECK0463 apt Y N N - 
62 63 EG10052 ECK0063 araA Y u X 3 
63 64 EG10053 ECK0064 araB Y u X 3 
64 65 EG10054 ECK0065 araC Y N N - 
65 66 EG10055 ECK0062 araD Y u X 3 
66 67 EG10056 ECK2839 araE Y N N - 
67 68 EG10057 ECK1899 araF Y N N - 
68 69 EG10058 ECK1898 araG Y N N - 
69 70 EG10059 ECK1897 araH Y N* N 1 
71 72 EG10061 ECK4393 arcA Y N N 1 
73 74 EG10063 ECK2814 argA X N Y 4 
74 75 EG10064 ECK3950 argB X N Y 4 
75 76 EG10065 ECK3949 argC X N Y 4 
76 77 EG10066 ECK3347 argD Y N N - 
77 78 EG10067 ECK0274 argF Y N N - 
78 79 EG10068 ECK3161 argG X N Y 4 
79 80 EG10069 ECK4247 argI Y N N - 
80 81 EG10070 ECK3226 argR Y N N - 
81 82 EG10071 ECK1877 argS Y E Y 1 
82 83 EG10072 ECK2304 argT Y N N - 
83 84 EG10073 ECK0899 aroA X N Y 4 
84 85 EG10074 ECK3376 aroB O N N! - 
85 86 EG10075 ECK2323 aroC O N N! - 
86 87 EG10076 ECK1691 aroD O N N! - 
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87 88 EG10077 ECK3268 aroE O N N! - 
88 89 EG10078 ECK2598 aroF Y N N - 
89 90 EG10079 ECK0743 aroG Y N N - 
90 91 EG10080 ECK1702 aroH Y N N - 
91 92 EG10081 ECK3377 aroK Y N*  N - 
92 93 EG10082 ECK0383 aroL Y N N - 
94 95 EG10084 ECK0111 aroP Y N N - 
98 99 EG10088 ECK3419 asd O E Y! 2 
101 102 EG10091 ECK3738 asnA Y N N - 
102 103 EG10092 ECK0662 asnB Y N N - 
104 105 EG10094 ECK0921 asnS Y E Y 1 
105 106 EG10095 ECK4133 aspA Y N* N - 
106 107 EG10096 ECK0919 aspC Y N N - 
107 108 EG10097 ECK1867 aspS Y E Y 1 
108 109 EG10098 ECK3727 atpA Y N N - 
109 110 EG10099 ECK3731 atpB Y N N - 
110 111 EG10100 ECK3724 atpC Y N N - 
111 112 EG10101 ECK3725 atpD Y N N - 
112 113 EG10102 ECK3730 atpE Y N N - 
113 114 EG10103 ECK3729 atpF Y N N - 
114 115 EG10104 ECK3726 atpG Y N N - 
115 116 EG10105 ECK3728 atpH Y N N - 
117 118 EG10107 ECK3561 avtA Y N* N - 
119 120 EG10109 ECK0309 betA Y N N - 
120 121 EG10110 ECK0310 betB Y N N - 
122 123 EG10112 ECK0312 betT Y N N - 
125 126 EG10115 ECK3715 bglF Y N N - 
127 128 EG10117 ECK0763 bioA Y N N - 
128 129 EG10118 ECK0764 bioB X N Y 4 
129 130 EG10119 ECK0766 bioC Y N N - 
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130 131 EG10120 ECK0767 bioD Y N N - 
131 132 EG10121 ECK0765 bioF Y N N - 
132 133 EG10122 ECK3399 bioH Y N N - 
133 134 EG10123 ECK3965 birA Y E Y 1 
134 135 EG10124 ECK3538 bisC Y N N - 
139 140 EG10129 ECK1708 btuE Y N N - 
141 142 EG10131 ECK4125 cadA Y N N - 
142 143 EG10132 ECK4126 cadB Y N N - 
144 145 EG10134 ECK0033 carA X N Y 4 
145 146 EG10135 ECK0034 carB X N Y 4 
147 148 EG10137 ECK2136 cdd Y N N - 
148 149 EG10138 ECK3910 cdh Y N N - 
149 150 EG10139 ECK0174 cdsA Y E Y 1 
158 159 EG10148 ECK1885 cheR Y N N - 
171 172 EG10161 ECK2043 cpsB Y N N - 
172 173 EG10162 ECK2042 cpsG Y N N - 
175 176 EG10165 ECK2412 crr Y N N - 
180 181 EG10170 ECK3800 cyaA Y N N - 
182 183 EG10173 ECK0721 cydA Y E Y 1 
183 184 EG10174 ECK0722 cydB Y N N - 
185 186 EG10176 ECK0336 cynT Y N N - 
187 188 EG10178 ECK0426 cyoA Y N N - 
188 189 EG10179 ECK0425 cyoB Y N N - 
189 190 EG10180 ECK0424 cyoC Y N N - 
190 191 EG10181 ECK0423 cyoD Y N N - 
191 192 EG10182 ECK0422 cyoE Y N N - 
192 193 EG10183 ECK2417 cysA O N N! - 
194 195 EG10185 ECK2745 cysC O N N! - 
195 196 EG10186 ECK2747 cysD O N N! - 
196 197 EG10187 ECK3597 cysE O N N! - 
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197 198 EG10188 ECK3356 cysG Y N N - 
198 199 EG10189 ECK2757 cysH O N N! - 
199 200 EG10190 ECK2758 cysI O N N! - 
200 201 EG10191 ECK2759 cysJ O N N! - 
201 202 EG10192 ECK2409 cysK Y N N - 
202 203 EG10193 ECK2416 cysM Y N N - 
203 204 EG10194 ECK2746 cysN O N N! - 
204 205 EG10195 ECK2420 cysP Y N N - 
205 206 EG10196 ECK0519 cysS Y E Y 1 
206 207 EG10197 ECK2419 cysU O N N! - 
207 208 EG10198 ECK2418 cysW O N* N! - 
208 209 EG10200 ECK3926 cytR Y N N - 
213 214 EG10205 ECK2474 dapA O E Y! 2 
214 215 EG10206 ECK0032 dapB O E Y! 2 
215 216 EG10207 ECK0164 dapD O E Y! 2 
216 217 EG10208 ECK2467 dapE O E Y! 2 
217 218 EG10209 ECK3804 dapF O N N! - 
221 222 EG10213 ECK0376 ddlA Y N N - 
222 223 EG10214 ECK0093 ddlB Y N N - 
225 226 EG10217 ECK2310 accD Y E Y 1 
227 228 EG10219 ECK4374 deoA Y N N - 
228 229 EG10220 ECK4375 deoB Y N N - 
229 230 EG10221 ECK4373 deoC Y N N - 
230 231 EG10222 ECK4376 deoD Y N N - 
232 233 EG10224 ECK4034 dgkA Y N N - 
233 234 EG10225 ECK0159 dgt Y N N - 
239 240 EG10231 ECK2126 dld Y N N - 
240 241 EG10232 ECK0885 dmsA Y N* N - 
241 242 EG10233 ECK0886 dmsB Y N N - 
242 243 EG10234 ECK0887 dmsC X N Y 4 
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243 244 EG10235 ECK3694 dnaA X E N - 
254 255 EG10246 ECK0211 mltD X N Y 4 
255 256 EG10247 ECK2561 acpS Y E Y 1 
256 257 EG10248 ECK3531 dppA Y N N - 
257 258 EG10249 ECK2362 dsdA Y N N - 
259 260 EG10251 ECK3630 dut Y E Y 1 
264 265 EG10256 ECK1851 eda Y N N - 
265 266 EG10257 ECK1852 edd Y N N - 
266 267 EG10258 ECK2773 eno Y E Y 1 
267 268 EG10259 ECK0589 entA Y N N - 
269 270 EG10261 ECK0586 entC Y N N - 
270 271 EG10262 ECK0575 entD Y E Y 1 
271 272 EG10263 ECK0587 entE Y N N - 
273 274 EG10265 ECK0097 lpxC Y E Y 1 
281 282 EG10273 ECK0945 fabA Y E Y 1 
282 283 EG10274 ECK2317 fabB Y E Y 1 
284 285 EG10276 ECK3243 accC Y E Y 1 
285 286 EG10277 ECK1077 fabH Y N N - 
286 287 EG10278 ECK3837 fadA Y N* N - 
287 288 EG10279 ECK3838 fadB Y N N - 
288 289 EG10280 ECK2338 fadL Y N N - 
290 291 EG10282 ECK2921 fbaA Y E Y 1 
291 292 EG10283 ECK4227 fbp Y N N - 
293 294 EG10285 ECK4072 fdhF Y N N - 
307 308 EG10299 ECK0577 fes Y N N - 
324 325 EG10316 ECK0178 lpxD Y E Y 1 
325 326 EG10317 ECK3248 fis Y N N - 
333 334 EG10325 ECK1330 fnr Y N N - 
334 335 EG10326 ECK0049 folA Y E Y 1 
335 336 EG10327 ECK2309 folC Y E Y 1 
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336 337 EG10328 ECK0522 folD Y E Y 1 
338 339 EG10330 ECK4150 frdA Y N N - 
339 340 EG10331 ECK4149 frdB Y N N - 
340 341 EG10332 ECK4148 frdC Y N N - 
341 342 EG10333 ECK4147 frdD Y N N - 
342 343 EG10334 ECK3836 fre Y N N - 
352 353 EG10344 ECK0090 ftsW Y E Y 1 
356 357 EG10348 ECK2795 fucA Y N N - 
357 358 EG10349 ECK2797 fucI Y N N - 
358 359 EG10350 ECK2798 fucK Y N N - 
359 360 EG10351 ECK2794 fucO Y N N - 
360 361 EG10352 ECK2796 fucP Y N N - 
362 363 EG10355 ECK2799 fucU X N Y 4 
363 364 EG10356 ECK1607 fumA Y N N - 
364 365 EG10357 ECK4115 fumB Y N N - 
365 366 EG10358 ECK1606 fumC Y N N - 
368 369 EG10361 ECK2656 gabT Y N N - 
369 370 EG10362 ECK0748 galE Y N* N - 
370 371 EG10363 ECK0746 galK Y N N - 
373 374 EG10366 ECK0747 galT Y N N - 
374 375 EG10367 ECK1777 gapA Y E Y 1 
375 376 EG10368 ECK2923 epd Y N N - 
377 378 EG10370 ECK2511 ispG Y E Y 1 
379 380 EG10372 ECK1759 gdhA Y N N - 
386 387 EG10379 ECK3416 glgC Y N N - 
389 390 EG10382 ECK3722 glmS Y E Y 1 
390 391 EG10383 ECK3863 glnA X N Y 4 
393 394 EG10386 ECK0800 glnH Y N N - 
395 396 EG10388 ECK0799 glnP Y N N - 
396 397 EG10389 ECK0798 glnQ Y N N - 
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397 398 EG10390 ECK0668 glnS Y E Y 1 
398 399 EG10391 ECK2233 glpA Y N N - 
399 400 EG10392 ECK2234 glpB Y N N - 
400 401 EG10393 ECK2235 glpC Y N N - 
401 402 EG10394 ECK3412 glpD Y N N - 
402 403 EG10395 ECK3411 glpE Y N N - 
403 404 EG10396 ECK3919 glpF Y N N - 
405 406 EG10398 ECK3918 glpK Y N N - 
406 407 EG10399 ECK2231 glpQ Y N N - 
409 410 EG10402 ECK0709 gltA Y N N - 
410 411 EG10403 ECK3202 gltB Y N N - 
411 412 EG10404 ECK3203 gltD Y N N - 
412 413 EG10405 ECK4070 gltP Y N N - 
414 415 EG10407 ECK2394 gltX - E X N/A 
415 416 EG10408 ECK2548 glyA Y N N - 
416 417 EG10409 ECK3548 glyQ Y E Y 1 
417 418 EG10410 ECK3547 glyS Y N N - 
418 419 EG10411 ECK2024 gnd Y N N - 
419 420 EG10412 ECK3485 gor - N X N/A 
420 421 EG10413 ECK3771 gpp Y N*  N - 
421 422 EG10414 ECK0239 gpt Y N N - 
425 426 EG10418 ECK2683 gshA Y N N - 
426 427 EG10419 ECK2942 gshB X N Y 4 
427 428 EG10420 ECK2503 guaA X N Y 4 
428 429 EG10421 ECK2504 guaB Y N N - 
429 430 EG10422 ECK0104 guaC X N Y 4 
432 433 EG10425 ECK1614 hdhA Y N N - 
434 435 EG10427 ECK1198 hemA X E N - 
435 436 EG10428 ECK0366 hemB X E* N - 
436 437 EG10429 ECK3799 hemC X E* N - 
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437 438 EG10430 ECK3798 hemD X E N - 
439 440 EG10432 ECK0153 hemL Y E Y 1 
447 448 EG10440 ECK1710 ihfA Y N N - 
448 449 EG10441 ECK0903 ihfB X N Y 4 
451 452 EG10444 ECK2019 hisA O N N! - 
452 453 EG10445 ECK2017 hisB O N N! - 
453 454 EG10446 ECK2016 hisC O N N! - 
454 455 EG10447 ECK2015 hisD O N N! - 
455 456 EG10448 ECK2020 hisF O N N! - 
456 457 EG10449 ECK2014 hisG O N N! - 
457 458 EG10450 ECK2018 hisH O N N! - 
458 459 EG10451 ECK2021 hisI O N N! - 
459 460 EG10452 ECK2300 hisP Y N N - 
460 461 EG10453 ECK2510 hisS X E N - 
464 465 EG10457 ECK1232 hns Y N N - 
471 472 EG10464 ECK1039 lpxL Y N N - 
472 473 EG10465 ECK3032 ribB Y E Y 1 
482 483 EG10475 ECK2719 hycB Y N N - 
483 484 EG10476 ECK2718 hycC Y N N - 
484 485 EG10477 ECK2717 hycD Y N N - 
485 486 EG10478 ECK2716 hycE X N Y 4 
486 487 EG10479 ECK2715 hycF Y N N - 
487 488 EG10480 ECK2714 hycG Y N N - 
496 497 EG10489 ECK1122 icd X N Y 4 
497 498 EG10490 ECK2912 argP Y N N - 
499 500 EG10492 ECK0027 ileS Y N N - 
500 501 EG10493 ECK3764 ilvA Y N N - 
501 502 EG10494 ECK3662 ilvB Y N N - 
502 503 EG10495 ECK3766 ilvC O N N! - 
503 504 EG10496 ECK3763 ilvD O N* N! - 
149 
 
504 505 EG10497 ECK3762 ilvE O N* N! - 
505 506 EG10498  ECK3760 
ilvG_2 
(pseudo) X N* Y 4 
506 507 EG10499 ECK0080 ilvH Y N N - 
507 508 EG10500 ECK0079 ilvI Y N* N - 
508 509 EG10501 ECK3761 ilvM Y N N - 
509 510 EG10502 ECK3661 ilvN Y N N - 
515 516 EG10508 ECK0415 ispA X E N - 
516 517 EG10509 ECK1730 katE Y N* N - 
518 519 EG10511 ECK3934 katG Y N N - 
519 520 EG10512 ECK3607 kbl Y N N - 
520 521 EG10513 ECK0686 kdpA Y N N - 
521 522 EG10514 ECK0685 kdpB Y N N - 
522 523 EG10515 ECK0684 kdpC Y N N - 
525 526 EG10518 ECK1203 kdsA Y E Y 1 
526 527 EG10519 ECK0909 kdsB Y E Y 1 
527 528 EG10520 ECK3623 waaA/kdtA Y E Y 1 
528 529 EG10521 ECK0048 kefC Y N N - 
531 532 EG10524 ECK0339 lacA Y N N - 
533 534 EG10526 ECK0340 lacY Y N N - 
534 535 EG10527 ECK0341 lacZ Y u X 3 
538 539 EG10531 ECK0078 leuO Y N* N - 
539 540 EG10532 ECK0635 leuS Y E Y 1 
540 541 EG10533 ECK4035 lexA Y E Y 1 
543 544 EG10536 ECK3438 livF Y N* N - 
544 545 EG10537 ECK3439 livG Y N N - 
545 546 EG10538 ECK3441 livH Y N N - 
546 547 EG10539 ECK3444 livJ Y N* N - 
547 548 EG10540 ECK3442 livK Y N N - 
548 549 EG10541 ECK3440 livM Y N N - 
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550 551 EG10543 ECK0115 lpd X N Y 4 
552 553 EG10545 ECK0180 lpxA Y E Y 1 
553 554 EG10546 ECK0181 lpxB Y E Y 1 
554 555 EG10547 ECK0880 lrp Y N N - 
556 557 EG10549 ECK2836 lysA O N N! - 
557 558 EG10550 ECK4016 lysC Y N N - 
559 560 EG10552 ECK2885 lysS Y N N - 
560 561 EG10553 ECK4123 lysU Y N N - 
567 568 EG10560 ECK3404 malP Y N* N - 
568 569 EG10561 ECK3403 malQ Y N N - 
571 572 EG10564 ECK1617 malY Y N N - 
572 573 EG10565 ECK0397 malZ Y N N - 
573 574 EG10566 ECK1608 manA Y N* N - 
574 575 EG10567 ECK1815 manX Y N N - 
575 576 EG10568 ECK1816 manY X N Y 4 
576 577 EG10569 ECK1817 manZ Y N* N - 
579 580 EG10572 ECK2775 mazG Y N N - 
583 584 EG10576 ECK3225 mdh Y N N - 
586 587 EG10579 ECK2258 menD Y N N - 
588 589 EG10581 ECK4005 metA O N N! - 
589 590 EG10582 ECK3931 metB O N N! - 
590 591 EG10583 ECK3000 metC Y N N - 
591 592 EG10584 ECK3823 metE Y N N - 
592 593 EG10585 ECK3933 metF O N N! - 
593 594 EG10586 ECK2107 metG Y E Y 1 
594 595 EG10587 ECK4011 metH Y N N - 
595 596 EG10588 ECK3930 metJ Y N N - 
596 597 EG10589 ECK2937 metK Y E Y 1 
597 598 EG10590 ECK3932 metL Y N N - 
602 603 EG10595 ECK4167 miaA Y N N - 
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611 612 EG10604 ECK0088 mraY Y E Y 1 
620 621 EG10613 ECK0905 msbA Y E Y 1 
621 622 EG10614 ECK1856 lpxM Y N N - 
623 624 EG10616 ECK3589 mtlD Y N N - 
624 625 EG10617 ECK3149 mtr Y N N - 
626 627 EG10619 ECK0092 murC Y E Y 1 
627 628 EG10620 ECK0089 murD Y E Y 1 
628 629 EG10621 ECK0086 murE Y E Y 1 
629 630 EG10622 ECK0087 murF Y E Y 1 
630 631 EG10623 ECK0091 murG Y E Y 1 
635 636 EG10628 ECK3916 fpr Y N N - 
636 637 EG10629 ECK0534 emrE Y N N - 
637 638 EG10630 ECK0739 nadA Y N N - 
638 639 EG10631 ECK2572 nadB Y N N - 
639 640 EG10632 ECK0665 nagA Y N N - 
641 642 EG10634 ECK0663 umpH/nagD Y N N - 
644 645 EG10637 ECK3214 nanA Y N N - 
649 650 EG10642 ECK1217 narK Y N N - 
650 651 EG10643 ECK1215 narL Y N N - 
656 657 EG10649 ECK1095 ndh Y N N - 
657 658 EG10650 ECK2514 ndk X N Y 4 
659 660 EG10652 ECK0020 nhaA Y N N - 
660 661 EG10653 ECK3353 nirB Y N N - 
661 662 EG10654 ECK3355 nirC Y N* N - 
662 663 EG10655 ECK3354 nirD Y N N - 
667 668 EG10660 ECK2226 nrdA Y E Y 1 
668 669 EG10661 ECK2227 nrdB Y E Y 1 
670 671 EG10663 ECK1738 nadE Y E Y 1 
671 672 EG10664 ECK2959 nupG Y N* N - 
677 678 EG10670 ECK2207 ompC Y N N - 
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678 679 EG10671 ECK0920 ompF Y N N - 
681 682 EG10674 ECK1237 oppA Y N N - 
682 683 EG10675 ECK1238 oppB Y N N - 
683 684 EG10676 ECK1239 oppC Y N N - 
684 685 EG10677 ECK1240 oppD Y N* N - 
685 686 EG10678 ECK1241 oppF Y N N - 
689 690 EG10682 ECK3348 pabA Y N N - 
690 691 EG10683 ECK1810 pabB Y N N - 
695 696 EG10688 ECK3390 pck Y N N - 
698 699 EG10691 ECK0053 pdxA Y N N - 
699 700 EG10693 ECK2562 pdxJ Y N N - 
700 701 EG10694 ECK4253 pepA Y N N - 
701 702 EG10695 ECK0238 pepD Y N N - 
702 703 EG10696 ECK0923 pepN Y N N - 
705 706 EG10699 ECK3908 pfkA Y N N - 
706 707 EG10700 ECK1721 pfkB Y N* N - 
708 709 EG10702 ECK4017 pgi Y N N - 
709 710 EG10703 ECK2922 pgk Y E Y 1 
710 711 EG10704 ECK0412 pgpA Y N N - 
711 712 EG10705 ECK1273 pgpB Y N N - 
712 713 EG10706 ECK1911 pgsA Y E Y 1 
713 714 EG10707 ECK2596 pheA O N N! - 
714 715 EG10708 ECK0568 pheP Y N N - 
715 716 EG10709 ECK1712 pheS Y E Y 1 
716 717 EG10710 ECK1711 pheT Y E Y 1 
719 720 EG10713 ECK4099 phnC Y N N - 
720 721 EG10714 ECK4098 phnD Y N N - 
729 730 EG10723 ECK4087 phnN Y N N - 
730 731 EG10724 ECK4086 phnO Y N N - 
732 733 EG10727 ECK0378 phoA Y N* N - 
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734 735 EG10729 ECK0242 phoE Y N N - 
739 740 EG10734 ECK3721 pstS Y N N - 
744 745 EG10739 ECK3819 pldB Y N* N - 
745 746 EG10740 ECK4033 plsB Y E*  Y 1 
747 748 EG10742 ECK0922 pncB Y N N - 
748 749 EG10743 ECK3152 pnp Y N* N - 
749 750 EG10744 ECK1598 pntA Y N N - 
750 751 EG10745 ECK1597 pntB Y N N - 
751 752 EG10746 ECK3855 polA Y N N - 
754 755 EG10749 ECK1112 potA Y N N - 
755 756 EG10750 ECK1111 potB Y N N - 
756 757 EG10751 ECK1110 potC Y N N - 
757 758 EG10752 ECK1109 potD Y N N - 
758 759 EG10753 ECK0680 potE Y N N - 
759 760 EG10754 ECK0862 poxB Y N N - 
760 761 EG10755 ECK4222 ppa X E N - 
761 762 EG10756 ECK3947 ppc Y N N - 
762 763 EG10757 ECK3351 ppiA Y N N - 
763 764 EG10758 ECK0518 ppiB Y N N - 
764 765 EG10759 ECK1700 ppsA/pps Y N N - 
772 773 EG10767 ECK0244 proA Y N N - 
773 774 EG10768 ECK0243 proB Y N N - 
774 775 EG10769 ECK0381 proC O N N! - 
775 776 EG10770 ECK0194 proS Y E Y 1 
776 777 EG10771 ECK2671 proV Y N N - 
777 778 EG10772 ECK2672 proW Y N N - 
778 779 EG10773 ECK2673 proX Y N N - 
779 780 EG10774 ECK1195 prs/prsA Y E Y 1 
786 787 EG10781 ECK2583 pssA Y E* Y 1 
787 788 EG10782 ECK3719 pstA X N Y 4 
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788 789 EG10783 ECK3718 pstB Y N N - 
789 790 EG10784 ECK3720 pstC Y N N - 
792 793 EG10787 ECK1087 ptsG Y N N - 
795 796 EG10790 ECK4173 purA X N Y 4 
796 797 EG10791 ECK2472 purC X N Y 4 
797 798 EG10792 ECK3997 purD X N Y 4 
798 799 EG10793 ECK0516 purE X N Y 4 
799 800 EG10794 ECK2306 purF X N Y 4 
800 801 EG10795 ECK3998 purH X N Y 4 
801 802 EG10796 ECK0515 purK X N Y 4 
802 803 EG10797 ECK2555 purL X N Y 4 
803 804 EG10798 ECK2495 purM X N Y 4 
804 805 EG10799 ECK2496 purN Y N N - 
806 807 EG10801 ECK1005 putA Y N N - 
807 808 EG10802 ECK1006 putP Y N N - 
808 809 EG10803 ECK1855 pykA Y N N - 
809 810 EG10804 ECK1672 pykF Y N N - 
810 811 EG10805 ECK4240 pyrB Y N N - 
811 812 EG10806 ECK1047 pyrC Y N N - 
812 813 EG10807 ECK0936 pyrD Y N N - 
813 814 EG10808 ECK3632 pyrE Y E Y 1 
814 815 EG10809 ECK1276 pyrF Y N N - 
815 816 EG10810 ECK2774 pyrG X E N - 
816 817 EG10811 ECK4239 pyrI Y N N - 
822 823 EG10817 ECK3742 rbsD Y N N - 
826 827 EG10821 ECK2210 rcsB Y N N - 
840 841 EG10835 ECK2778 relA Y N N - 
843 844 EG10838 ECK3609 rfaD Y N N - 
849 850 EG10844 ECK3772 rhlB Y N N - 
860 861 EG10855 ECK0634 lptE/rlpB Y E Y 1 
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861 862 EG10856 ECK0604 rna Y N N - 
862 863 EG10857 ECK2565 rnc Y E Y 1 
863 864 EG10858 ECK1802 rnd Y N N - 
864 865 EG10859 ECK1069 rne Y E Y 1 
865 866 EG10860 ECK0214 rnhA Y N N - 
866 867 EG10861 ECK0182 rnhB Y N N - 
867 868 EG10862 ECK3696 rnpA Y E Y 1 
868 869 EG10863 ECK3633 rph Y N N - 
869 870 EG10864 ECK3975 rplA X N Y 4 
870 871 EG10865 ECK3304 rplB X E N - 
871 872 EG10866 ECK3307 rplC X E N - 
872 873 EG10867 ECK3306 rplD X E N - 
873 874 EG10868 ECK3295 rplE X E N - 
874 875 EG10869 ECK3292 rplF X E N - 
875 876 EG10870 ECK4199 rplI X N Y 4 
876 877 EG10871 ECK3976 rplJ X E N - 
877 878 EG10872 ECK3974 rplK X N Y 4 
878 879 EG10873 ECK3977 rplL X E N - 
879 880 EG10874 ECK3220 rplM X E N - 
880 881 EG10875 ECK3297 rplN X E N - 
881 882 EG10876 ECK3288 rplO X E N - 
882 883 EG10877 ECK3300 rplP X E N - 
883 884 EG10878 ECK3281 rplQ X E N - 
884 885 EG10879 ECK3291 rplR X E N - 
885 886 EG10880 ECK2603 rplS X E N - 
886 887 EG10881 ECK1714 rplT X E N - 
887 888 EG10882 ECK3302 rplV X E N - 
888 889 EG10883 ECK3305 rplW X E N - 
889 890 EG10884 ECK3296 rplX X E N - 
890 891 EG10885 ECK2179 rplY X N Y 4 
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891 892 EG10886 ECK3627 rpmB X E N - 
892 893 EG10887 ECK3299 rpmC X E N - 
893 894 EG10888 ECK3289 rpmD X E N - 
894 895 EG10889 ECK3928 rpmE X N Y 4 
895 896 EG10890 ECK1075 rpmF X N Y 4 
896 897 EG10891 ECK3626 rpmG X N Y 4 
897 898 EG10892 ECK3695 rpmH X E N - 
898 899 EG10893 ECK3282 rpoA X E N - 
899 900 EG10894 ECK3978 rpoB X E N - 
900 901 EG10895 ECK3979 rpoC X E N - 
905 906 EG10900 ECK0902 rpsA X E N - 
906 907 EG10901 ECK0168 rpsB X E N - 
907 908 EG10902 ECK3301 rpsC X E N - 
908 909 EG10903 ECK3283 rpsD X E N - 
909 910 EG10904 ECK3290 rpsE X E N - 
910 911 EG10905 ECK4196 rpsF X N Y 4 
911 912 EG10906 ECK3328 rpsG X E N - 
912 913 EG10907 ECK3293 rpsH X E N - 
913 914 EG10908 ECK3219 rpsI X E N - 
914 915 EG10909 ECK3308 rpsJ X E N - 
915 916 EG10910 ECK3284 rpsK X E N - 
916 917 EG10911 ECK3329 rpsL X E N - 
917 918 EG10912 ECK3285 rpsM X E N - 
918 919 EG10913 ECK3294 rpsN X E N - 
919 920 EG10914 ECK3154 rpsO X N Y 4 
920 921 EG10915 ECK2606 rpsP X E N - 
921 922 EG10916 ECK3298 rpsQ X E N - 
922 923 EG10917 ECK4198 rpsR X E N - 
923 924 EG10918 ECK3303 rpsS X E N - 
924 925 EG10919 ECK0024 rpsT X N Y 4 
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925 926 EG10920 ECK3055 rpsU X N Y 4 
927 928 EG10922 ECK3966 coaA Y N N - 
931 932 EG10928 ECK0372 sbmA Y N N - 
932 933 EG10929 ECK3909 sbp Y N N - 
933 934 EG10930 ECK1812 sdaA Y N N - 
934 935 EG10931 ECK0712 sdhA Y N N - 
935 936 EG10932 ECK0713 sdhB Y N N - 
936 937 EG10933 ECK0710 sdhC Y N N - 
937 938 EG10934 ECK0711 sdhD Y N N - 
947 948 EG10944 ECK2909 serA Y N N - 
948 949 EG10945 ECK4380 serB Y N N - 
949 950 EG10946 ECK0898 serC Y N N - 
950 951 EG10947 ECK0884 serS Y E Y 1 
951 952 EG10948 ECK1473 maeA/sfcA Y N N - 
953 954 EG10950 ECK4384 slt Y N* N - 
963 964 EG10960 ECK2932 speB Y N N - 
964 965 EG10961 ECK2960 speC Y N* N - 
966 967 EG10963 ECK0120 speE Y N N - 
967 968 EG10964 ECK0681 speF Y N N - 
968 969 EG10965 ECK3638 gmk X E N - 
969 970 EG10966 ECK3640 spoT Y E Y 1 
974 975 EG10971 ECK2700 srlD Y N N - 
976 977 EG10973 ECK2703 gutQ Y N N - 
982 983 EG10979 ECK0714 sucA Y N N - 
983 984 EG10980 ECK0715 sucB Y N N - 
984 985 EG10981 ECK0716 sucC Y N N - 
985 986 EG10982 ECK0717 sucD Y N N - 
988 989 EG10985 ECK0054 surA Y N N - 
993 994 EG10990 ECK3106 tdcB Y N N - 
994 995 EG10991 ECK3105 tdcC Y N N - 
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996 997 EG10993 ECK3606 tdh Y N N - 
997 998 EG10994 ECK1233 tdk Y N N - 
1001 1002 EG10998 ECK0002 thrA Y N N - 
1002 1003 EG10999 ECK0003 thrB O N N! - 
1003 1004 EG11000 ECK0004 thrC O N N! - 
1004 1005 EG11001 ECK1717 thrS Y E Y 1 
1005 1006 EG11002 ECK2823 thyA X N Y 4 
1006 1007 EG11003 ECK0430 tig Y N N - 
1008 1009 EG11005 ECK3701 tnaA Y N* N - 
1009 1010 EG11006 ECK3702 tnaB Y u X 3 
1011 1012 EG11008 ECK0729 tolB Y N N - 
1012 1013 EG11009 ECK3026 tolC Y N N - 
1018 1019 EG11015 ECK3911 tpiA Y N N - 
1023 1024 EG11020 ECK1362 trkG Y N N - 
1024 1025 EG11021 ECK3841 trkH Y N* N - 
1026 1027 EG11023 ECK2604 trmD Y E Y 1 
1027 1028 EG11024 ECK1254 trpA O N N! - 
1028 1029 EG11025 ECK1255 trpB Y N N - 
1029 1030 EG11026 ECK1256 trpC O N N! - 
1030 1031 EG11027 ECK1257 trpD O N N! - 
1031 1032 EG11028 ECK1258 trpE O N N! - 
1032 1033 EG11029 ECK4385 trpR Y N N - 
1033 1034 EG11030 ECK3371 trpS Y E Y 1 
1035 1036 EG11032 ECK0879 trxB O N N! - 
1038 1039 EG11035 ECK0405 tsx Y N N - 
1042 1043 EG11039 ECK2597 tyrA O N N! - 
1043 1044 EG11040 ECK4046 tyrB Y N N - 
1044 1045 EG11041 ECK1906 tyrP Y N N - 
1045 1046 EG11042 ECK1319 tyrR Y N N - 
1046 1047 EG11043 ECK1633 tyrS Y E Y 1 
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1048 1049 EG11045 ECK3825 udp Y N N - 
1049 1050 EG11046 ECK3436 ugpA Y N N - 
1050 1051 EG11047 ECK3437 ugpB Y N N - 
1051 1052 EG11048 ECK3434 ugpC Y N N - 
1052 1053 EG11049 ECK3435 ugpE Y N N - 
1053 1054 EG11050 ECK3433 ugpQ Y N N - 
1063 1064 EG11060 ECK0474 ushA Y N N - 
1068 1069 EG11065 ECK1514 uxaB Y N* N - 
1069 1070 EG11066 ECK4313 uxuA Y N N - 
1070 1071 EG11067 ECK4251 valS Y E Y 1 
1077 1078 EG11074 ECK3554 xylA Y N N - 
1078 1079 EG11075 ECK3553 xylB Y N N - 
1079 1080 EG11076 ECK4023 xylE Y N N - 
1081 1082 EG11079 ECK0026 ribF Y E Y 1 
1082 1083 EG11080 ECK0029 fkpB Y N N - 
1083 1084 EG11081 ECK0030 ispH Y E Y 1 
1084 1085 EG11082 ECK0031 rihC Y N N - 
1092 1093 EG11090 ECK0158 mtn/pfs Y N N - 
1097 1098 EG11095 ECK0398 acpH/yajB Y N N - 
1104 1105 EG11102 ECK0471 gsk Y N N - 
1112 1113 EG11112 ECK0876 aat Y N N - 
1133 1134 EG11135 ECK1766 pncA Y N* N - 
1136 1137 EG11138 ECK1866 nudB Y N N - 
1141 1142 EG11143 ECK2224 ubiG Y N N - 
1155 1156 EG11158 ECK2907 fau/ygfA Y N* N - 
1164 1165 EG11167 ECK3031 zupT/ygiE Y N N - 
1165 1166 EG11168 ECK3051 ttdA Y N N - 
1166 1167 EG11169 ECK3052 ttdB Y N N - 
1168 1169 EG11172 ECK3104 tdcD Y N N - 
1171 1172 EG11175 ECK3112 garK Y N*  N - 
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1172 1173 EG11176 ECK3113 garR Y N N - 
1173 1174 EG11177 ECK3155 truB Y N N - 
1184 1185 EG11189 ECK3611 waaC/rfaC Y N N - 
1185 1186 EG11190 ECK3624 coaD Y E Y 1 
1189 1190 EG11194 ECK3644 xanP/yicE Y N N - 
1190 1191 EG11195 ECK3689 yidA Y N N - 
1193 1194 EG11198 ECK3723 glmU Y E Y 1 
1196 1197 EG11202 ECK3807 yigB Y N N - 
1198 1199 EG11204 ECK3959 murI Y E Y 1 
1199 1200 EG11205 ECK3964 murB Y E Y 1 
1213 1214 EG11221 ECK1853 zwf Y N N - 
1215 1216 EG11223 ECK3951 argH X N Y 4 
1217 1218 EG11225 ECK4132 dcuA Y N N - 
1218 1219 EG11226 ECK0076 leuA O N N! - 
1219 1220 EG11227 ECK1468 fdnG Y N N - 
1220 1221 EG11228 ECK1469 fdnH Y N N - 
1221 1222 EG11229 ECK1470 fdnI Y N N - 
1223 1224 EG11231 ECK1715 rpmI X N* Y 4 
1224 1225 EG11232 ECK3286 rpmJ X N Y 4 
1226 1227 EG11234 ECK1690 ydiB Y N N - 
1231 1232 EG11239 ECK0755 ybhA Y N N - 
1235 1236 EG11245 ECK2926 yggF Y N N - 
1247 1248 EG11258 ECK0895 focA Y N N - 
1248 1249 EG11259 ECK4175 rnr Y N* N - 
1253 1254 EG11265 ECK0901 cmk Y N N - 
1256 1257 EG11268 ECK3274 fmt Y E Y 1 
1269 1270 EG11283 ECK4096 phnE Y N N - 
1270 1271 EG11284 ECK0179 fabZ Y E Y 1 
1272 1273 EG11286 ECK3948 argE X N Y 4 
1274 1275 EG11288 ECK0389 mak Y N N - 
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1275 1276 EG11289 ECK2140 preA/yeiA Y N N - 
1278 1279 EG11292 ECK2997 yghA Y N N - 
1280 1281 EG11294 ECK1196 ispE Y E Y 1 
1284 1285 EG11298 ECK3236 yhdE Y N N - 
1285 1286 EG11299 ECK3235 rng Y N N - 
1292 1293 EG11306 ECK0621 lipA Y N N - 
1297 1298 EG11313 ECK3900 rhaT Y N N - 
1298 1299 EG11314 ECK1117 purB O E Y! 2 
1299 1300 EG11315 ECK3241 yhdH Y N N - 
1301 1302 EG11317 ECK1078 fabD Y E Y 1 
1302 1303 EG11318 ECK1079 fabG Y E Y 1 
1305 1306 EG11321 ECK0408 ribD Y E Y 1 
1306 1307 EG11322 ECK0409 ribE Y E Y 1 
1308 1309 EG11324 ECK2902 ubiH Y N N - 
1309 1310 EG11325 ECK1271 acnA Y N N - 
1310 1311 EG11326 ECK0334 codA Y N N - 
1313 1314 EG11329 ECK2655 gabD Y N N - 
1314 1315 EG11330 ECK2657 gabP Y N N - 
1315 1316 EG11331 ECK1272 ribA Y E Y 1 
1316 1317 EG11332 ECK2494 upp Y N N - 
1317 1318 EG11333 ECK2901 ubiI/visC Y N N - 
1319 1320 EG11335 ECK4382 nadR Y N N - 
1321 1322 EG11337 ECK2149 lysP Y N N - 
1323 1324 EG11339 ECK3621 waaG/rfaG Y N N - 
1324 1325 EG11340 ECK3620 waaP/rfaP Y N* N - 
1325 1326 EG11341 ECK3622 waaQ/rfaQ Y N N - 
1333 1334 EG11351 ECK3618 waaB/rfaB Y N N - 
1334 1335 EG11352 ECK3617 waaO/rfaI Y N N - 
1335 1336 EG11353 ECK3616 waaJ/rfaJ Y N N - 
1340 1341 EG11358 ECK3178 murA Y E Y 1 
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1349 1350 EG11368 ECK2256 menB Y N N - 
1350 1351 EG11369 ECK4031 ubiC Y N* N - 
1351 1352 EG11370 ECK4032 ubiA Y E Y 1 
1352 1353 EG11371 ECK2558 pgpC/yfhB Y N*  N - 
1353 1354 EG11372 ECK2557 tadA Y E Y 1 
1354 1355 EG11373 ECK2556 mltF/yfhD Y N N - 
1355 1356 EG11374 ECK0141 folK Y E Y 1 
1356 1357 EG11375 ECK2146 folE Y E Y 1 
1358 1359 EG11377 ECK3009 plsC Y E Y 1 
1360 1361 EG11379 ECK0970 appB Y N N - 
1361 1362 EG11380 ECK0969 appC Y N N - 
1372 1373 EG11392 ECK1174 nhaB Y N N - 
1376 1377 EG11396 ECK3835 ubiD Y E Y 1 
1381 1382 EG11402 ECK4234 treC Y N N - 
1384 1385 EG11405 ECK0878 cydD Y N N - 
1385 1386 EG11406 ECK1658 ribC Y E Y 1 
1386 1387 EG11407 ECK1177 dadA Y N N - 
1387 1388 EG11408 ECK1178 dadX Y N N - 
1388 1389 EG11409 ECK0906 lpxK Y E Y 1 
1395 1396 EG11417 ECK4233 nrdD Y N N - 
1396 1397 EG11418 ECK2059 dcd Y N N - 
1400 1401 EG11423 ECK3613 waaU/rfaK Y E Y 1 
1402 1403 EG11425 ECK3615 waaY/rfaY Y N* N - 
1403 1404 EG11426 ECK3614 waaZ/rfaZ Y N* N - 
1404 1405 EG11427 ECK2930 tktA Y N* N - 
1405 1406 EG11428 ECK3954 sthA Y N N - 
1410 1411 EG11433 ECK4215 msrA Y N N - 
1413 1414 EG11436 ECK4262 ahr/yjgB Y N* N - 
1417 1418 EG11440 ECK3273 def Y E Y 1 
1419 1420 EG11442 ECK2900 gcvT Y N N - 
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1420 1421 EG11443 ECK2910 rpiA Y N N - 
1421 1422 EG11444 ECK2913 scpA/yliK Y N N - 
1424 1425 EG11448 ECK4062 acs Y N N - 
1427 1428 EG11451 ECK3778 wecB/rffE Y N* N - 
1429 1430 EG11453 ECK3780 rffG Y N* N - 
1430 1431 EG11454 ECK3781 rffH Y N N - 
1432 1433 EG11456 ECK3783 wecE/rffA Y N N - 
1438 1439 EG11463 ECK3810 corA Y N N - 
1443 1444 EG11468 ECK3817 rhtC Y N* N - 
1445 1446 EG11470 ECK3820 yigL Y N*  N - 
1448 1449 EG11473 ECK3827 ubiE Y N* N - 
1454 1455 EG11485 ECK3842 hemG Y E Y 1 
1456 1457 EG11487 ECK1634 pdxH Y N N - 
1459 1460 EG11490 ECK1487 gadB Y N N - 
1461 1462 EG11492 ECK4043 qorA/qor Y N N - 
1462 1463 EG11493 ECK1082 pabC Y N N - 
1470 1471 EG11501 ECK4110 adiA Y N N - 
1473 1474 EG11504 ECK0197 metQ Y N N - 
1477 1478 EG11508 ECK1474 sra X N* Y 4 
1479 1480 EG11510 ECK2497 ppk Y N N - 
1481 1482 EG11512 ECK0010 satP/yaaH Y N N - 
1485 1486 EG11517 ECK3917 glpX Y N N - 
1495 1496 EG11528 ECK1283 fabI Y E Y 1 
1497 1498 EG11530 ECK1803 fadD Y N N - 
1499 1500 EG11532 ECK2255 menC Y N N - 
1506 1507 EG11539 ECK0170 pyrH O E Y! 2 
1507 1508 EG11540 ECK0995 wrbA Y N N - 
1508 1509 EG11541 ECK3741 kup/trkD Y N* N - 
1509 1510 EG11542 ECK0488 tesA Y N N - 
1510 1511 EG11543 ECK3989 hemE Y N N - 
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1513 1514 EG11546 ECK0108 nadC Y N N - 
1514 1515 EG11547 ECK1648 rnt Y N N - 
1517 1518 EG11551 ECK2707 hypF X N Y 4 
1519 1520 EG11553 ECK3165 glmM X N Y 4 
1522 1523 EG11556 ECK0008 talB Y N N - 
1533 1534 EG11568 ECK0047 kefF Y N N - 
1534 1535 EG11569 ECK0055 lptD/imp Y E Y 1 
1540 1541 EG11575 ECK0073 leuD O N N! - 
1541 1542 EG11576 ECK0074 leuC X N Y 4 
1542 1543 EG11577 ECK0075 leuB Y N* N - 
1547 1548 EG11583 ECK0500 gcl Y N N - 
1548 1549 EG11585 ECK3986 thiC Y N N - 
1549 1550 EG11586 ECK3985 thiE Y N N - 
1550 1551 EG11587 ECK3984 thiF Y N* N - 
1551 1552 EG11589 ECK3982 thiG Y N* N - 
1552 1553 EG11590 ECK3981 thiH Y N N - 
1553 1554 EG11591 ECK0623 lipB Y N N - 
1564 1565 EG11603 ECK3044 ygiF Y N N - 
1567 1568 EG11606 ECK1244 kch Y N N - 
1569 1570 EG11608 ECK1243 clsA/cls Y N N - 
1573 1574 EG11612 ECK4104 proP Y N N - 
1576 1577 EG11615 ECK4106 basR Y N N - 
1579 1580 EG11618 ECK2075 baeR Y N N - 
1581 1582 EG11620 ECK1281 rnb Y N N - 
1582 1583 EG11621 ECK0199 metN Y N N - 
1584 1585 EG11623 ECK2792 sdaB Y N N - 
1585 1586 EG11624 ECK0855 artP Y N N - 
1587 1588 EG11626 ECK0853 artQ Y N N - 
1588 1589 EG11627 ECK0852 artM Y N N - 
1589 1590 EG11628 ECK0851 artJ Y N N - 
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1590 1591 EG11629 ECK0845 potF Y N N - 
1591 1592 EG11630 ECK0846 potG Y N* N - 
1592 1593 EG11631 ECK0847 potH Y N N - 
1593 1594 EG11632 ECK0848 potI Y N N - 
1596 1597 EG11636 ECK1521 ydeA Y N N - 
1598 1599 EG11639 ECK1526 eamA Y N* N - 
1604 1605 EG11647 ECK0184 accA Y E Y 1 
1605 1606 EG11648 ECK0207 dkgB Y N N - 
1619 1620 EG11663 ECK3336 slyD Y N N - 
1625 1626 EG11669 ECK2214 atoD Y N N - 
1626 1627 EG11670 ECK2215 atoA Y N N - 
1628 1629 EG11672 ECK2217 atoB Y N N - 
1629 1630 EG11673 ECK3048 folB Y N N - 
1631 1632 EG11675 ECK0133 panB Y N N - 
1635 1636 EG11679 ECK2832 aas Y N N - 
1636 1637 EG11680 ECK3190 lptB/yhbG Y N N - 
1645 1646 EG11689 ECK3653 nepI/yicM Y N N - 
1648 1649 EG11692 ECK3656 adeD/ade X N Y 4 
1654 1655 EG11698 ECK0745 galM Y N N - 
1655 1656 EG11699 ECK0744 gpmA Y N N - 
1657 1658 EG11701 ECK2060 udk Y N N - 
1659 1660 EG11703 ECK0457 acrA Y N N - 
1660 1661 EG11704 ECK0456 acrB Y N N - 
1675 1676 EG11723 ECK3706 yieF Y N N - 
1687 1688 EG11735 ECK1009 efeB/ycdB Y N N - 
1688 1689 EG11736 ECK0200 gmhB Y N N - 
1689 1690 EG11737 ECK0198 metI Y N N - 
1697 1698 EG11746 ECK0132 panC Y N N - 
1702 1703 EG11751 ECK1895 otsA Y N N - 
1703 1704 EG11752 ECK1896 otsB Y N N - 
166 
 
1704 1705 EG11753 ECK1210 chaA Y N N - 
1705 1706 EG11754 ECK0072 setA Y N* N - 
1707 1708 EG11758 ECK4163 nnr/yjeF Y N N - 
1720 1721 EG11773 ECK2271 nuoM Y N N - 
1721 1722 EG11774 ECK2278 nuoF Y N N - 
1743 1744 EG11796 ECK4378 lplA Y N N - 
1744 1745 EG11797 ECK2459 talA Y N N - 
1756 1757 EG11809 ECK1850 purT Y N N - 
1757 1758 EG11810 ECK2898 gcvP Y N N - 
1758 1759 EG11811 ECK4183 aidB Y N* N - 
1762 1763 EG11816 ECK2741 ispF Y E Y 1 
1763 1764 EG11817 ECK2739 umpG/surE Y N N - 
1764 1765 EG11819 ECK1227 purU Y N N - 
1766 1767 EG11821 ECK0445 amtB Y N N - 
1767 1768 EG11822 ECK1296 puuB Y N N - 
1771 1772 EG11826 ECK0972 etk/yccC Y N N - 
1772 1773 EG11827 ECK4083 rpiB Y N N - 
1776 1777 EG11831 ECK3851 srkA/yihE Y N N - 
1780 1781 EG11836 ECK3860 hemN Y N N - 
1789 1790 EG11845 ECK3873 yihS Y N*  N - 
1791 1792 EG11847 ECK3875 yihU Y N N - 
1792 1793 EG11848 ECK3876 yihV Y N N - 
1794 1795 EG11850 ECK3878 yihX Y N*  N - 
1800 1801 EG11856 ECK3885 fdoI Y N N - 
1801 1802 EG11857 ECK3886 fdoH Y N N - 
1802 1803 EG11858 ECK3887 fdoG Y N N - 
1809 1810 EG11865 ECK3894 rhaM/yiiL Y N N - 
1810 1811 EG11866 ECK3895 rhaD Y u X 3 
1811 1812 EG11867 ECK3896 rhaA Y N*  N - 
1812 1813 EG11868 ECK3897 rhaB Y u X 3 
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1816 1817 EG11873 ECK3907 fieF Y N N - 
1823 1824 EG11880 ECK3922 menA Y N N - 
1839 1840 EG11896 ECK2008 plaP/yeeF Y N N - 
1844 1845 EG11902 ECK3935 yijE Y N* N - 
1846 1847 EG11904 ECK3937 gldA Y N* N - 
1860 1861 EG11919 ECK4012 yjbB Y N N - 
1875 1876 EG11934 ECK4047 aphA Y N N - 
1880 1881 EG11939 ECK4057 ghxP/yjcD Y N N - 
1896 1897 EG11956 ECK4077 alsK Y E Y 1 
1897 1898 EG11957 ECK4078 alsE Y N N - 
1898 1899 EG11958 ECK4079 alsC Y N N - 
1899 1900 EG11959 ECK4080 alsA Y N N - 
1900 1901 EG11961 ECK3593 lldP Y N N - 
1902 1903 EG11963 ECK3595 lldD Y N N - 
1909 1910 EG11971 ECK2388 nupC Y N N - 
1916 1917 EG11978 ECK2033 rfbA Y N N - 
1917 1918 EG11979 ECK2032 rfbC Y N N - 
1919 1920 EG11981 ECK2030 glf Y N N - 
1921 1922 EG11983 ECK2028 wbbI Y N* N - 
1956 1957 EG12026 ECK2147 yeiG Y N N - 
1960 1961 EG12030 ECK2155 rihB Y N N - 
1963 1964 EG12033 ECK2158 psuG/yeiN Y N N - 
1964 1965 EG12034 ECK2163 setB Y N N - 
1967 1968 EG12037 ECK2171 yejA Y N*  N - 
1968 1969 EG12038 ECK2172 yejB Y N N - 
1969 1970 EG12040 ECK2173 yejE Y N N - 
1970 1971 EG12041 ECK2174 yejF Y N N - 
1991 1992 EG12069 ECK2202 mqo Y N N - 
1994 1995 EG12075 ECK3460 nikA Y N N - 
1995 1996 EG12076 ECK3461 nikB Y N N - 
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1996 1997 EG12077 ECK3462 nikC Y N N - 
1997 1998 EG12078 ECK3463 nikD Y N N - 
1998 1999 EG12079 ECK3464 nikE Y N N - 
2001 2002 EG12082 ECK2282 nuoA Y N* N - 
2002 2003 EG12083 ECK2281 nuoB Y N N - 
2003 2004 EG12084 ECK2280 nuoC Y N N - 
2004 2005 EG12086 ECK2279 nuoE Y N N - 
2005 2006 EG12087 ECK2277 nuoG Y N* N - 
2006 2007 EG12088 ECK2276 nuoH Y N N - 
2007 2008 EG12089 ECK2275 nuoI Y N N - 
2008 2009 EG12090 ECK2274 nuoJ Y N N - 
2009 2010 EG12091 ECK2273 nuoK Y N N - 
2010 2011 EG12092 ECK2272 nuoL Y N N - 
2011 2012 EG12093 ECK2270 nuoN Y N N - 
2018 2019 EG12100 ECK2460 tktB Y N N - 
2020 2021 EG12102 ECK3396 feoB Y N N - 
2032 2033 EG12115 ECK4365 yjjG Y N N - 
2040 2041 EG12124 ECK2303 hisJ Y N N - 
2041 2042 EG12125 ECK2302 hisQ Y N N - 
2044 2045 EG12129 ECK2493 uraA Y N N - 
2049 2050 EG12134 ECK0802 rhtA Y N N - 
2056 2057 EG12142 ECK2791 sdaC Y N N - 
2058 2059 EG12144 ECK0676 pgm Y N N - 
2061 2062 EG12148 ECK2938 galP X N Y 4 
2064 2065 EG12152 ECK4261 idnK Y N N - 
2077 2078 EG12168 ECK0395 brnQ Y N N - 
2091 2092 EG12189 ECK2431 hemF Y N N - 
2094 2095 EG12192 ECK2611 nadK/yfjB Y E Y 1 
2110 2111 EG12210 ECK3610 waaF/rfaF Y N N - 
2115 2116 EG12215 ECK3453 zntA Y N N - 
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2120 2121 EG12221 ECK3459 acpT Y N N - 
2128 2129 EG12230 ECK3478 pitA Y N N - 
2130 2131 EG12232 ECK3481 dtpB/yhiP Y N N - 
2134 2135 EG12236 ECK3487 arsB Y N* N - 
2135 2136 EG12237 ECK3488 arsC Y N N - 
2142 2143 EG12245 ECK3504 treF Y N N - 
2149 2150 EG12253 ECK3511 kdgK Y N N - 
2162 2163 EG12267 ECK3533 eptB Y N N - 
2167 2168 EG12272 ECK3540 ghrB/tiaE Y N N - 
2170 2171 EG12275 ECK3556 xylG Y N N - 
2171 2172 EG12276 ECK3557 xylH Y N N - 
2174 2175 EG12279 ECK3564 yiaK Y N N - 
2179 2180 EG12284 ECK3569 lyxK Y N N - 
2180 2181 EG12285 ECK3570 sgbH Y N N - 
2181 2182 EG12286 ECK3571 sgbU Y N N - 
2182 2183 EG12287 ECK3572 sgbE Y N N - 
2187 2188 EG12292 ECK3577 aldB Y N* N - 
2188 2189 EG12293 ECK3578 yiaY Y N* N - 
2191 2192 EG12296 ECK3602 gpmM Y N N - 
2193 2194 EG12298 ECK3604 yibQ Y N*  N - 
2195 2196 EG12302 ECK1084 tmk X E N - 
2201 2202 EG12310 ECK2520 pepB Y N* N - 
2203 2204 EG12312 ECK0103 coaE Y N N - 
2207 2208 EG12316 ECK0117 acnB Y N N - 
2208 2209 EG12318 ECK0122 cueO Y N N - 
2209 2210 EG12319 ECK0125 can Y E Y 1 
2220 2221 EG12331 ECK0154 clcA Y N N - 
2234 2235 EG12345 ECK1532 ydfG Y N N - 
2235 2236 EG12347 ECK1916 tcyN/yecC Y N N - 
2236 2237 EG12352 ECK3767 ppiC Y N N - 
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2239 2240 EG12357 ECK1699 fadK/ydiD Y N* N - 
2240 2241 EG12358 ECK0924 ssuB Y N N - 
2243 2244 EG12361 ECK2840 kduD Y N N - 
2244 2245 EG12362 ECK2259 menF Y N* N - 
2250 2251 EG12368 ECK1860 znuB Y N N - 
2262 2263 EG12381 ECK2670 nrdF Y N N - 
2263 2264 EG12384 ECK0514 ybcF Y N N - 
2266 2267 EG12387 ECK2654 lhgD/ygaF Y N N - 
2269 2270 EG12392 ECK1194 dauA/ychM Y N N - 
2271 2272 EG12394 ECK1776 msrB/yeaA Y N N - 
2275 2276 EG12399 ECK1186 dhaM/dhaH Y N N - 
2285 2286 EG12410 ECK2462 nudK/yffH Y N N - 
2286 2287 EG12411 ECK2034 rfbD Y N N - 
2287 2288 EG12412 ECK2035 rfbB Y N N - 
2292 2293 EG12419 ECK2089 gatY Y N N - 
2296 2297 EG12424 ECK1200 prmC Y E Y 1 
2301 2302 EG12432 ECK1692 ydiF Y N N - 
2305 2306 EG12437 ECK2254 menE Y N N - 
2306 2307 EG12438 ECK2257 menH/yfbB Y N N - 
2308 2309 EG12440 ECK4228 mpl Y N N - 
2312 2313 EG12445 ECK2576 eamB/yfiK Y N N - 
2319 2320 EG12458 ECK4081 alsB Y N N - 
2321 2322 EG12469 ECK4124 dtpC/yjdL Y N N - 
2325 2326 EG12504 ECK4204 cycA Y N N - 
2330 2331 EG12525 ECK4237 mgtA Y N N - 
2337 2338 EG12563 ECK4312 gntP Y N N - 
2338 2339 EG12576 ECK4328 mdtM/yjiO Y N N - 
2340 2341 EG12591 ECK4349 opgB/mdoB Y N N - 
2341 2342 EG12600 ECK4386 yjjX Y N N - 
2343 2344 EG12606 ECK1081 fabF Y N N - 
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2351 2352 EG12625 ECK3530 dppB Y N N - 
2352 2353 EG12626 ECK3529 dppC Y N N - 
2353 2354 EG12627 ECK3528 dppD Y N N - 
2354 2355 EG12628 ECK3527 dppF Y N N - 
2355 2356 EG12629 ECK3422 gntK Y N N - 
2358 2359 EG12633 ECK3025 nudF X N Y 4 
2360 2361 EG12656 ECK3019 mdaB X N Y 4 
2363 2364 EG12661 ECK0647 gltJ Y N N - 
2364 2365 EG12662 ECK0646 gltK Y N N - 
2365 2366 EG12663 ECK0645 gltL Y N N - 
2366 2367 EG12666 ECK0517 lpxH Y E Y 1 
2372 2373 EG12693 ECK1811 nudL/yeaB X N Y 4 
2383 2384 EG12712 ECK2681 luxS Y N N - 
2384 2385 EG12713 ECK1467 yddG Y N* N - 
2385 2386 EG12715 ECK0172 dxr Y E Y 1 
2388 2389 EG12732 ECK3080 sstT Y N N - 
2389 2390 EG12734 ECK3082 uxaA Y N N - 
2390 2391 EG12738 ECK3084 exuT Y N N - 
2395 2396 EG12768 ECK3125 kbaY Y N N - 
2435 2436 EG12882 ECK2982 gss Y N N - 
2436 2437 EG12883 ECK2981 pitB Y N N - 
2440 2441 EG12957 ECK2384 glk Y N N - 
2442 2443 EG13159 ECK2400 xapB Y N N - 
2449 2450 EG13270 ECK0866 aqpZ Y N N - 
2451 2452 EG20044 ECK3513 dctA Y N N - 
2452 2453 EG20049 ECK3685 dgoA Y N* N - 
2456 2457 EG20091 ECK3598 gpsA Y E Y 1 
2457 2458 EG20098 ECK0124 hpt Y N* N - 
2458 2459 EG20110 ECK3338 kefB X N Y 4 
2459 2460 EG20173 ECK2291 pta Y N N - 
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2460 2461 EG20248 ECK4314 uxuB Y N N - 
2462 2463 EG20252 ECK3555 xylF Y N N - 
2464 2465 EG20257 ECK2669 nrdE X N Y 4 
2465 2466 EG50001 ECK3175 rplU X E N - 
2466 2467 EG50002 ECK3174 rpmA X E N - 
2470 2471 EG50006 ECK2436 eutB X N* Y 4 
2471 2472 EG50007 ECK2435 eutC Y N N - 
2473 2474 EG50009 ECK3502 gadA X N Y 4 
2474 2475 EG50010 ECK0353 frmA X N Y 4 
2475 2476 EG50011 ECK3166 folP X N* Y 4 
2488 2489 
G0-
10439 ECK0687 kdpF Y N* Y - 
2490 2491 
G0-
10441 ECK0723 cydX/ybgT X N Y 4 
2599 2600 G0-8601 ECK2972 glcF X N* Y 4 
2644 2645 G436 ECK3213 nanT X N* Y 4 
2646 2647 G58 ECK0453 maa X N Y 4 
2647 2648 G592 ECK1377 ldhA Y N N - 
2655 2656 G6092 ECK0173 uppS/ispU X E N - 
2657 2658 G6094 ECK0185 ldcC X N Y 4 
2659 2660 G6096 ECK0187 tilS Y E Y 1 
2662 2663 G6099 ECK0212 gloB X N Y 4 
2668 2669 G6105 ECK0222 fadE Y N N - 
2669 2670 G6106 ECK0223 gmhA/lpcA Y N N - 
2699 2700 G6136 ECK0263 mmuM Y N N - 
2703 2704 G6140 ECK0269 yagE X N Y 4 
2704 2705 G6141 ECK0270 yagF X N Y 4 
2749 2750 G6190 ECK0323 yahK Y N N - 
2755 2756 G6196 ECK0329 prpB Y N N - 
2756 2757 G6198 ECK0330 prpC Y N N - 
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2757 2758 G6199 ECK0331 prpD Y N N - 
2758 2759 G6200 ECK0332 prpE Y N N - 
2760 2761 G6205 ECK0349 mhpE Y N N - 
2763 2764 G6208 ECK0352 frmB Y N N - 
2785 2786 G6234 ECK0411 thiL Y E Y 1 
2787 2788 G6237 ECK0414 dxs Y E Y 1 
2788 2789 G6238 ECK0417 thiI Y N N - 
2789 2790 G6239 ECK0419 panE Y N N - 
2794 2795 G6244 ECK0437 fadM/ybaW Y N N - 
2796 2797 G6246 ECK0440 cof Y N N - 
2807 2808 G6260 ECK0478 copA X N Y 4 
2808 2809 G6261 ECK0479 glsA/ybaS X N Y 4 
2816 2817 G6269 ECK0487 ybbO X N Y 4 
2823 2824 G6277 ECK0501 hyi Y N N - 
2824 2825 G6278 ECK0502 glxR X N Y 4 
2826 2827 G6281 ECK0505 allB X N Y 4 
2828 2829 G6283 ECK0507 glxK Y N N - 
2829 2830 G6284 ECK0508 allE/ylbA Y N N - 
2830 2831 G6285 ECK0509 allC Y N N - 
2852 2853 G6310 ECK0546 rrrD/ybcS Y N N - 
2870 2871 G6329 ECK0594 ybdL Y N N - 
2884 2885 G6344 ECK0611 citC Y N* N - 
2890 2891 G6350 ECK0632 nadD Y E Y 1 
2898 2899 G6358 ECK0644 rihA Y N N - 
2899 2900 G6359 ECK0648 gltI Y N N - 
2904 2905 G6364 ECK0653 miaB Y N N - 
2905 2906 G6365 ECK0654 ubiF Y N N - 
2911 2912 G6378 ECK0698 dtpD/ybgH Y N N - 
2921 2922 G6393 ECK0741 zitB Y N N - 
2925 2926 G6397 ECK0756 pgl/ybhE Y N N - 
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2934 2935 G6406 ECK0778 clsB/ybhO Y N N - 
2952 2953 G6425 ECK0812 ybiV Y N N - 
2956 2957 G6429 ECK0819 gsiA/yliA Y N N - 
2957 2958 G6430 ECK0820 gsiB/yliB Y N N - 
2958 2959 G6431 ECK0821 gsiC/yliC Y N N - 
2959 2960 G6432 ECK0822 gsiD/yliD Y N N - 
2964 2965 G6437 ECK0827 yliI X N Y 4 
2966 2967 G6439 ECK0831 ybjG Y N N - 
2967 2968 G6440 ECK0832 mdfA/cmr X N Y 4 
2969 2970 G6442 ECK0834 ybjI Y N* N - 
2982 2983 G6455 ECK0861 ltaE Y N N - 
2985 2986 G6458 ECK0865 lysO/ybjE Y N N - 
2995 2996 G6468 ECK0896 ycaO Y N* N - 
3002 3003 G6475 ECK0918 gloC/ycbL Y N N - 
3003 3004 G6476 ECK0925 ssuC Y N* N - 
3004 3005 G6477 ECK0926 ssuD Y N N - 
3005 3006 G6478 ECK0927 ssuA X N* Y 4 
3006 3007 G6479 ECK0928 ssuE Y N N - 
3024 3025 G6497 ECK0954 mgsA X N Y 4 
3030 3031 G6503 ECK0973 etp Y N* N - 
3043 3044 G6517 ECK0997 rutG/ycdG X N Y 4 
3054 3055 G6530 ECK1013 pgaB/ycdR Y N N - 
3060 3061 G6539 ECK1019 ghrA/ycdW X N Y 4 
3072 3073 G6551 ECK1032 clsC/ymdC Y N N - 
3081 3082 G6561 ECK1054 murJ/mviN Y E Y 1 
3096 3097 G6576 ECK1105 nagK/ycfX Y N N - 
3100 3101 G6580 ECK1120 nudJ/ymfB Y N N - 
3141 3142 G6622 ECK1181 emtA X N Y 4 
3145 3146 G6626 ECK1187 dhaL Y N N - 
3146 3147 G6627 ECK1188 dhaK X N* Y 4 
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3162 3163 G6643 ECK1291 puuP X N* Y 4 
3163 3164 G6644 ECK1292 puuA X N* Y 4 
3164 3165 G6645 ECK1293 puuD Y N* N - 
3165 3166 G6646 ECK1297 puuE Y N N - 
3174 3175 G6655 ECK1312 ycjU X N Y 4 
3180 3181 G6661 ECK1321 ycjG X N* Y 4 
3181 3182 G6662 ECK1322 mpaA X N Y 4 
3184 3185 G6665 ECK1326 mppA Y N N - 
3217 3218 G6701 ECK1374 ydbK Y N N - 
3223 3224 G6708 ECK1384 paaZ/maoC X N Y 4 
3224 3225 G6709 ECK1385 paaA Y N N - 
3225 3226 G6710 ECK1386 paaB Y N N - 
3226 3227 G6711 ECK1387 paaC X N Y 4 
3228 3229 G6713 ECK1389 paaE Y N N - 
3229 3230 G6714 ECK1390 paaF Y N N - 
3230 3231 G6715 ECK1391 paaG X N Y 4 
3231 3232 G6716 ECK1392 paaH X N Y 4 
3232 3233 G6717 ECK1393 paaI X N Y 4 
3233 3234 G6718 ECK1394 paaJ X N Y 4 
3234 3235 G6719 ECK1395 paaK X N Y 4 
3244 3245 G6731 ECK1405 azoR X N Y 4 
3262 3263 G6755 ECK1438 patD/ydcW X N Y 4 
3266 3267 G6759 ECK1442 mnaT/yncA Y N N - 
3271 3272 G6764 ECK1447 ansP X N* Y 4 
3277 3278 G6770 ECK1457 nhoA X N Y 4 
3282 3283 G6775 ECK1472 adhP X N* Y 4 
3289 3290 G6782 ECK1482 ddpX X N Y 4 
3293 3294 G6786 ECK1486 gadC X N Y 4 
3305 3306 G6798 ECK1504 lsrK/ydeV X N* Y 4 
3307 3308 G6800 ECK1506 lsrA/ego X N Y 4 
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3308 3309 G6801 ECK1507 lsrC X N Y 4 
3309 3310 G6802 ECK1508 lsrD X N Y 4 
3310 3311 G6803 ECK1509 lsrB X N Y 4 
3311 3312 G6804 ECK1510 lsrF X N Y 4 
3312 3313 G6805 ECK1511 lsrG X N Y 4 
3317 3318 G6810 ECK1517 glsB/yneH X N Y 4 
3318 3319 G6811 ECK1518 sad/yneI X N Y 4 
3349 3350 G6842 ECK1579 speG X N Y 4 
3364 3365 G6857 ECK1594 mdtI X N Y 4 
3365 3366 G6858 ECK1595 mdtJ X N Y 4 
3366 3367 G6859 ECK1596 tqsA/ydgG X N Y 4 
3369 3370 G6862 ECK1601 folM X N Y 4 
3384 3385 G6877 ECK1630 dtpA/ydgR X N Y 4 
3386 3387 G6879 ECK1632 pdxY X N Y 4 
3393 3394 G6886 ECK1642 sodC X N Y 4 
3398 3399 G6891 ECK1647 gloA X N Y 4 
3413 3414 G6906 ECK1676 sufS X N Y 4 
3418 3419 G6912 ECK1683 menI/ydiI X N Y 4 
3424 3425 G6918 ECK1693 ydiO X N* Y 4 
3446 3447 G6940 ECK1742 astE X N Y 4 
3447 3448 G6941 ECK1743 astB X N Y 4 
3448 3449 G6942 ECK1744 astD X N Y 4 
3449 3450 G6943 ECK1745 astA X N Y 4 
3450 3451 G6944 ECK1746 astC X N Y 4 
3464 3465 G6958 ECK1769 ydjG X N Y 4 
3472 3473 G6967 ECK1779 yeaE X N Y 4 
3474 3475 G6969 ECK1781 yeaG X N Y 4 
3489 3490 G6984 ECK1796 leuE/yeaS X N Y 4 
3491 3492 G6986 ECK1798 dmlA/yeaU X N Y 4 
3504 3505 G6999 ECK1819 mntP/yebN X N Y 4 
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3510 3511 G7005 ECK1831 msrC/yebR X N* Y 4 
3516 3517 G7011 ECK1837 pphA X N* Y 4 
3522 3523 G7017 ECK1858 znuA X N* Y 4 
3523 3524 G7018 ECK1859 znuC X N Y 4 
3539 3540 G7037 ECK1917 tcyL/yecS X N Y 4 
3540 3541 G7038 ECK1918 dcyD/yedO X N* Y 4 
3541 3542 G7039 ECK1919 tcyJ/fliY X N Y 4 
3556 3557 G7055 ECK1963 hchA X N Y 4 
3590 3591 G7091 ECK2023 ugd X N Y 4 
3597 3598 G7098 ECK2041 wcaJ X N Y 4 
3604 3605 G7105 ECK2054 wzc X N Y 4 
3605 3606 G7106 ECK2055 wzb X N Y 4 
3606 3607 G7107 ECK2056 wza X N Y 4 
3620 3621 G7123 ECK2082 yegS X N Y 4 
3622 3623 G7128 ECK2088 gatZ X N Y 4 
3623 3624 G7129 ECK2090 fbaB X N* Y 4 
3629 3630 G7135 ECK2096 thiD X N Y 4 
3631 3632 G7138 ECK2099 rcnA/yohM X N Y 4 
3634 3635 G7145 ECK2139 preT/yeiT X N Y 4 
3635 3636 G7146 ECK2168 lpxT/yeiU X N*  Y 4 
3636 3637 G7147 ECK2169 mepS/spr X N Y 4 
3644 3645 G7158 ECK2238 yfaU X N Y 4 
3646 3647 G7160 ECK2240 rhmD/yfaW X N Y 4 
3650 3651 G7164 ECK2244 nudI/yfaO X N Y 4 
3652 3653 G7166 ECK2246 arnB/yfbE X N* Y 4 
3654 3655 G7168 ECK2248 arnA/yfbG X N Y 4 
3661 3662 G7175 ECK2262 rbn/elaC X N* Y 4 
3669 3670 G7184 ECK2284 alaA/yfbQ X N Y 4 
3670 3671 G7185 ECK2285 yfbR X N Y 4 
3672 3673 G7187 ECK2287 hxpA/yfbT X N Y 4 
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3680 3681 G7195 ECK2297 folX X N Y 4 
3697 3698 G7212 ECK2335 fadJ/yfcX X N Y 4 
3698 3699 G7213 ECK2336 fadI/yfcY X N Y 4 
3715 3716 G7230 ECK2355 yfdR X N Y 4 
3719 3720 G7234 ECK2367 yfdE X N Y 4 
3721 3722 G7236 ECK2369 oxc X N Y 4 
3722 3723 G7237 ECK2370 frc X N Y 4 
3726 3727 G7241 ECK2374 lpxP/ddg X N* Y 4 
3727 3728 G7242 ECK2375 alaC/yfdZ X N Y 4 
3738 3739 G7254 ECK2387 mntH X N Y 4 
3743 3744 G7259 ECK2413 pdxK X N Y 4 
3747 3748 G7263 ECK2423 murQ/yfeU X N Y 4 
3750 3751 G7266 ECK2426 yfeX X N* Y 4 
3772 3773 G7288 ECK2453 eutD/eutI X N Y 4 
3777 3778 G7293 ECK2458 maeB X N Y 4 
3807 3808 G7325 ECK2527 iscS X N*  Y 4 
3842 3843 G7365 ECK2626 rnlA/yfjN X N* Y 4 
3872 3873 G7399 ECK2664 alaE/ygaW X N* Y 4 
3878 3879 G7405 ECK2676 ygaZ X N Y 4 
3879 3880 G7406 ECK2677 ygaH X N* Y 4 
3882 3883 G7409 ECK2695 pncC/ygaD X N Y 4 
3883 3884 G7410 ECK2696 mltB X N Y 4 
3886 3887 G7415 ECK2729 pphB X N Y 4 
3893 3894 G7422 ECK2740 truD X N Y 4 
3894 3895 G7423 ECK2742 ispD X E N - 
3918 3919 G7449 ECK2785 truC/yqcB X N Y 4 
3923 3924 G7454 ECK2806 csdA X N Y 4 
3925 3926 G7456 ECK2808 tcdA/ygdL X N Y 4 
3926 3927 G7457 ECK2809 mltA X N Y 4 
3953 3954 G7485 ECK2862 xdhA X N Y 4 
179 
 
3954 3955 G7486 ECK2863 xdhB X N Y 4 
3955 3956 G7487 ECK2864 xdhC X N Y 4 
3969 3970 G7501 ECK2878 xanQ/ygfO X N Y 4 
3970 3971 G7502 ECK2879 guaD X N Y 4 
3971 3972 G7503 ECK2880 ghxQ/ygfQ X N* Y 4 
3974 3975 G7507 ECK2883 uacT/ygfU X N Y 4 
3975 3976 G7508 ECK2884 idi X N Y 4 
3983 3984 G7516 ECK2915 scpB/ygfG X N*  Y 4 
3984 3985 G7517 ECK2916 scpC/ygfH X N Y 4 
3996 3997 G7530 ECK2949 rdgB/yggV X N Y 4 
3999 4000 G7533 ECK2958 mltC X N Y 4 
4007 4008 G7542 ECK2969 glcA/yghK X N Y 4 
4009 4010 G7544 ECK2973 glcE X N* Y 4 
4010 4011 G7545 ECK2974 glcD X N Y 4 
4023 4024 G7558 ECK2995 gpr/yghZ X N Y 4 
4026 4027 G7564 ECK3003 yqhD X N Y 4 
4027 4028 G7565 ECK3004 dkgA X N Y 4 
4039 4040 G7579 ECK3023 cpdA X N Y 4 
4048 4049 G7590 ECK3042 hldE/rfaE X N Y 4 
4052 4053 G7596 ECK3063 patA/ygjG X N* Y 4 
4078 4079 G7624 ECK3101 tdcG X N* Y 4 
4083 4084 G7631 ECK3120 kbaZ X N Y 4 
4093 4094 G7641 ECK3134 rsmI/yraL X E N - 
4099 4100 G7647 ECK3141 yhbO X N Y 4 
4112 4113 G7662 ECK3186 kdsD X N Y 4 
4113 4114 G7663 ECK3187 kdsC X N Y 4 
4114 4115 G7664 ECK3188 lptC/yrbK X E N - 
4115 4116 G7665 ECK3189 lptA/yhbN X E N - 
4125 4126 G7676 ECK3211 nanK X N* Y 4 
4126 4127 G7677 ECK3212 nanE X N Y 4 
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4162 4163 G7716 ECK3334 fkpA X N Y 4 
4168 4169 G7723 ECK3359 frlB X N Y 4 
4169 4170 G7724 ECK3360 frlC X N* Y 4 
4170 4171 G7726 ECK3361 frlD X N Y 4 
4186 4187 G7742 ECK3386 yrfG X N* Y 4 
4222 4223 G7826 ECK4117 dcuR X N Y 4 
4228 4229 G7833 ECK4135 yjeH X N Y 4 
4231 4232 G7836 ECK4140 epmB/yjeK X N Y 4 
4237 4238 G7842 ECK4158 orn X E*  N - 
4252 4253 G7858 ECK4192 ulaD X N Y 4 
4253 4254 G7859 ECK4193 ulaE X N Y 4 
4254 4255 G7860 ECK4194 ulaF X N Y 4 
4259 4260 G7865 ECK4203 fklB X N* Y 4 
4262 4263 G7868 ECK4207 qorB/ytfG X N Y 4 
4280 4281 G7888 ECK4254 lptF/yjgP X E N - 
4281 4282 G7889 ECK4255 lptG/yjgQ X E*  N - 
4284 4285 G7892 ECK4259 idnO X N Y 4 
4285 4286 G7893 ECK4260 idnD X N Y 4 
4301 4302 G7910 ECK4286 yjhG X N Y 4 
4302 4303 G7911 ECK4287 yjhH X N* Y 4 
4311 4312 G7920 ECK4301 nanM/yjhT X N* Y 4 
4312 4313 G7921 ECK4302 nanC/yjhA X N* Y 4 
4337 4338 G7948 ECK4356 bglJ X N Y 4 
4344 4345 G7961 ECK1382 feaB X N* Y 4 
4346 4347 G812 ECK4232 nrdG X N Y 4 
4347 4348 G81 ECK3083 uxaC X N Y 4 
4355 4356 G8221 ECK3760 ilvG (pseudo) X N* Y 4 
4356 4357 G85 ECK2401 xapA X N Y 4 
4364 4365 M004 ECK3373 rpe X N Y 4 
4370 4371 M013 ECK0347 mhpD X N Y 4 
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4371 4372 M014 ECK0348 mhpF X N Y 4 
 
